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Introduction
As the life expectancy of human beings, and in particular women, is 
increasing, problems related to advancing age are becoming more important. 
As an increasing number of women wants to stay active and maintain their 
way of life, they expect their problems and inconveniences to be solved. 
Pelvic organ prolapse and overactive bladder syndrome are both major 
problems for aging women; the prevalence is associated with increasing age 
and can have a serious negative influence on their quality of life.(1,2)
Pelvic organ prolapse
Loss of support of uterus, bladder, colon or rectum can lead to a pelvic organ 
prolapse (POP) of one or more of these organs into or outside the vagina.(3) 
The localisation of POP can be described by the anterior, middle or posterior 
compartments, which consist of the bladder, the uterus or vaginal vault and 
the rectum, respectively. POP can be localized in one or more compartments. 
The only complaint specific for POP is vaginal bulging.(4) Patients may also 
have complaints and symptoms of micturition or defaecation, such as 
urgency, incontinence or frequency. These symptoms are not specifically 
related to POP stage and may also be related to other diseases.(5) Therefore, 
POP is a multidimensional disorder that demands a multidimensional 
approach for diagnosis and evaluation.(6)
Up to 50% of parous women have some degree of genital prolapse(1), 
although the prevalence of a symptomatic prolapse varies between 4% (in a 
Swedish study(7)) and 12% found on the basis of a questionnaire in a Dutch 
cross-sectional study.(8) The difference in the definition of the prolapse, 
anatomical versus symptomatic, partly explains the difference in percentage. 
The relationship between prolapse and symptoms is still not completely 
understood. In the normal population of women without symptoms of 
prolapse, signs of a prolapse during vaginal examination were present in a 
minority of the women,.(9,10) However, there are quite some women (35%) in 
the normal population without symptoms of a prolapse where a prolapse is 
found in a vaginal examination.(9)
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Various risk factors for prolapse have been described: vaginal child birth, 
POP during pregnancy, maternal history of POP, advancing age, white race, 
obesity, smoking, previous hysterectomy, chronic straining, heavy physical 
work, abnormalities in connective tissue or connective tissue repair. (8,11,12) It 
is therefore multifactorial in its etiology. A twin study found that 40% of the 
variability in prolapse is explained by heriditary factors and 40% by 
environmental factors.(13)
The POP-Q was introduced to document an anatomically found prolapse by 
vaginal examination. It is a systematic method to score the compartments at 
specific places. Therefore, several investigators have only slight differences 
in their description of the seriousness of the prolapse.(14)
Pelvic organ symptoms and quality of life have been evaluated with patient- 
reported questionnaires. There are several questionnaires available in the 
international literature. In the Netherlands, the Urogenital Distress Inventory 
(UDI), Defaecatory Distress Inventory (DDI) and Incontinence Impact 
Questionnaire (IIQ) are primarily used, as these contain disease-specific 
questions and the Dutch translation has been validated .(15,16) In these 
questionnaires patients record the presence or absence of various symptoms 
and, in case a symptom is present, they rate the amount of bother of the 
symptom on a 5 point Likert scale, from 0 (no complaints at all) to 4 (very 
serious complaints).(17)
POP is not only a problem in our today’s society. Uterine prolapse was one 
of the ailments described by Cleopatra, who prescribed an astringent solution 
as a vaginal treatment.(18) Hippocrates described succussion as treatment for 
a prolapse, where women went up and downwards for 3 to 5 minutes in an 
upside down position on a ladder-like frame. The shaking and gravity were 
supposed to see to it that the prolapsed organs would return to the normal 
position (Figure 1).(19)
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Figure 1. Succussion, a treatment for POP by 
Hypocrates.(20)
Luckily, over the centuries many other solutions have been developed to try 
to solve this problem: all kinds of pessaries and abdominal and vaginal 
surgery. In the US 80-90%, of prolapse surgeries are carried out vaginally.(21) 
For prolapse in the anterior and posterior compartment, the traditional 
operation was colporrhaphy; this is a technique to support the vagina by 
plicating the remnants of the vaginal fascia between bladder or rectum and 
vagina. For the middle compartment the traditional operation technique is a 
vaginal hysterectomy. In case the patient wants to preserve the uterus several 
techniques exist to strengthen the normal anatomical structures or to suspend 
the uterus to fixed ligaments or bony structures in the pelvis. Dependent on 
the technique , this surgery is performed vaginally or abdominally. 
Abdominal techniques are increasingly performed laparoscopically.
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Factors in making a choice of the type of prolapse surgery are the doctor’s 
preference and skills, the woman’s goals, the patient’s surgical history, 
strength of the surgery, safety of the surgery, individual risk factors for 
complications and chance of prolapse recurrence.(6)
At the moment, meshes are increasingly used to reduce the high failure rates. 
In this way collagen of lesser quality may be replaced by mesh material for 
better support. Meshes are available in biological and synthetic form and the 
efficacy of mesh increases with mesh strength and durability.(22) A 
systematic review concluded that any mesh was better than no mesh for 
preventing objective recurrence in anterior repair and in the combination of 
anterior and posterior repair.(22) However, mesh is associated with 
complications such as pain, dyspareunia, erosions, seromas and rejection.(22) 
Patients’ expectations after surgery are improvement of the pelvic floor 
problems, although in a part of the patients the problem returns or a new 
problem arises. This can lead to reoperation, which had a prevalence of 
nearly 30% in a cross sectional study of Olsen.(23) Clinical studies have 
found a percentage of reoperation of 12% after a first procedure and17% 
after a second procedure.(24,25)
Overactive bladder
An overactive bladder (OAB) is another prevalent problem associated with 
increasing age in both sexes and has an important impact on quality of life. 
This term refers to a lower urinary tract problem composed of several 
storage symptoms which together form the syndrome. OAB syndrome is 
defined by the ICS as urgency, with or without urge incontinence, usually 
with frequency and nocturia.(26) This term is only applicable in case there is 
no proven infection or obvious pathology such as bladder stones or 
tumours.(26) Urgency is defined as the complaint of a sudden compelling 
desire to pass urine which is difficult to defer, in which the patients have a 
fear of urine leakage.(27) Urge incontinence is the complaint of involuntary 
leakage accompanied by or immediately preceded by urgency.(27) Frequency 
is the complaint of voiding too often by day; defined as eight or more voids
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in 24 hours.(27) Nocturia is the complaint that the individual wakes one or 
more times at night to void.(27)
The overall prevalence of OAB symptoms in women varies between 17% 
and 49%, with an increase in the prevalence with age.(28,29)). The difference 
in definitions used in the studies, may partly explain the difference in the 
percentage. Temml has used the actual definition of OAB of ICS and found 
that 15% of the women aged 20-29 years reported having symptoms of 
OAB; this percentage increased to 21% for women older than 70 years.(2) 
Detrusor overactivity (DO) is defined by the ICS as a urodynamic 
observation characterised by involuntary detrusor contractions during the 
filling phase that may be spontaneous or provoked.(30) DO is usually 
considered to be related to OAB, but the relationship between both entities is 
still not clear. One large study found that the overlap between OAB and DO
was incomplete.(31)
Described risk factors for an OAB are increasing age, overweight/high body 
mass index (BMI), post-menopausal status, smoking, excessive use of coffee 
and previous stress incontinence surgery (SUI).(28,29,32-42)
As OAB can only be diagnosed in case there is no obvious other pathology, 
other causes for OAB symptoms should be precluded. The physician 
interview and a micturition diary with quantification of the fluid intake and 
voiding pattern, and the number of episodes with urgency and urge 
incontinence are a first step to identify OAB symptoms. To objectify these 
results, questionnaires are an important and useful tool for diagnosing OAB 
symptoms and the impact on the quality of life. Many questionnaires have 
been developed for the evaluation of urinary symptoms; the focus of various 
questionnaires differ. Most have not been translated and validated for the 
Dutch language. UDI(15) and IIQ(16) are validated and are therefore raised to 
a standard by the Dutch Pelvic Floor Society.
Furthermore, a urodynamic study may be helpful. Unfortunately, as not all 
women with OAB also have DO, OAB symptoms cannot always be 
objectified by urodynamic studies.(31) In 55% of the group of women with
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OAB complaints DO was found, while in the group of women where DO 
was found only 28% had OAB symptoms.(31)
There is a wide scope of treatment options for OAB symptoms. The first line 
of treatment for OAB are behavioural interventions, which consists of 
lifestyle modifications such as managing fluid intake, eliminating bladder 
irritants from the diet, weight control, managing bowel irregularity, smoking 
cessation and timed voiding regiments.(43) In addition, there are training 
techniques to improve the use of the pelvic floor muscles. Sometimes this 
supplements pharmacological treatment for OAB, such as antimuscarinics. 
Other treatment options are intravesical botulinum toxin injections, 
neuromodulation for stimulating the sacral nerves with electrical devices, 
posterior tibial nerve stimulation and surgical procedures such as bladder 
augmentation and urinary diversion.
Thesis: ‘Aspects o f  surgery fo r  Pelvic Organ Prolapse and its relationship 
to overactive bladder symptoms’
This thesis studies the outcome of surgery for POP from an anatomic and 
functional point of view and considers whether prolapse surgery can play a 
role in the treatment of OAB symptoms.
The prevalence and risk factors of prolapse and/or incontinence surgery in a 
Dutch population are presented. The measurement of the functional results is 
investigated by comparing the data of the physician interview versus patient 
self-assessment in patients who underwent pelvic organ surgery. The 
objective and functional results after two types of surgery for POP are 
studied.
The available evidence on the relationship between OAB and POP is 
summarised, the prevalence and risk factors for OAB symptoms are 
determined and finally the results and risk factors for OAB symptoms after 
surgery for POP are considered.
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The aims o f  this thesis are:
- to determine the prevalence and risk factors for undergoing POP 
and/or incontinence surgery
- to compare a physician interview with the self-assessment of the 
patient after surgery for POP
- to compare the objective/anatomical and functional results of 
vaginal hysterectomy and modified Manchester in POP surgery
- to study the effect o f porcine dermal implant Pelvicol® in 
POP surgery
- to provide an overview of the available studies on the combination 
of POP and OAB
- to determine the prevalence and risk factors of OAB symptoms in 
relation to POP symptoms
- to assess the predictors for OAB symptoms after POP surgery.
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Chapter 2
The prevalence and factors associated with 
previous surgery for pelvic organ prolapse 
and/or urinary incontinence in a cross 
sectional study in the Netherlands.
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Abstract
Objective: To estimate the prevalence and identify the factors associated 
with previous pelvic organ prolapse(POP) and/or incontinence surgery .
Study Design: In a cross-sectional study, all women, who were aged 45-85 
years and registered in eight general practices, were invited to participate. 
They completed standardised questionnaires (UDI and DDI) and answered 
questions on previous pelvic floor surgery.
Results: Out of 2979 women eligble for this study, 1380 women were 
included. Previous surgery was performed in 119 women. The prevalence of 
surgery increased with age, with a prevalence of 20.3% in the age group 76­
85 years. Pelvic floor symptoms were more prevalent in women who had 
undergone previous surgery, with higher UDI and DDI scores. Factors 
associated with previous surgery were age, higher BMI, POP symptoms 
during pregnancy and previous hernia surgery.
Conclusion: In the Netherlands, approximately one out of five women will 
undergo surgery for POP and/or incontinence during lifetime. The women 
who underwent surgery were more likely to have symptoms of pelvic floor 
dysfunction than those who did not undergo surgery
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Introduction
Pelvic organ prolapse (POP) is a considerable problem with a prevalence up 
to 50% in parous women.(1) In a recent Dutch study, POP symptoms were 
found in 11.5% of women.(2) Known risk factors for a POP include 
advancing age, white race, obesity, vaginal delivery, increased intra­
abdominal pressure, smoking, connective tissue disorders, previous 
hysterectomy, POP symptoms during pregnancy and having a mother with 
POP.(32)
Several studies have been published on the prevalence of POP and 
incontinence, but only three studies have investigated the epidemiology of 
surgery for these conditions.(4,5) Two studies demonstrated that 11% of the 
women had undergone surgery for POP and/or urinary incontinence by the 
age of 80,(4,5) but a recent Australian study found a 19% lifetime risk of 
undergoing surgery for POP.(6)
As we see a changing society with increasing numbers of surgical 
procedures(7) we decided to study the prevalence of POP and/or 
incontinence surgery as well as the possible risk factors in a cross-sectional 
study in a small homogenic city in the Netherlands. Furthermore, women 
with previous surgery were compared to those without surgery with regard to 
pelvic floor symptoms.
Materials and Methods
The study had a cross-sectional design and was performed in Brielle, which 
is a small city in the Netherlands. Brielle was chosen because of a 
homogenic population. All women aged 45 to 85 years registered on the 
patients lists of eight out of nine general practices were invited to participate 
in the study, which represents 95% of the women in this age group. The 
women received information about the study and they could participate 
after completion of the informed consent form. All women who agreed, 
were asked to complete a self-report questionnaire. Non-responders received 
a reminder eight week later that contained the same questionnaire. To check 
for selection bias, permanent non-responders were invited to complete a 
short questionnaire that comprised five questions on age, parity, presence of
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stress urinary incontinence (yes/no), faecal incontinence (yes/no) and feeling 
of vaginal bulging (yes/no). To encourage a high response to the 
questionnaire, we used envelopes with the name and logo of the Erasmus 
University, coloured paper and stamped addressed return envelopes.
Three options were possible: women refused to participate in the study, 
women filled out only the questionnaire and women filled out the 
questionnaire and underwent vaginal examination. For the purpose of this
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study data on vaginal examination were not used. The relationship between 
symptoms and signs of vaginal prolapse has been extensively described in an 
earlier study.(2) A flowchart of the study design is presented in Figure 1. For 
the present study all women who have returned the questionnaires were 
included.
The self-reported questionnaires used for this study are a composite of 
internationally well-known questionnaires that have been validated for the 
Dutch language. It contains, amongst others, disease-specific questions from 
the validated Dutch translation of the Urinary Distress Inventory (UDI-6)(8) 
and the Defaecatory Distress Inventory (DDI)(9). Women rated the bother of 
various symptoms on a 5 point Likert scale, from 0 (no bother at all) to 4 
(very serious bother). Scores on various domains are composed(10) on the 
basis of the womens Likert scale values and each domain scale ranged from 
0 (best quality of life) to 100 (worst quality of life). In addition, questions 
were asked on previous incontinence or prolapse surgery, ethnicity, parity, 
POP symptoms during pregnancy, family history, menopausal status, 
hormone replacement therapy (HRT), educational level, smoking and past 
and actual heavy physical work.
The Medical Ethics Research Committee (METC) of the Erasmus MC in 
Rotterdam, the Netherlands, approved to this study.
Measurements
For this study, all symptoms (OAB, vaginal bulging etc) were dichotomized 
as present or absent based on responses to each symptom and the degree of 
bother of these symptoms. Women who indicated no symptoms or a specific 
symptom, without any bother were considered as negative (absent), whilst 
women with any bother (little to very serious) were considered as positive 
(present). POP symptoms were defined as present in case of seeing and/or 
feeling vaginal bulging. Bladder retention was defined present in case of 
positive response to 'difficulty with bladder emptying’ and/or 'feeling that 
the bladder after micturition is not completely empty'.
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Data are presented as number of women (percentage) or mean (standard 
deviation) as appropriate. Chi-square test was used to compare the difference 
between women with and without previous POP/incontinence surgery and 
the independent t-test was used to compare the difference in the domain 
scores. Logistic regression was used for univariate and multivariate analysis. 
The backward elimination procedure was used. Variables with a P<0.05 in 
univariate analysis were included in the multivariate analysis; variables with 
more than 20% missings were excluded from the multivariate analysis. Odds 
Ratios (OR) and 95% Confidence Interval (CI) were presented for the factors 
associated with previous POP surgery. Nagelkerke R2 was used as a measure 
to describe the variance explained by the multivariate model. The level of 
significance was set at alpha of 0.05. All data were entered and analysed in a 
SPSS 15.0 database for Windows (SPSS, Inc., Chicago, IL).
Results
Out of the 2979 women eligble for this study, 1397 women completed the 
questionnaire. In the non-responder group 59% filled out and returned the 
short questionnaire (620/1051), resulting in a response rate of 62.7%.
(Figure 1) Scores in the short questionnaire group were not significantly 
different from those in the total study group. Details of the response rate 
were presented in a previous publication.(2)
Seventeen women were excluded , because the answers to the questions on 
previous POP/incontinence surgery were missing. The remaining 1380 
women were included in this study. A total of 119 women have undergone 
previous POP/ incontinence surgery. Table 1 shows the characteristics of the 
groups with and without previous POP/incontinence surgery.
Table 2 shows that the prevalence of POP/incontinence surgery increases 
with age, with a prevalence of 20.3% in the age group 76-85 years.
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Table 1 Characteristics of patients with and without previous POP and/or 
incontinence surgery____________________________________________
W ithout previous POP 
and/or incontinence
surgery**
Previous POP 
and/or incontinence
surgery**
P
Number of patients 1261 119
Age (years)a
45-55 617 (49.3%) 28 (24.3%) 0.000
56-65 397 (31.7%) 36 (31.3%)
66-75 186 (14.9%) 38 (33.0%)
76-85 51(4.1%) 13 (11.3%)
Body Mass Index (kg/m2) b
<20 45 (3.6%) 7(6.2%) 0.007
20-25 562 (45.5%) 33 (29.2%)
25-30 462 (37.4%) 51 (45.1%)
>=30 167 (13.5%) 22 (19.5%)
Race c
Caucasian 1229 (98.8%) 109 (96.5%) 0.066
Family history
Maternal history of POPd 317 (34.9%) 39 (56.5%) 0.000
Parity
0 114 (9.0%) 3 (2.5%) 0.041
1 194 (15.4%) 21 (17.6%)
2 613 (48.6%) 54 (45.4%)
>=3 340 (27.0%) 41 (34.5%)
Mode of delivery*
Caesarean section6 50 (4.6%) 5 (4.5%) 1.000
Forcepsf 48 (4.4%) 8 (7.2%) 0.229
Vacuum extraction8 77 (7.0%) 2 (1.8%) 0.040
Episiotomyh 629 (56.6%) 61 (55.5%) 0.764
Perineal teari 471 (43.1%) 45 (42.5%) 0.919
POP symptoms during
pregnancyJ 212 (17.4%) 58 (49.2%) 0.000
Heavy workk 254 (20.3%) 14 (12.3%) 0.048
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Former heavy workl 556 (44.3%) 57 (50.0%) 0.279
Smoking
Former smokingm 300 (24.1%) 22 (18.5%) 0.213
Smokingm 251 (20.1%) 27 (22.7%) 0.551
Postmenopausal statusn 891 (70.9%) 114 (96.6%) 0.000
Hormone suppletion therapyo 79 (6.3%) 9 (8.0%) 0.427
Pessary treatment
Pessary in the pastp 44 (3.5%) 42 (35.6%) 0.000
Actual pessaryq 15 (1.2%) 4 (3.4%) 0.076
Comorbidity
Pulmonary diseaser 103 (8.4%) 10 (8.9%) 0.859
Sneezing/Hay fever1 234 (18.9%) 31(26.7%) 0.050
Connective tissue disease1 9 (0.8%) 3 (2.7%) 0.076
Previous hernia surgeryu 83 (6.7%) 14 (12.4%) 0.035
Varicosesv 353 (29.3%) 41 (36.6%) 0.107
Previous gynaecological
surgery
Hysterectomy" 161 (12.8%) 70 (59.8%) 0.000
Data are presented as number of women (percentage); P = p value using Chi-square comparing 
women without and with previous POP surgery; * Women can be included in more than one 
category; ** For the missings we mentioned firstly the group without previous surgery and secondly 
the group with previous POP/incontinence surgery; a 10 respectively 4 women are missing; b 25 
respectively 5 women are missing; c 17 respectively 6 women are missing; d 352 respectively 50 
women are missing; e 159 respectively 8 women are missing. The women included in the category 
without previous POP and/or incontinence surgery consists of 13 women who had exclusively 
caesarean section and all other women had a combination of vaginal delivery with caesaran section. 
All women in the category with previous POP and/or incontinence surgery had combination of 
vaginal delivery and caesaran section. f160 respectively 8 women are missing g161 respectively 9 
women are missing; h 160 respectively 8 women are missing; i 169 respectively 13 women are 
missing; j 44 respectively 1 women are missing; k 9 respectively 5 women are missing; l 6 
respectively 5 women are missing; m 14 women in the group without previous surgery are missing; n 
5 respectively 1 women are missing; o 14 respectively 7 women are missing; p 15 respectively 1 
women are missing; q 10 women in the group without previous surgery are missing;r 34 respectively
7 women are missing; s 24 respectively 3 women are missing; 4 62 respectively 7 women are missing; 
u 31 respectively 6 women are missing; v 55 respectively 7 women are missing; w 3 respectively 2 
women are missing
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Table 2 Prevalence of POP and/or incontinence surgery per age category______________________________
Prolapse surgery1 Incontinence surgery13 Prolapse and/or incontinence
surgery1
A ge % O R % O R % O R
category (95%  Cl) (95% Cl) (95% Cl)
45-55 24 (3.7%) R e f 1 7 (2 .6 % ) Ref 28 (4.3%) Ref
56-65 28 (6.4%) 1.8 (1 ,0 ;3 .1) 22 (5.1%) 2.0 (1.0;3.8) 36 (8.3%) 1.9 (1.2;3.2)
66-15 35 (15.6%) 4.8 (2.8;8.3) 7  (3.1%) 1.2 (0.5;2.9) 38 (17.0%) 4.2 (2.5;7.2)
76-85 13 (19.7%) 6.3 (3 .1;1 3.2) 0 (0%) 0 ( 0 ) 13 (20.3%) 5.6 (2 ,7 ;11.5)
Data are presented as number of women (percentage) and OR (95% Cl)
4 27 women aremisang;*1 29 women are m issin g .c 31 women are missing.
u>
u>
Table 3 Bothersome pelvic floor symptoms in women with and without 
previous POP/incontinence surgery______________________________
Previous surgery No previous P
surgery
Frequencya 57 (49.6%) 326 (26.3%) 0.000
Urgencyb 64 (56.1%) 391 (32.2%) 0.000
Urge incontinencec 54 (46.2%) 348 (27.9%) 0.000
Stress incontinenced 52 (43.7%) 187 (15.0%) 0.000
Bladder retentione 64 (53.8%) 280 (22.2%) 0.000
Vaginal bulgingf 25 (21.2%) 95 (7.6%) 0.000
Data are presented as number of women (percentage)
P = p value using Chi-square comparing women with and without previous POP surgery 
a 42 women are missing; b 68 women are missing; c 32 women are missing; d 29 women are 
missing; e17 women are missing; f26 women are missing.
Bothersome symptoms of pelvic floor disorders in women with and without 
previous POP/incontinence surgery are presented in Table 3. All symptoms 
are more frequent in women with previous surgery compared with those 
without. Table 4 shows the domain scores on the various pelvic floor 
symptoms for women with and without previous surgery. Women who have 
undergone previous POP/incontinence surgery had significantly higher 
domainscores on all domains, indicating that they have more complaints 
than women without previous surgery.
In Table 5 the various possible risk factors for previous POP/incontinence 
surgery are presented as derived from the univariate and multivariate 
logistic regression model. An OR >1 indicates a factor which is positively 
correlated with the outcome variable; an OR<1 that the factor indicates a 
negatively correlated.
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Table 4 Domainscore on the several pelvic floor symptoms for women with and
without previous POP/incontinence surgery
Previous No previous P
POP/incontinence POP/incontinence
surgery* surgery*
UDI
Overactive bladder3 32.9 (28.4) 17.1 (21.2) 0.000
Incontinence0 29.0 (28.2) 20.0 (20.1) 0.001
Obstruction0 22.7 (23.3) 10.8 (16.9) 0.000
Paind 17.8 (23.2) 12.6 (18.1) 0.020
Genital prolapsee 13.1 (22.0) 5.7 (13.0) 0.001
DDI
Constipationf 17.3 (26.4) 9.3 (17.1) 0.002
Obstruction8 13.8 (18.6) 8.4 (14.4) 0.003
Painh 12.3 (21.1) 7.7 (16.3) 0.024
Incontinencei 13.3 (20.9) 5.9 (13.2) 0.000
Flatus1 28.4 (30.5) 16.3 (22.9) 0.000
Data are presented as mean (SD); P= p value using indepent t-test comparing domainscores on women 
with and without previous; POP/incontinence surgery; UDI Urogenital distress inventory; DDI 
Defaecation distress inventory; *For the missings we mentioned firstly the group with previous surgery 
and secondly the group without previous POP/incontinence surgery; a 11 respectively 97 women are 
missing; b 7 respectively 39 women are missing; c 6 respectively 42 women are missing; d 5 
respectively 40 women are missing; e 6 respectively 24 women are missing; f 5 respectively 33 women 
are missing; g 7 respectively 60 women are missing; h 4 respectively 32 women are missing; i 1 
respectively 18 women are missing; J 3 respectively 29 women are missing
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Table 5 Uni- and multivariate logistic regression analysis on women with 
previous POP/incontinence surgery versus without previous POP/incontinence 
surgery___________________________________________________________
Previous prolapse surgery*
Univariate Multivariate
analysis analysis
OR ( 95% CI) OR ( 95% CI)
Age (years)3 45-55 ref ref
56-65 2.0 (1.2;3.3) 2.1 (1.2;3.5)
66-75 4.5 (2.7;7.5) 4.6 (2.6;8.2)
76-85 5.6 (2.7;11.5) 6.3 (2.9;13.9)
Body Mass Index (kg/m2)b <25 ref ref
>25 1.8 (1.2;2.6) 1.6 (1.0;2.5)
Family history
Maternal history of POPc Yes 2.4 (1.5;4.0)
No ref
Parity Nullipara
ref
Para 3.8 (1.2;12.3)
Mode of delivery
Caesarean sectiond Yes 1.0 (0.4;2.5)
No ref
Forcepse Yes 1.7 (0.8;3.7)
No ref
Vacuum extractiond Yes 0.2 (0.1; 1.0)
No ref
Episiotomyg Yes 1.0 (0.6;1.4)
No ref
Perineal tearingh Yes 1.0 (0.7;1.5)
No ref
POP symptoms during
pregnancyi Yes 4.6 (3.1;6.8) 5.2 (3.4;8.1)
No ref ref
Former heavy workJ Yes 1.3 (0.9;1.8)
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No ref
Heavy workk Yes 0.6 (0.3;1.0)
No ref
Smoking
Former smokingl Yes 0.7 (0.4;1.2)
No ref
Smokingl Yes 1.2 (0.7;1.8)
No Ref
Comorbidity
Pulmonary diseasem Yes 1.1 (0.5;2.1)
No ref
Sneezing/Hay fevern Yes 1.6 (1.0;2.4)
No ref
Connective tissue diseaseo Yes 3.6 (1.0; 13.6)
No ref
Previous hernia surgeryp Yes 2.0 (1.1;3.6)
No ref
Varicosesq Yes 1.4 (0.9;2.1)
No ref
Previous hysterectomyr Yes 10.1 (6.8;15.2)
No ref
Variance explained by the
model1
2.2 (1.1;4.3) 
ref
18.2%
1 Nagelkerke R2; All values with p<0.05 are illustrated in bold; *For the missings we mention 
first the group without previous surgery and secondly the group with previous POP/incontinence 
surgery; a10 respectively 4 women are missing; b25 respectively 5 women are missing; c352 
respectively 50 women are missing; d159 respectively 8 women are missing; e160 respectively
8 women are missing; f161 respectively 9 women are missing; g160 respectively 8 women are 
missing; h169 respectively 13 women are missing; i 44 respectively 1 women are missing;j 9 
respectively 5 women are missing; k6 respectively 5 women are missing; l14 women in the 
group without previous surgery are missing; m 34 respectively 7 women are missing; n 24 
respectively 3 women are missing; o 62 respectively 7 women are missing; p 31 respectively 6 
women are missing; q 55 respectively 7 women are missing; r3 respectively 2 women are 
missing.
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Discussion
In this cross-sectional study, focused on the prevalence of POP/incontinence 
surgery, we found that the prevalence increased with age. The prevalence 
was 4.3% by the age of 45-55 years and increased up to 20.3% by the age of 
76-85 years. This prevalence is higher compared with the results from the 
studies by Olsen and Fialkow, who have found that women by the age of 80 
had an 11% risk of previous POP/incontinence surgery.(4,5) Our finding, 
however, is in agreement with the finding of a recent Australian study (2001­
2005), which has found that by the age of 85 years, 19% of the women had 
undergone a first-time procedure for prolapse. (6) Furtherwe found an 
increasing number of incontinence operations in the Netherlands between 
2000 and 2003 .(7) Possible explanations for this expansion of 
POP/incontinence surgery is the increasing number of aging women and the 
changing treatment seeking behaviour. It is also consistent with an American 
study which expected an increase by 155% of women with pelvic floor 
disorders or urinary incontinence problems in the near future.(11) As our 
definition was as broad as the definition of Olsen and Fialkow and included 
also the incontinence surgery, this might explain that the percentage is a bit 
higher than the percentage found in the Australian study.(4,5,6)
In addition the introduction of less invasive types of incontinence surgery 
(transvaginal tape and transobturator tape) may play a role.(7) Similar 
developments can be seen with regard to POP surgery. In the nearby future 
we expect a further increase of POP/incontinence surgery.
The methodology of our study differs from the studies by Olson and 
Fialkow(4,5). Both used the database of a large health maintenance 
organisation (Kaiser Permanente Northwest(5) and Group Health,Seatle 
WA(4), respectively), which contained health histories, medical records, 
demographics of the local population, whereas our study was a cross­
sectional study in one city. In addition, the health care system of the 
Netherlands is different from the health care system in the USA. All citizens 
in the Netherlands have obligatory health insurance coverage, which might 
influence the claim on the health care system in the Netherlands.
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There were, furthermore, differences in study population s between studies. 
In our study, the majority of women (96.6%) with previous surgery were 
postmenopausal versus 71.3% in the study of Olsen.(5) This can be explained 
by the differences in age between the populations in the studies.In our study 
group, less women were morbidly obese (BMI >30); 14.1% versus 31.3% in 
the Olsen study.(5) Since obesity has been identified as a risk factor for POP, 
a higher percentage of POP surgery would have be expected in the study by 
Olsen.(5) Obesity may, however, also be a contraindication for surgery, 
which might explain this phenomena. All other factors described were 
comparable.
Pelvic floor symptoms
A surprising finding was that women with previous POP/incontinence 
surgery (still) have significantly more pelvic floor symptoms compared with 
women without previous POP/incontinence surgery (Table 3). The following 
potential explanations came up::
First, the symptoms are a characteristic of the patient and independent of the 
previous surgery. For example overactive bladder symptoms such as 
urgency, frequency and urge incontinence caused by nerval damage might 
not improve after prolapse and/or incontinence surgery. However, various 
pelvic floor symptoms can be cured by surgery.
Secondly, it is possible that the surgery was not effective or not effective 
anymore. We found that the prevalence of vaginal bulging in the group 
without previous surgery was comparable to other population studies(12,13,14) 
whilst the prevalence within the operated group was significantly higher. 
From surgical studies it is well known that for instance the symptom of 
vaginal bulging is often resolved, at least within the follow-up period of the 
study which is usually one year or less. We have no information on the time 
span that passed since the previous surgeries, but it is highly unlikely that all 
women had surgery shortly before completion of the questionnaire.
Thirdly, the surgery may have induced the symptoms. For example, after 
POP/incontinence surgery, de novo OAB symptoms have been reported in 5-
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22% of cases.(15,16) De novo stress incontinence has been described in 15% of 
cases,(17) and bladder retention is a fairly common problem after POP 
surgery.(18)
The study design does not provide information on the relation between 
previous surgery and the presence of pelvic floor symptoms. It is, however, 
sobering to realize that, despite our surgical efforts, these women still have 
significant pelvic floor symptoms and the overall effects of surgery on the 
long term is probably only modest.
Risk factors
Higher body mass index (BMI), POP symptoms during pregnancy, older age 
and hernia surgery were positively associated with previous 
POP/incontinence surgery. Older age is a well known factor for development 
of POP. (3,19) We have, furthermore, found that POP symptoms during 
pregnancy were a risk factor for undergoing previous surgery. This factor 
has also been described as a risk factor for the presence of POP after
delivery.(2)
Although our population was less obese compared with the study of Olsen, 
we found, consistent with earlier findings, that higher BMI was a risk factor 
for previous surgery. (5) The BMI at the time of cross sectional study was 
used in this study, which disregards weight changes since the surgery.
Previous hysterectomy was not included as a risk factor for 
POP/incontinence surgery in our analysis, because there was a large overlap 
between previous hysterectomy and previous POP/incontinence surgery.
This indicates that a large number of hysterectomies may have been 
performed during POP surgery, which would have lead to an overestimation 
of the risk of POP surgery after hysterectomy. Other studes found a positive 
relationship between hysterectomy and POP.(19)
We were not able to draw conclusions on menopausal status as a risk factor, 
since we had no information on the women’s status at the time of surgery.
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Strengths and limitations
Strengths of this study were the large study population , and the use of 
validated questionnaires.
A limitation of this study might be the homogenous population of mainly 
Caucasian women. Since white race has been recognized as a risk factor for 
POP, our conclusions may not be extrapolated to other ethnic groups or 
other, more mixed, populations. The methodology of this study, a cross­
sectional study based on questionnaires, may have induced recall bias, since 
the questionnaire asks for events in the past, such as maternal history of 
POP. Another limitation was that we did not study the re-operation rate, 
which is in contrast with the earlier studies by Olsen and Fialkow and 
remains an important topic.
Conclusion
By the age of 76-85 years, one out of five women had undergone surgery for 
POP and/or incontinence in the present study. Women with previous 
POP/incontinence surgery experienced (still) more pelvic floor symptoms 
compared with women who never had an operation. Risk factors for 
previous surgery were older age, higher BMI, POP symptoms during 
pregnancy and previous hernia surgery.
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Chapter 3
Discrepancies between physician interview 
and a patient self-assessment questionnaire 
after surgery for Pelvic Organ Prolapse.
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Abstract
Objective: To investigate whether there were discrepancies between the 
physician interview and a patients self-assessment questionnaire on the 
functional results after surgery for pelvic organ prolapse (POP).
Methods: Before their follow-up appointment 79 patients were sent a 
urogynaecological questionnaire. At the follow-up visit, the physician 
interviewed the patients using a checklist with ten symptoms and scored the 
items as present or absent.
Results: 72 patients (91.1%) attended the follow-up visit and had completed 
the questionnaire. There was poor to slight agreement between the interview 
score and the self-reported responses to the questionnaire on nearly all items. 
This was illustrated by low Kappa coefficients.
Conclusion: The physician was more optimistic about the outcome of the 
operation than was justified according to the answers to a patient self­
assessment questionnaire. We therefore recommend the use of validated 
self-assessment questionnaires to evaluate surgical outcome, because they 
provide a more realistic (objective) view of the functional results.
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Introduction
It is essential to evaluate quality of life and the functional results after 
prolapse surgery.1 Traditionally, the physician evaluates the outcome by 
interviewing and examining the patient. In clinical studies, these data are 
often obtained by a (self-report) questionnaire.
Several studies showed discrepancies in the interpretation of surgical 
outcome between the physician and the patient.2 Physicians tended to 
underestimate the degree of bother in 25-37% of the patients.1 
The rating of the severity of the complaints of incontinence before treatment 
gives contradictory results between patient and physician. 3, 4 
Although the above-mentioned aspects have been studied in relation with 
various surgical interventions, no data are available on the outcome of 
Pelvic Organ Prolapse (POP) surgery. As POP surgery is an important and 
growing field of interest, we investigated whether there were discrepancies 
between the interview recorded by the physician and the answers to a 
patient self-assessment questionnaire on the functional results after POP 
surgery.
Materials and methods
Several weeks before the one year follow- appointment, the standard 
urogynecological questionnaire (proposed by the Pelvic Floor Committee of 
the Dutch Gynaecological Society) was sent to all the patients who had 
undergone vaginal repair POP surgery with porcine denatured dermal 
collagen (Pelvicol®) between December 2003 and August 2005. Details of 
the study population and procedures are presented in table 1.
The patient self-assessment questionnaire contained questions on general 
quality of life and health, derived from the Dutch version of the Euroqol 
5D,5 disease-specific questions from the validated Dutch translation of the 
Incontinence Impact Questionnaire (IIQ) and Urogenital Distress Inventory 
(UDI) 6 and questions from the Defaecatory Distress Inventory (DDI).7 If a 
specific symptom was present, the patient was asked to rate the amount of 
bother it was causing her on a 4 point Likert scale. The complete Dutch
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language standardized version of this questionnaire has been validated.8 In 
addition, two questions were included about urinary symptoms, derived from 
the Patient Global Impression of Improvement scale.9
At the one year follow-up visit, all the patients were interviewed by the same 
surgeon who had performed the surgery, using a checklist with ten 
symptoms (Table 2). Items were scored as present or absent. The physician 
was unaware of the patient self-assessment responses to the questionnaire.
Table 1 Patient characteristics
N
Age (years) median and range 72 66.6 [37;87]
Parity median and range 72 2 [0;9]
Recurrence 47 65.3%
Degree of prolapse (Baden Walker)
Grade 2 3 4.2%
Grade 3 64 88.9%
Grade 4 5 6.9%
Use of Pelvicol®
Anterior 21 29.2%
Posterior 35 48.6%
Anterior and posterior 16 22.2%
The data obtained with the interviews and the questionnaire were entered 
into an SPSS 13.0 database. Statistical analyses were performed using 
Cohen’s kappa coefficient, which is a statistical measure of inter-rater 
agreement. Kappa takes into account the agreement that occurs by chance. 
When raters are in complete agreement, kappa is one. If there is no 
agreement, other than that expected by chance, then kappa is zero. Also the 
95% confidence interval for Kappa is calculated. For the statistical analyses 
were used SPSS 13.0 and SAS version 8.2.
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Results
A total of 79 patients were sent the questionnaire and invited for a one year 
follow-up visit. Interview and questionnaire data were available for analysis 
in 72 patients (response rate: 91.1%). Reasons for not attending were illness, 
living in a foreign country and one patient had died from another illness.
Table 2 Inter-rater discrepancies between the physician and the patient___________
Physician No Physician Yes
Patient No Patient Yes Patient No Patient Yes
Urinary stress incontinence 
Urinary urge
Urinary Urge incontinence
Frequency micturition
Nocturia
Urinary retention
Constipation
Urge for defaecation
Faecal evacuation
difficulties
Flatal incontinence
N % N %
35 50.0% 20 28.6%
24 34.3% 27 38.6%
30 42.3% 27 38.0%
35 52.2% 28 41.8%
10 14.7% 4 5.9%
36 50.7% 25 35.2%
47 73.4% 3 4.7%
33 48.5% 31 45.6%
54 80.6% 7 10.4%
21 32.4% 28 43.1%
N % N %
2 2.9% 13 18.6%
6 8.6% 13 18.6%
1 1.4% 13 18.3%
1 1.5% 3 4.5%
21 30.9% 33 48.5%
4 5.6% 6 8.5%
11 17.2% 3 4.7%
2 2.9% 2 2.9%
2 3.0% 4 6.0%
1 1.5% 15 23.1%
Mean age of the participants was 66.6 years (range 37;87); 65.3% had 
undergone surgery because of recurrent prolapse. Table 2 shows the 
differences in ratings on ten items between the interview scores recorded by 
physician and the patient self-assessments on the questionnaire. The results 
of the analysis are shown in table 3. We found bidirectional differences in 
opinion between the physician and the patient: there was underestimation on 
8 items and overestimation on 2 items. The low Kappa coefficients on all 
items illustrated poor to slight agreement between the patients and the 
physician. Table 4 shows the amount of bother reported by patients in the 
group whose complaints were underestimated by the physician.
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Table 5 shows the responses to the Patient Global Impression of 
Improvement scale question about urinary tract functioning before and after 
the operation in the group of patients whose
complaints were underestimated by the physician. Most of the patients 
reported improvement in their symptoms after the operation.
Table 3 Analysis of inter-rater discrepancies between the physician and the patient
P
N Missing Discordance Kappa 95% CI Kappa Kappa
Urinary stress incontinence 70 2 22 0.350 0.161 0.540 0.001
Urinary urge 70 2 33 0.115 -0.074 0.304 0.244
Urinary urge incontinence 71 1 28 0.268 0.111 0.424 0.002
Frequency micturition 67 5 29 0.073 -0.052 0.199 0.235
Nocturia 68 4 25 0.224 0.023 0.426 0.029
Urinary retention 71 1 29 0.101 -0.080 0.282 0.261
Constipation 64 7 14 0.194 -0.078 0.466 0.080
Urge for defaecation 68 4 33 0.004 -0.111 0.118 0.952
Faecal evacuation 0.090 0.712
difficulties 67 6 9 0.401 0.000
Flatal incontinence 65 7 29 0.233 0.085 0.382 0.007
Table 4 Amount of bother reported by the patients in the physician no/patient
yes group whose complaints were underestimated by the physician_________
Moderate to severe 
Little or no bother bother
N % N %
Urinary stress incontinence 16 80.0% 4 20.0%
Urinary urge 17 63.0% 10 37.0%
Urinary urge incontinence 22 81.5% 5 18.5%
Frequency micturition 15 53.6% 13 46.4%
Nocturia 2 50.0% 2 50.0%
Urinary retention 23 92.0% 2 8.0%
Constipation 1 33.3% 2 66.7%
Urge for defaecation 20 64.5% 11 35.5%
Faecal evacuation difficulties 6 85.7% 1 14.3%
Flatal incontinence 21 75.0% 7 25.0%
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Discussion
There were large discrepancies in the judgements of functional outcome 
between the physician-based interview data and the self-report answers to 
the questionnaire given by the patients. This is best illustrated by the low 
Kappa coefficients. The physician showed a strong tendency to 
underestimate the complaints of the patients. This phenomenon is well- 
known in gynaecological follow-up studies and in other fields of medicine.
1,2,4,10,11
There are several possible explanations for the differences in judgement 
between the physician and the patients.
First, the complaints may be relatively slight and therefore not mentioned by 
the patient in the interview. In this study, this was valid in a considerable 
proportion of the patients. Table 4 shows that roughly 2/3 of the patients 
who had a positive score on a specific complaint on the questionnaire versus 
a negative score from the physician (physician no/patient yes group) had 
slight to moderate complaints reported in the questionnaire. The severity of 
the complaints are not measured by the physician.
We see that on a few topics slightly more missing data are found, which 
might indicate that some patients had problems with understanding these 
questions. Because we only used questions from validated questionnaires, 
.misinterpretation of the questions by the patients is unlikely to be an 
explanation, The semantics of the questions asked by physician were not 
monitored and could be an important factor. A question might be formulated 
slightly differently by the physician than in the questionnaire. If the 
physician asks the patient about a complaint, he might say: “Do you ever 
have complaints about...?”, while the questionnaire formulates the same 
question as: “Do you ever have the following symptoms?” In this way, the 
physician will hear about the patient’s complaints, whereas the questionnaire 
scores the symptoms.
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Table 5 Average improvement in urinary symptoms compared to before the 
operation according to Patients Global Impression of Improvement scale in
the physician no/patient yes group___________________________________
Better Unchanged or worse
N %  N %
Urinary stress incontinence 13 65.0 7 35.0
Urinary urge 19 73.1 7 26.9
Urinary urge incontinence 19 70.4 8 29.6
Frequency micturition 20 74.1 7 25.9
Nocturia 4 100 0 0
Urinary retention_____________ 18_______ 72.0________7________28.0
Another possible explanation is what we call the "waiter effect". In general, 
people are reluctant to complain after a meal, even when it was 
unsatisfactory, because they consider this to be impolite. Along these lines 
Hall12 reported that a patient may believe that being liked is one way to 
ensure prompt, conscientious, thorough and considerate care. Being a good 
patient is motivated by the desire to obtain good will by minimizing the 
burden placed on health care providers, so that care would be forthcoming 
when it was really needed. 12,13,14
Another explanation is that a specific symptom has improved, which 
suppresses its importance during the interview, although the symptom is 
still present. We compared the surgical outcome to the original situation 
using a question from the Patient Global Impression of Improvement scale. 
Table 5 shows that the physician no/patient yes group (table 4) had an 
average improvement of 72.1% compared to before the operation. 
Symptoms may have changed in the time between filling in the 
questionnaire at home and being interviewed by the physician. Although we 
did not record this time specifically, it is unlikely to be an important factor, 
because the questionnaires were sent to the patients only a few weeks before 
their visit to the outpatient department.
Physicians tend to overestimate their own surgical results.15 If an 
independent physician had interviewed the patients, the results might have
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been different. However, this would have been contrary to normal clinical 
practice.
Distress and embarrassment during the interview could lead to denial of 
symptoms in order to escape awkward situations. However, our patients 
knew their physician well, so there was less likelihood of hesitance. In the 
literature, conflicting information is given about how embarrassment 
influenced the results.16,17
Conclusion
The physician was more optimistic about the outcome of the operation than 
was justified according to the answers to the patient self-assessment 
questionnaire. We therefore recommended the use of validated self­
assessment questionnaires in clinical studies and to evaluate surgical 
outcome, because they help to obtain a more realistic view of the functional 
results.
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Chapter 4
The effectiveness of surgical correction of 
uterine prolapse: Cervical amputation with 
uterosacral ligament plication (Modified 
Manchester) versus vaginal hysterectomy 
with high uterosacral ligament plication.
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Abstract
Objective: To evaluate cervical amputation with uterosacral ligament 
plication (modified Manchester) and compare it to vaginal hysterectomy 
with high uterosacral ligament plication procedure (vaginal hysterectomy) 
with special regard to the middle compartment.
Methods: Consecutive women with pelvic organ prolapse who underwent 
either vaginal hysterectomy or a modified Manchester procedure were 
included. Assessments were made preoperatively and at one year follow-up, 
including physical examination with POP-Q, standardised questionnaires 
(IIQ, UDI and DDI).
Results: Between 2002-2007, 156 patients, were included. Ninety-eight 
patients returned for a one year follow-up. In the modified Manchester 
group we found no middle compartment recurrence versus two (4%) in the 
vaginal hysterectomy group. Anterior and posterior compartment prolapse 
recurrences (stage>2) were similar (approximately 50%). Considering 
operating time and blood loss, modified Manchester was more favourable. 
There was no difference in the pre and postoperative subjective scores. The 
overall functional outcome was acceptable.
Conclusion: We found an excellent performance of both procedures 
regarding middle compartment recurrences.
58
Introduction
Pelvic floor dysfunction is a major health issue in elderly women.
Prevalence rates of pelvic organ prolapse (POP) increase with age. The 
lifetime risk of undergoing at least one operation for POP or incontinence by 
the age of 80 years is 11%. One third of all operated women will undergo 
repeat surgery for recurrent POP.(1)
Whether or not to preserve the prolapsed uterus is still a matter of debate.(2-4) 
Furthermore in recent years more emphasis on the uterosacral ligaments as 
the most prominent structures to prevent uterine or middle compartment 
descensus has emerged.(5) Therefore it appeared logical to use techniques 
which incorporate these ligaments in the restoration of the middle 
compartment. Cervical amputation is part of the classical Manchester 
procedure, a surgical procedure for the correction of a prolapsed uterus. In 
this classical procedure the cardinal ligaments are transposed from its lateral 
position to an anterior position.(6-8)
In the last decennium we have modified the Manchester procedure in such a 
way that more benefit is achieved from the uterosacral ligaments. In the 
present study, we have evaluated this modified Manchester procedure with 
uterine preservation in comparison to vaginal hysterectomy with high 
uterosacral plication with special regard to the middle compartment.
Materials and methods
Procedures.
Cervical amputation with uterosacral ligament plication:
In case of concomitant anterior colporrhaphy, this procedure is performed 
first. The colporrhaphy is started with hydrodissection with 20-30 cc of 
normal saline followed by a vaginal midline incision from the urethrovesical 
junction till the fold of the bladder at the cervix. The cervix is circumcised. 
The bladder is then dissected from the cervix over 2-3 centimetres. The 
peritoneal cavity is not opened. The dissection of the bladder from the 
vagina is performed sharply with either scissors or knife. The bladder is 
subsequently plicated with a number, usually five or six, interrupted sutures
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Vicryl 2-0. In order to prevent an anterior enterocele, the most proximal 
plicating suture incorporates the cervix cranial to the level of subsequent 
cervical amputation. After removal of excessive vaginal epithelium, the 
vagina is closed with a continuous non-locking Vicryl 2-0 stitch.
Figure 1.
a. Schematic diagram to illustrate the modified Sturmdorf suture on the 
posterior side after the amputation of the cervix.
The suture starts at the left uterosacral ligament about 1 % cm from the 
amputated cervix (1). With a deep bite through the cervix it comes out close 
to the cervical canal (2). It then takes a superficial double bite through the 
posterior vaginal wall (3&4) after which another deep bite through the cervix 
starting in or close to the cervical canal (5) comes out in the right uterosacral 
ligament around 1 % cm from the amputated cervix(6).
b. After tying this suture the two uterosacral ligaments (1&6) are united in 
the midline which shortens the uterosacral ligaments and thus elevates the 
uterus. It also partially closes the pouch of Douglas and thus has a preventive 
effect on the development of an enterocele. Posteriorly the raw amputated 
surface of the cervix is now covered with vaginal epithelium (3&4).
■.uterosacral ligament
b
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In case the procedure is not combined with an anterior colporrhaphy the 
cervix is simply circumcised and the bladder is dissected from the cervix 
over 2 to 3 centimetres.
The next step is to identify the uterosacral ligaments by palpating them at the 
lateral posterior side of the cervix. The uterosacral ligaments are marked 
with an Allis clamp on both sides. The cervix is now amputated over 1 to 2.5 
centimetres depending on the amount of cervical elongation. The vaginal 
epithelium of the cervix is dissected from the cervix over 0.5 centimetres in 
order to get a better application of the epithelium to the amputated cervix 
after suturing. Haemostasis of the cervix and vaginal wall is achieved by 
cauterization.
Plication of the uterosacral ligaments is now performed by a deep Sturmdorf 
Vicryl 1 suture. This suture was originally used to re-epithelialise the cervix 
after a conisation We modified it in such a way that the uterosacral ligaments 
are incorporated (Figure 1). It starts with a deep bite at the left, still 
clamped, uteroscacral ligament, running to or close to the cervical ostium. 
The vaginal epithelium of the posterior vaginal wall is grasped in the same 
stitch in the midline in one or two bites and on the patient’s right side the 
same deep stitch runs from the cervical ostium through the clamped 
uterosacral ligament on the right side. Before tying this suture the anterior 
side of the cervix is re-epithelialised with either a very superficial Sturmdorf 
suture or simple interruptured Vicryl 2-0 sutures. In contrast with the 
original Manchester procedure, the ligaments are not cut and transposed, but 
they are transposed merely by plication with the Sturmdorf stitch.
Knot-tying of the deep posterior Sturmdorf suture on the posterior side of the 
cervix now elevates the cervix, because it shortens the uterosacral ligaments 
and prevents the development of a posterior enterocele. After this procedure 
it is checked that the cervical canal is still open and easily accessible. 
Posterior colporrhaphy is then performed with use of midline fascial 
plication if deemed necessary.
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Vaginal hysterectomy with high uterosacral ligament plication.
In case of additional anterior colporrhaphy, this procedure is performed 
before or after the vaginal hysterectomy at the discretion of the surgeon.
The cervix is grasped with a tenaculum forceps and circumcised. The 
bladder is dissected and the anterior peritoneum is opened. Posteriorly, a 
similar procedure is performed and the pouch of Douglas is opened. Now the 
uterosacral ligaments are palpated and grasped with a forceps and cut and 
ligated with a Vicryl 2-0 suture which is left long. The uterus is removed in 
several steps with clamps and ligatures of Vicryl 1. After removal of the 
uterus the adnexa are inspected. The patient is placed in deep Trendelenburg 
position. A wetted gauze with a securing suture is introduced in the 
peritoneal cavity and a high purse string suture monocryl 0 is started on the 
left side with a deep bite through the uterosacral ligaments usually about 2 
to 3 centimetres proximally from the previous attachment to the cervix and 
close to the level of the ischial spine. Identification of the uterosacral 
ligaments is facilitated by firm traction on the sutures through the ligament 
which had been left long. Care is taken to avoid the ureters. The purse string 
is now proceeding clockwise to the middle of the posterior vaginal wall 
which is taken in full thickness. Thus, this monocryl suture runs through the 
peritoneum in to the vaginal cavity and back into the peritoneal cavity. The 
purse string is continued with a similar deep bite on the uterosacral ligament 
on the right side and anteriorly only superficial peritoneum of the vesico­
uterine fold is incorporated. With the closure of this purse string suture, the 
posterior vaginal wall is elevated to the level of the deep bites in the 
uterosacral ligaments. Adaptation of the vaginal epithelium is performed 
with Vicryl 2-0 interrupted sutures.
Posterior colporrhaphy is performed if deemed necessary with use of 
midline fascial plication. Our group has a very restrictive policy for 
concomitant anti-incontinence surgery and these combined operations were 
not present in this case series. In both operations a vaginal pack (for 12-24 
hours) and a catheter (for 24-48 hours) are inserted after the procedure. The
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procedures are performed under antibiotic prophylaxis coverage with 
metronidazole and cefazolin Cystoscopy was not performed.
Patients
The study groups consist of consecutive women who underwent either 
vaginal hysterectomy with high uterosacral ligament plication or cervical 
amputation with uterosacral plication in the years 2002-2007 in three large 
teaching hospitals in the Netherlands (Radboud University Nijmegen 
Medical Centre, Erasmus University Medical Centre and Reinier de Graaf 
Group Delft). The choice for the type of surgery was made in mutual 
agreement between physician and patient. All women underwent 
preoperative cytology of the cervix and ultrasound screening of the uterus 
and adnexa to exclude abnormalities. All women underwent a full 
gynaecological examination including the POP-Q quantification score(9) and 
were invited for a postoperative visit one year after the operation in which 
the POP-Q score was repeated. For the compartmental POP-Q stages the 
points Ba (anterior), C (middle) and Bp (posterior) were used in the study. 
The overall staging was assigned by the leading compartment.
Patient characteristics and peri-operative complications were collected from 
the medical files.
Procedures were performed or supervised by senior (uro)gynaecologists. The 
choice for either procedure was left to the surgeon’s discretion. All data are 
part of a registration project which was formally deemed exempt from CME 
/ IRB approval.
Measurements
The patient self-reported questionnaire is a composite of internationally 
well-known questionnaires that have been validated for the Dutch language. 
It contains disease-specific questions from the validated Dutch translation of 
the IIQ (10) and UDI(10) and the DDI.(11) Patients rate the amount of bother of 
various symptom on a 5 point Likert scale, from 0 (no complaints at all) to 4 
(very serious complaints). Scores on various domains are composed (12) on
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the basis of their Likert scale values on a scale ranging from 0 (best quality 
of life) and 100 (worst quality of life).
Table 1. Baseline patient’s characteristics____________________________
Cervical Vaginal
amputation hysterectomy P
n=81 n=75
Age (years)** 58(34;83) 57 (34;87) 0.542
Parity** 2 (0;10) 2 (1;8) 0.476
Body Mass Index (kg/m2)** 24 (19; 41) 25(19; 31) 0.966
Postmenopausal status 44 (55) 38 (51) 0.552
Hormonal replacement therapy * 5 (6) 3 (4)
Previous urogynaecological
surgery a
Anterior compartment 5 (6) 5 (7) 0.882
Posterior compartment 6 (7) 6 (8) 0.870
Middle compartment 2 (3) 1 (2) 0.614
Incontinence surgery 5 (6) 5 (7) 0.917
Comorbidity b
CNS disease 7 (9) 6 (8) 0.772
Cardiovascular disease 16 (21) 17 (23) 0.844
Respiratory disease 4 (5) 9 (12) 0.147
Gastrointestinal disease 10 (13) 11 (15) 0.814
Endocrine disease 3 (4) 3 (4) 1.000
Musculoskeletal disease 11 (15) 11 (15) 1.000
Data are presented as number of women (percentage), * mean (SD) or ** median (range); P = p value 
using chi square test, Mann Whitney or t test as appropriate; a note that data on 1 vaginal hysterectomy 
patient is missing; b note that data on 6 cervical amputation patients are missing.
Data are presented as number of women (percentage), mean (standard 
deviation) or median (range) as appropriate. To compare the difference 
between groups, the independent samples Student-T test was used in case of 
normally distributed numerical values, Mann Whitney in case of not 
normally distributed numerical values and Chi square in case of two by two 
tables. The level of significance was set at alpha of 0.05. All data were 
entered and analysed in a SPSS 15.0 database for Windows (SPSS, Inc., 
Chicago, IL).
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Table 2 Concomitant operations intra- and postoperative details.
Cervical Vaginal
amputation hysterectomy
n=81 n=75 P
Concomitant operation
Anterior colporhaphy 63 (85) 58 (92) 0.161
Posterior colporhaphy 54 (73) 47 (75) 0.493
Perineoplasty 18 (32) 16 (26) 0.308
In tra  operative*
Operation time [minutes] 78 (28) 110 (35) 0.000
Intraoperative bloodloss [ml] 191 (116) 251 (149) 0.006
Postoperative*
Catheterization [days] 3.7 (4) 3.1 (2) 0.198
Length of hospitalisation
[days] 6.1 (3) 5.2 (2) 0.018
Complications during hospital stay
Urinary retention 9 (11) 12 (16) 0.277
Bleeding 0 1 (1) 0.487
Data are presented as number of women (percentage) or * mean (SD); P = p value using chi square test 
or t test as appropriate; **Note: urinary retention was resolved with prolonged catheterisation or 
intermittent self catheterisation, there were no longterm consequences; the patient with the bleeding 
received 2 packed cells and left the hospital in good condition.
Results
Table 1 shows the characteristics of the 156 women. No baseline differences 
between the two groups were found .
In Table 2 an overview of the concomitant operations and complications is 
presented. The vast majority of women underwent additional anterior and/or 
posterior repair. Operating time and intraoperative blood loss were more 
favourable in the cervical amputation group, hospitalization time however 
was shorter in the vaginal hysterectomy group.
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Table 3 The nine points and distances from the pre- and postoperative POP-Q scores 
Pre operative values Postoperative values (1 year)
Cervical Vaginal Cervical Vaginal
amputation hysterectomy amputation hysterectomy
n=77 n=75 P n=51 n=48 P
Aa 0.4 (1.6) 0.8 (1.7) 0.160 -1.7 (1.2) -1.7 (1.2) 0.935
Ba 1.7 (2.1) 2.0 (1.9) 0.299 -1.4 (1.2) -1.6 (1.3) 0.525
C -1.8 (2.6) 0.4 (3.4) 0.000 -7.0 (1.1) -6.8 (2.2) 0.546
GH 4.5 (1.1) 5.0 (1.1) 0.006 4.0 (0.9) 3.6 (0.9) 0.027
PB 3.3 (1.0) 3.7 (0.9) 0.006 3.9 (0.9) 3.6 (0.8) 0.034
TV
L 9.4 (0.9) 9.7 (1.2) 0.030 8.7 (0.9) 8.9 (1.2) 0.319
Ap -1.2 (1.3) -0.9 (1.2) 0.145 -2.4 (0.9) -2.5 (0.9) 0.427
Bp -1.1 (1.3) -0.7 (1.5) 0.053 -2.4 (1.2) -2.4 (1.0) 0.770
D -5.1 (2.0) -3.8 (3.1) 0.002 -7.5 (1.2) - -
Data are presented as mean (SD); P= p value using an independent samples Student’s t-test.
Table 3 compares the 9 points and distances from the POP-Q before and 
after surgery. Table 4 gives the overall and compartmental pre- and 
postoperative POP-Q stages. In Table 5 the pre-operative, post-operative 
outcomes and the differences between pre- and postoperative outcomes in 
the various domains from the UDI, IIQ and DDI are presented. There were 
no statistically significant differences for any comparison between the two 
groups of patients.
Discussion
We have compared the modified Manchester procedure with uterine 
preservation with vaginal hysterectomy with high uterosacral plication with 
special regard to the middle compartment. Both procedures performed 
excellent with no middle compartment recurrences in the modified 
Manchester group and 4% of recurrences in the hysterectomy group.
66
In our hands, the Manchester procedure performed better as compared with 
the results from earlier studies(13,14) , whereas the results from vaginal 
hysterectomy were comparable.(15,16)
Table 4. The overall and compartmental stages of the pre- and postoperative POP-Q 
examinations
Pre-operative Post-operative 1 year
Cervical Vaginal Cervical Vaginal
amputation hysterectom amputation hysterectom
n=73 y n il ~-
4 n=50 n=48
Overall POP-Q stage
stage 0 0 (0) 0 (0) 6 (12.0) 6 (18.8)
stage 1 0 (0) 1 (1.4) 14 (28.0) 13 (27.1)
stage 2 24 (32.9) 19 (26.4) 29 (58.0) 25 (52.1)
stage 3 48 (65.8) 51 (70.8) 1 (2.0) 1 (2.1)
stage 4 1 (1.4) 1 (1.4) 0 (0) 0 (0)
Anterior POP-Q stage (Ba)
stage 0 2 (2.7) 0(0) 10 (20.0) 17 (35.4)
stage 1 2 (2.7) 5 (6.9) 17 (34.0) 8 (16.7)
stage 2 27 (37.0) 22 (30.6) 22 (44.0) 23 (47.9)
stage 3 41 (56.2) 44 (61.1) 1 (2.0) 0 (0)
stage 4 1 (1.4) 1 (1.4) 0 (0) 0 (0)
Posterior POP-Q stage (Bp)
stage 0 8 (11.0) 5 (6.9) 30 (60.0) 33 (68.8)
stage 1 27 (37.0) 14 (19.4) 7 (14.0) 8 (16.7)
stage 2 33 (45.2) 48 (66.7) 13 (26.0) 7 (14.6))
stage 3 4 (5.5) 4 (5.6) 0 (0) 0 (0)
stage 4 1 (1.4) 1 (1.4) 0 (0) 0 (0)
Vault/cervix POP-Q stage (C)
stage 0 0(0) 0 (0) 23 (46.0) 18 (37.5)
stage 1 43 (58.9) 24 (33.3) 27 (54.0) 28 (58.3)
stage 2 20 (27.4) 15 (20.8) 0 (0) 1 (2.1)
stage 3 9 (12.3) 32 (44.4) 0(0) 1 (2.1)
stage 4 1 (1.4) 1 (1.4) 0 (0) 0 (0)
Data are presented as n (%)
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Table 5 Pre-operative scores and change in scores (pre-operative minus post-operative scores) on the Incontinence Impact 
Questionnaire, Urogenital Distress Inventory and Defaecatory Distress Inventory
Pre-op erative Post-Operative
Cervical
HQ
Change b etween p re arid p ostop erative
P
ançutatio Vaginal Cervical Vaginal Cervical Vaginal
n hysterectomy anç utatio n hysterectomy amputation hysterectomy
1
Mobility 28.7(24.5) 26.6(22.0) 23.7 (27.4) 21.6(25.8) 8.3(24.2) 7 .6 (19 .3 ) 0.900
Physical 29.0(29.3) 27.3(29.5) 22.6 (28.9) 15.3(28.3) 6.4(33.3) 13.8(26.4) 0.301
Social 17.2(20.4) 13.2(14.1) 14.1 (24.5) 9.2(16.0) 7.7(16.3) 6.0(12.4) 0.630
Embarassment 18.4(21.3) 14.6 (16.9) 14.4 (22.4) 11.7 (22.4) 6.2(20.2) 6.8(19.8) 0.890
Emotion
il
32. â (28.1) 25.9(22.8) 19.8(23.4) 16.2(26.0) 13.7(23.4) 12.8(22.9) 0.868
■1
Overac tive b ladder 21.5(20.5) 28.5(23.9) 19.4(19.7) 18.1 (22.6) 5.8(19.8) 6.5(15.7) 0.903
Incontinence 25.5(25.5) 24.0(25.2) 18.7 (20.1) 17.2(19.6) 12.6(25.6) 6.4(20.5) 0.249
Obstructive micturition 26.0(2 5.5) 24.0(25.2) 13.4 (20.0) 12.9(22.1) -7.8(17.1) -10.6(19.9) 0.523
Disc omfortp ain 30.9(24.3) 30.6(30.3) 17.3(20.3) 9.4(13.5) 15.2(22.6) 18.8(28.3) 0.548
Genital p rolap se 
.1
51.7(33.4) 54.0(32.7) 7.8(14.7) 10.5(19.1) 43.1 (35.0) 41.9(32.5) 0.879
■1
Obstipation 14.2(18.7) 11.9 (17.3) 12.1 (18.6) 7.8(14.2) 2.9(14.8) 5.0(15.1) 0.555
Obstructive defaecation 15.4(19.4) 14.2(16.8) 9.4(13.7) 5.3(10.3) 5.7(14.6) 9.5(15.5) 0.307
Disc omfortp ain 14.2(23.0) 12.2(23.5) 9.0(17.2) 3.1 (9.9) 4.4(25.1) 7.0(18.4) 0.621
Incontinence 2.4 (7.7) 6.0(13.7) 5.2 (16.8) 5.6(15.5) -1.0(12.7) 0.9(22.6) 0.669
Flatus 21.2(27.4) 22.5(25.4) 20.1 (26.4) 24.4 (26.7) -4.0(24.21 -3.7(19.2) 0.959
D ata are presente d a s  m ean (3D); P= p value using an independent t te s t  on the difference betw een Hie ^ o u p s  in change of pre- operative minus 
postoperative scores, IIQ= Inc onlinenc e Impact Questionnaire, UDI=—Urogenital Distress Inventory; DDI = Defaecatory Distress Inventory; Note: The 
change is pre sente d as pr e- operative scare m inus p o s t operative score), consequently positive values indicate an improvement whereas negative values 
indicate a deterioration in outcome.
We need to mention that the POP-Q stage pre operative in the middle 
compartment was lower in the cervical amputation group than in the 
hysterectomy group and that a third o f the patients not came for follow up. 
The low number of middle compartment recurrences is in contrast with the 
high anterior compartment recurrence rate in both groups which was 
approximately 50%, where recurrency is defined as stage 2 or more 
independent if  there was an operation performed in the compartment. The 
vulnerability o f the anterior compartment for recurrence is however well 
known.(17) Most recurrences [60.9%] appeared asymptomatic with regard to 
prolapse sensations. There were no differences between the two operations 
with regards to anterior, middle or posterior compartment recurrences. 
Considering that the hysterectomy cases were more severe preoperatively it 
is possible that the modified Manchester is less protective o f recurrent or de 
novo anterior compartment prolapse if  we take all stages (including stage 1) 
into account. We have no explanation for this, because postoperative point 
C is similar for both operations and the technique used for the concomitant 
anterior colporrhaphy is identical.
As usual in our hospitals the postoperative follow up was performed by the 
operating surgeon. This possibly introduces some bias in the POP-Q 
results.
Our study was not a randomized controlled trial. The choice between the two 
operations was done in mutual agreement between the patient and the 
surgeon and patient's and/or surgeon's preference was not specifically 
studied. As expected, surgeons choose a vaginal hysterectomy more often in 
case o f more severe descend of the uterus and a cervical amputation more 
often in case the uterine prolapse is less pronounced. One might expect more 
surgeons to choose for a cervical amputation in case o f significant cervical 
elongation which should be reflected in a relatively low point C with a 
relatively well positioned point D. However this is not reflected in our series. 
In fact the opposite held true with the distance D minus C, which was 3.3 
cm in the cervical amputation group and 4.2 cm in the vaginal hysterectomy 
group. This difference was not statistically significant. Apparently only the
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position of the cervix determined the choice between the two operations. We 
have no information on whether or not the choice o f the patient, and in 
particular the wish to preserve their uterus, has influenced the type of 
operation.
The operating time was, as expected, shorter for the cervical amputation 
group as was the case for the amount o f blood loss. However this might also 
be a reflection o f the more severe prolapse cases in the vaginal hysterectomy 
group with more stage 3 middle compartment prolapse.
To our surprise we found a slightly longer hospital stay for the cervical 
amputation group. We have no explanation for this.
With regard to the difference between pre-and post operative functional 
outcome there were no significant differences on the UDI, DDI and IIQ 
results. Our data on the functional outcome with regard to the vaginal 
hysterectomy group are comparable to a study which studied vaginal 
hysterectomy with sacrospinous fixation and used the same pre- and 
postoperative domain scores as outcomes(18).
We found a improvement in the urinary incontinence domain in both groups. 
The improvement in the cervical amputation group was somewhat bigger but 
this did not reach significance. This is in contrast to earlier studies where 
22-28% of the patients developed stress incontinence after the Manchester 
procedure.(19,20)
It is difficult to compare our results o f this modified Manchester procedure 
with the literature. Most literature on the Manchester operation is written 
early in the last century. Only one recent study has been found which 
focuses especially on the complications after a Manchester operation.(21)
In conclusion we found a excellent performance o f both procedures with 
regard to middle compartment recurrence. Both procedures had a high 
recurrence rate for especially the anterior compartment .One has to realize 
that the modified Manchester was done in less severe cases and thus 
possibly performs poorer in this regard than the vaginal hysterectomy. No 
significant difference in functional outcome was found. The modified
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Manchester is therefore a viable option in women who wish to preserve 
their uterus.
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Chapter 5
Factors influencing success of Pelvic Organ 
Prolapse repair using porcine dermal 
implant Pelvicol®.
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Abstract
Objective: To evaluate factors influencing pelvic organ prolapse (POP) 
recurrence after repair surgery with a porcine dermal collagen implant 
(Pelvicol®).
Method: From December 2003 to August 2005, 78 patients with mainly 
stage 3 pelvic organ prolapse (POP-Q) underwent vaginal repair using 
porcine dermal implant. Assessments were made preoperatively and at 6 
weeks and one year follow-up. These included physical examination with 
POP-Q, IIQ, UDI-6, DDI and questions from the PGI. Data were recorded 
on changes in functional status, mesh erosion and adverse events. Procedural 
success was defined as POP-Q stage 0/1.
Results: 71 patients returned for 1 year follow-up. The overall cure rate was 
74.6%. The chance o f a successful operation in the younger group was 
significant higher than in the older group (OR:7.5;95%CI(1.38;40.69), but 
this effect is lower and no longer significant after adjusting for compartment 
(post, anterior, post + anterior) (adjusted OR: 5.5; 95%CI (0.92; 32.6). 
Conclusions: A low complication rate and satisfactory overall results were 
observed in a group of women after POP repair surgery with Pelvicol®. 
Whether these results are better or worse than with conventional surgery or 
non resorbable mesh implantation is unclear and can only be determined in 
a randomized controlled trial. There was a strong tendency towards better 
results in the younger women than in the older women, but the reason for 
this phenomenon is unclear.
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Introduction
Pelvic floor dysfunction is a major health issue in older women. Prevalence 
rates o f pelvic organ prolapse [POP] increase with age. The lifetime risk of 
undergoing at least one operation for prolapse or incontinence by the age of 
80 years is 11%.1 Over the next 30 years, the number o f women aged 65 
years and older will double in the Netherlands and in other western 
countries.2 Thus, the need for operations to correct POP is expected to 
increase sharply. Recurrence o f pelvic organ prolapse is observed in nearly 
one third o f women after repair surgery.3 Implants [meshes] are frequently 
used as a way to reduce the high failure rates. Biological and synthetic 
meshes are presently available. Biological meshes exists in different kinds: 
autologous tissue (rectus fascia or fascia lata), allograft tissue (cadaveric 
human fascia lata, dura or dermis) and xenograft tissue (porcine dermal or 
intestine mucosa). All have the advantage o f a much lower risk o f graft 
erosion than permanent, polypropylene meshes.4 
Pelvicol® is a porcine dermal collagen implant that has been studied 
extensively in animals5, 6 In women, it has been used to repair anterior and 
posterior vaginal prolapse with different success rates.7, 8 We investigated the 
anatomical and functional results o f a series o f operations with porcine 
dermal implant (Pelvicol®) and specifically focused on factors influencing 
the objective outcomes.
Materials and Methods
From December 2003 to August 2005, 78 patients with predominantly stage 
3 pelvic organ prolapse (POP-Q) underwent vaginal repair by one surgeon 
[DG] in the anterior and/or posterior compartment. Middle compartment 
repair was performed if  appropriate.
Operation techniques 
Anterior compartment
A solution o f lidocain/adrenalin 1:200000 was injected in the anterior 
vaginal wall; a full thickness midline anterior vaginal wall incision was
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made starting at or close to the bladder neck, up to the cervix or the scar of 
the vaginal cuff; the vagina was dissected free from the bladder on each side 
laterally to the subpubic arch in such a way that the muscularis layer was 
left on the site o f the mucosa; the porcine dermal implant, Pelvicol® 4x7, 
was fixed: laterally to the fascia endopelvina with two prolene 2x0, to the 
cervix with one prolene 2x0 or to the remnants o f the sacrouterin ligaments 
with two prolene 2x0 and distally to the vesicovaginal fascia with one vicryl 
2x0. The vaginal wall was closed with running vicryl 2x0.
Posterior compartment
A solution of lidocain/adrenalin 1:200000 was injected in the posterior 
vaginal wall under the muscularis layer; full-thickness incision o f the vaginal 
wall started from fornix posterior or the scar o f the vaginal cuff up to 1 cm 
proximal from the hymen; the vaginal wall was dissected free laterally to the 
pararectal space in such a way that the muscularis layer was left on the site 
of the mucosa; in the case o f existing enterocele the sac was opened and a 
purse string suture was applied; the porcine dermal implant, Pelvicol®
12x4, was fixed laterally to the parietal fascia on the musculus puborectalis 
with vicryl 2x0, to the cervix with one prolene 2x0 or to the remnants o f the 
sacrouterin ligaments with two prolene 2x0 and distally to the perial body 
with vicryl 2x0. Excess o f dermal implant was trimmed; the vaginal wall 
was closed with running vicryl 2x0.
Middle compartment
Simultaneous vaginal hysterectomy was never performed.
IVS posterior procedure: A solution of lidocain/adrenalin 1:200000 was 
injected in the fornix posterior under the muscularis layer or 1 cm distal of 
the scar o f the vaginal cuff; a 4 cm horizontal full-thickness incision o f the 
vaginal wall was performed ; in case o f a posterior procedure the same 
incision was used; IVS-Posterior® tape was inserted through the ischioanal 
space up to the level o f the ischial spine and was brought medial towards the 
vaginal cuff; the tape was fixed to the porcine dermal implant with vicryl 
2x0 and to the uterus if  present; the vaginal wall was closed with running 
vicryl 2x0.
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Assessments
All the patients underwent a preoperative assessment that included physical 
examination with POP-Q9, 10, which was repeated at 6 weeks and 1 year 
follow-up. Several weeks before the one year follow-up appointment, a 
standard urogynaecological questionnaire (advised by the Pelvic Floor 
Committee of the Dutch Gynaecological Society) was sent to all the patients. 
This patient self-assessment questionnaire is a composite o f well-known 
internationally validated questionnaires that have been validated for the 
Dutch language. It contains disease-specific questions from the validated 
Dutch translation of the Incontinence Impact Questionnaire (IIQ)11 
Urogenital Distress Inventory (UDI-6)11 and the Defaecatory Distress 
Inventory (DDI).12 Patients rate the amount of bother a specific symptom is 
causing on a 4-point Likert scale. Scores on various domains are composed 
on the basis o f their Likert scale values, from 0 (no complaints at all) to 100 
(very serious complaints). In addition, two questions were included in the 
questionnaire derived from the Patient Global Impression of Improvement 
scale.13
Perioperative data, including operation time, per-operative and post­
operative complications, estimated blood loss and data on previous 
operations were abstracted from the patient files. Records were made of 
changes in functional status (urinary, defaecatory and prolapse symptoms, 
vaginal pain, sexual dysfunction), mesh erosion and adverse events. The 
outcome variable is determined by the POP-Q stage in the operated 
compartment with Pelvicol®. In case the patients had an operation in both 
the anterior and posterior compartment, the highest stage of the POP-Q is 
taken, defined as total POP-Q. Procedural success (cure) was defined as total 
POP-Q stage 0/1.
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Table 1 Patient characteristics , details o f previous pelvic operations, 
characteristics o f surgery, complications and further surgery in the study group
n=78
Age (years)* 69 (37 - 91)
Age>75 years 27 (34.6%)
BMI* 26 (18 - 40)
Parity* 2 (0 - 9)
Comorbiditya 32 (41.0%)
Cardiovascular 26 (33.3%)
Diabetes Mellitus 6 (7.7%)
Other 8 (10.3%)
Previous prolapse surgeryb 52 (66.7%)
Hysterectomy for prolapse 34 (43.6%)
Anterior repair 38 (48.7%)
Posterior repair 30 (38.5%)
Middle compartment repair 5 (6.4%)
Incontinence surgery 12 (15.4%)
Previous hysterectomy other reason 20 (25.6%)
Previous surgery in same compartment 42 (53.8%)
Surgery using Pelvicol®
Anterior repair 22 (28.2%)
> 75years (n) 10
Posterior repair 38 (48.7%)
> 75years (n) 7
Anterior and posterior repair 18 (23.1%)
> 75years (n) 10
Concomitant additional operations
IVS posterior 34 (43.6%)
Anterior repair (classical) 2 (2.6%)
TVT-O 6 (7.7%)
Blood loss > 100ml 5 (6.5%)
Operation time >60 min 23 (29.9%)
Complications
Intra-operative
Haemorrhage (>500ml) 1 (1.3%)
Post-operativec
Erosion d 5 (7.0%)
Stress incontinence 2 (2.8%)
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Obstructive voiding 1 (1.4%)
Wound infection 1 (1.4%)
Urinary tract infection 1 (1.4%) 
Further surgeryc
TVT-O 2 (2.8%)
Excision erosion d 2 (2.8%)
Excision top granulomad 1(1.4%)
Excision mesh because o f pain_________________________1 (1.4%)
Data are presented as number of women (percentage), * median (range)
a some women had multiple comorbidity;b some women had multiple prior surgical procedures; c 
note that data on 7 patients are missing; d exclusive due to IVS-Posterior®; TVT-O: Tension free 
vaginal tape-obturator).
Univariate logistic regression was used to study differences in success at 
one year after surgery (total POP-Q stage 0/1) between groups. The crude 
Odds Ratios with the 95% confidence intervals are presented. Multivariate 
logistic regression was used to study possible confounders in the relation of  
success at one year after surgery and the age. The adjusted Odds Ratio with 
the 95% confidence intervals is presented when appropriate.
SPSS 13.0 and SAS 8.2 were used to perform the statistical analyses.
Results
From December 2003 to August 2005, 78 women underwent pelvic organ 
prolapse (POP) repair with porcine dermis in the anterior and/or posterior 
compartment (POP-Q, stage > 2). One patient had two operations between 
December 2003 and August 2005, firstly in the posterior compartment and 
secondly in the anterior compartment. Only the second operation was 
included in this study, while the first operation is mentioned in the column 
“previous pelvic surgery”.
Assessment results and questionnaire data were available for analysis in 71 
patients (response rate: 91.0%). Reasons for non response were illness (n=5), 
living in a foreign country (n=1) or non prolapse related death (n=1).
Table 1 shows the characteristics, surgical details, complications and further 
surgery of the patients. Median age o f the women was 69 years (range 37­
91); 66.7% had undergone earlier prolapse surgery. There were no major 
intra-operative complications.
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Table 2 Overall and compartmental stages o f pelvic organ prolapse at 
baseline, 6 weeks and 1 year post-operatively_____________________
Baseline (n=78) 6 weeks (n=78) 1 year(n=71)
n (%) n (%) n (%)
Overall POP-Q
stage 0 0 (0%) 63 (80.8%) 35 (49.3%)
stage 1 0 (0%) 13 (16.6%) 18 (25.3%)
stage 2 4 (5.1%) 2 (2.6%) 11 (15.5%)
stage 3 66 (84.6%) 0 (0%) 7 (9.9%)
stage 4 8 (10.3%) 0 (0%) 0 (0%)
Anterior POP-Q
stage 0 15 (19.2%) 64 (82.1%) 45 (63.7%)
stage 1 17 (21.8%) 12 (15.4%) 14 (19.7%)
stage 2 6 (7.7%) 2 (2.6%) 7 (9.9%)
stage 3 33 (42.3%) 0 (0%) 5 (7.0%)
stage 4 7 (9.0%) 0 (0%) 0 (0%)
Posterior POP-Q
stage 0 12 (15.4%) 73 (93.6%) 54 (76.1%)
stage 1 6 (7.7%) 5 (6.4%) 10 (14.1%)
stage 2 6 (7.7%) 0 (0%) 5 (7.0%)
stage 3 46 (59.0%) 0 (0%) 2 (2.8%)
stage 4 8 (10.3%) 0 (0%) 0 (0%)
Vault/cervix POP-Q
stageO 22 (28.2%) 75 (97.4%) 63 (88.7%)
stage 1 14 (17.9%) 2 (2.6%) 3 (4.2%)
stage 2 15 (19.2%) 0 (0%) 0 (0%)
stage 3 20 (25.6%) 0 (0%) 5 (7.0%)
stage 4 7 (9.0%) 0 (0%) 0 (0%)
No erosions from a Pelvicol® implant was seen however erosion o f the 
IVS-Posterior® was observed in 5 women. In 2 cases, the IVS-Posterior® 
was removed. In 3 patients, the erosions disappeared after 3 months of 
estrogen treatment.
One Pelvicol® implant had to be removed because of unexplained pelvic 
pain without any erosion or clinical signs o f infection or rejection. The 
implant was removed 18 months after the operation and the pain
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disappeared. Histopathology showed focal degradation o f the porcine dermal 
implant and collagen fibrosis.
Table 2 describes the POP-Q before, at six weeks and one year after surgery 
in all the compartments. A total o f 18 (25.4%) patients had prolapse 
recurrence after one year (overall POP-Q >2).
Of these 18 patients 10 had a failures in another compartment then the 
operated compartment; 7 patients had an anterior failure after posterior mesh 
(4 stage 2, 3 stage 3), 2 patients had a posterior failure after anterior mesh 
(stage 2) and one patient had a vault prolapse (stage 3) after an operation in 
the posterior compartment without any operation on the middle 
compartment.
Table 3 shows the crude ORs for a successful operation at one year after 
surgery (total POP-Q < 1) o f various risk factors. The best result was seen in 
the posterior compartment, while the poorest result was seen with the 
combined anterior and posterior repair.
The chance o f a successful operation in the younger group was significant 
higher than in the older group (OR:7.5;95%CI(1.38;40.69) but this effect is 
lower and no longer significant after adjusting for compartment (post, 
anterior, post + anterior) (adjusted OR: 5.5; 95%CI (0.92; 32.6). POP 
recurrence in group younger than or equal to 75 years was 4.7% compared to 
25.0% in the group older than 75 years.
A BMI of <25 gave a higher chance of a successful operation than a BMI of >25, 
but this was not significant. None of the other factors showed significant results.
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Table 3 Crude ORs with 95% confidence intervals for a successful 
operation (POP-Q < 1) at 1 year follow-up
OR 95% CI
Age (years)
< 75 7.5 (1.38; 40.69)
> 75 1.00 (reference)
BMI
< 25 4.00 (0.45;35.35)
> 25 1.00 (reference)
Parity
(n) 0.86 (0.42; 1.76)
Age first parity
(Years) 1.19 (0.96; 1.49)
Comorbidity
No 2.90 (0.63; 13.26)
Yes 1.00 (reference)
Previous prolapse surgery
No 1.30 (0.24; 7.01)
Yes 1.00 (reference)
Previous hysterectomy
No 0.70 (0.16;3.20)
Yes 1.00 (reference)
Surgery using Pelvicol®
Anterior repair 3.09 (0.48; 19.84)
Posterior repair 6.36 (1.02; 39.58
Anterior-Posterior repair 1.00 (reference)
IVS Posterior
No 1.03 (0.23; 4.68)
Yes 1.00 (reference)
Concomitant additional operations 
except IVS Posterior
No 0.92 (0.17; 4.91)
Yes 1.00 (reference)
Operation time
< 60 min 1.00 (reference)
> 60 min 0.72 (0.16; 3.32)
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Table 4 Mean (SD) of the general quality of life, domain scores on
IIQ, UDI and DDI after surgery
Mean (SD)
Quality of life 6.8 (2.1)
IIQ 15.0 (16.9)
Mobility 24.9 (28.2)
Physical 16.7 (22.8)
Social 8.5 (13.6)
Embarrassment 13.3 (22.8)
Emotion 18.7 (22.1)
UDI 25.4 (15.2)
Overactive bladder 22.6 (22.7)
Incontinence 20.9 (20.1)
Obstructive micturition 35.0 (18.2)
Discomfort/pain 22.4 (27.1)
Genital prolapse 9.5 (23.6)
DDI 15.5 (12.2)
Constipation 17.4 (22.1)
Obstructive defaecation 10.9 (13.2)
Discomfort/pain 11.3 (19.6)
Faecal incontinence 8.1 (14.4)
Flatus incontinence 31.3 (31.2)
IIQ - Incontinence Impact Questionnaire, with a mean score composed of the topics 
mentioned below; UDI- Urogenital Distress Inventory , with a mean score composed 
of the topics mentioned below; DDI - Defaecatory Distress Inventory, with a mean 
score composed of the topics mentioned below
Table 4 shows the UDI, DDI and IIQ scores o f the total population after 
surgery. Two questions o f the PGI, Table 5, indicated an improvement 
(much better-a little better) o f 76% o f the women.
Discussion
In this study we found a low complication rate and an overall recurrence 
rate o f 25% of a porcine dermal collagen implant (Pelvicol®) in POP repair 
surgery. Several studies have been performed on the efficacy o f Pelvicol®. 
Overall recurrence rates varied from less than 10% - 19% in the anterior 
compartment14, 15, to between 17% or more than 50% in the posterior 
compartment.16, 17
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Table 5 Results on the questions of the PGI
N (%)
Which number best describes your present 
condition compared to before the operation
9a
1. Very much better 13 (17.8%)
2. Much better 30 (41.1%)
3. A little better 14 (19.2%)
4. No change 10 (13.7%)
5. A little worse 2 (2.7%)
6. Much worse 4 (5.5%)
7. Very much worse -
Which number best describes your present 
condition or symptoms?b
1. Normal 31 (41.9%)
2 Mild 36 (48.6%)
3 Moderate 4 (5.4%)
4 Severe 3 (4.1%)
PGI - Patient Global Impression of Improvement;a note that data on 5 patients are 
missing; b note that data on 4 patients are missing.
In our study, recurrence in the anterior compartment was comparable 
(16.9%), while in the posterior compartment, it was lower (9.8%). 
Randomized controlled trials about biological grafts are sparse. The RCT's 
about the anterior compartment are not conclusive; one describes less 
recurrencies after biological grafts vs anterior colporrhaphy (Pelvicol®; 7% 
vs 19%)18, the other shows no differences (fascia lata 21% vs 29%)19. In the 
posterior compartment the results with biological graft was found to be 
worse when compared with site specific repair and posterior colporrhaphy 
(46% vs 22% vs 14%).20 In our group we found 25% objective recurrency. 
This is similar to results after traditional operation techniques. However 
55% of these failures were in the non operated compartment! Recently a 
systematic review concluded that any mesh was better than no mesh for 
preventing objective recurrence in anterior repair and combination of 
anterior and posterior repair21.
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The efficacy of mesh increases with increasing mesh strength and 
durability.22 The durability o f biological materials are influenced by their 
absorbability by the host tissue. Reoperation after mesh appeared necessary 
in 3% of the women treated with biological grafts compared to 1% treated 
with non-absorbable synthetic mesh.
There are different types o f biological grafts on the market; cross-linked and 
non-cross linked. A drawback of the cross-linked is that they may become 
encapsulated, leading to hardening and shrinkage which may increase the 
risk o f failure. The non-crosslinked meshes appear to be well integrated in 
the host tissue, but with a bigger change of degradation of the graft.
Seromas, infections and erosions are described complications after 
Pelvicol®. In our study with one year follow-up we found none o f these 
complications, although one patient had pain complaints and therefore the 
Pelvicol® had to be removed.
In our study the recurrence was lower in the group 75 years or younger as 
compared to the older group. This result is in contrast with studies that found 
young age to be a risk factor for recurrence.23, 24 However, all these studies 
used classical surgical techniques.
The younger group had significant more operations in the posterior 
compartment than the older group. The results in the posterior compartment 
are better than in the anterior compartment or in the combination of anterior 
and posterior compartment. The difference between the age groups is no 
longer significant after adjusting for compartment.
In the literature on prolapse recurrence another risk factor is previous 
hysterectomy. However we did not find any statistically significant 
differences in POP recurrence rates between patients who underwent a 
previous hysterectomy and those who did not.
A high BMI was found to be a risk factor for prolapse 25 and prolapse 
recurrence.26 In our study, we only found a tendency that patients with a 
BMI of <25 had better results than the patients with a BMI of >25.
We observed low post-operative urogenital symptom scores and a good 
disease-specific quality o f life. As we did not have any preoperative data, we
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compared our results to those from studies that had used the same 
questionnaires. In several studies postoperative UDI domain scores varied 
between 10.2 and 32.5, the DDI scores varied between 6.5 and 9.4 and the 
IIQ scores varied between 7.6 and 25.4.27-29 Our UDI and IIQ results were 
comparable, whereas the DDI results were not as good. It is difficult to 
interpret these difference in results, but a possible explanation is that 2/3 of  
our patients had undergone earlier prolapse repair surgery. To measure the 
actual post-operative improvement, we added two questions from the PGI, 
which indicated that the majority o f women experienced improvement after 
the operation.
The tendency towards difference in a successful operation between the older 
and the younger age group is puzzling. Differences in collagen metabolism 
might be an explanation for this. Pelvic floor connective tissue undergoes 
continuous remodelling and a balanced relationship between production and 
degradation is essential to maintain the tensile strength.30 With ageing, 
metabolism changes and collagen loses strength.31
In an experimental New Zealand rabbit animal model Pelvicol® degraded in 
50% of the cases after one year, but the cause remained unclear.32 The 
ingrowth and regeneration of native connective tissue showed normal 
patterns, whereas the collagen deposited and ingrowth at the mesh interface 
was o f poorer quality.33 These histological changes in focal degradation and 
the ingrowth of healthy connective tissue were also found in several human 
studies on biomesh34 and in our patient with pain symptoms. Given the 
results o f the above-mentioned studies, the relationship between the POP 
recurrence rates with Pelvicol® and the age o f the women might be caused 
by the quality o f the collagen that replaces the degrading implant. However, 
this aspect certainly needs more investigation before any definite 
conclusions can be drawn.
Conclusions
In conclusion a low complication rate and satisfactory overall results were 
observed after one year follow-up in a group o f women after POP repair
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surgery with Pelvicol®. Whether these results are better or worse than with 
conventional surgery or non resorbable mesh implantation is unclear and can 
only be determined in a randomized controlled trial. There was a strong 
tendency towards better results in the younger women than in the older 
women, but the reason for this is unclear.
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Chapter 6
Pelvic organ prolapse and overactive 
bladder.
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Abstract
Aims: In this review we try to shed light on the following questions:
• How frequently are symptoms of overactive bladder(OAB) and is 
detrusor overactivity(DO) present in patients with pelvic organ 
prolapse (POP) and is there a difference from women without POP?
• Does the presence o f OAB symptoms depend on the prolapsed 
compartment and/or stage o f the prolapse?
• What is the possible pathophysiology o f OAB in POP?
• Do OAB symptoms and detrusor overactivity (DO) change after 
conservative or surgical treatment o f POP?
Methods: We searched on Medline and Embase for relevant studies. We 
only included studies in which actual data about OAB symptoms were 
available. All data for prolapse surgery were without the results of 
concomitant stress urinary incontinence (SUI) surgery.
Results: Community and hospital based studies showed that the prevalence 
of OAB symptoms was greater in patients with POP than without POP. No 
evidence was found for a relationship between the compartment or stage of  
the prolapse and the presence o f OAB symptoms.
All treatments for POP (surgery, pessaries) resulted in an improvement in 
OAB symptoms. It is unclear what predicts whether OAB symptoms 
disappear or not.
When there is concomitant detrusor overactivity and POP, following POP 
surgery DO disappear in a proportion of the patients.
Bladder outlet obstruction is likely to be the most important mechanism by 
which POP induces OAB symptoms and DO signs. However several other 
mechanisms might also play a role.
Conclusions: There are strong indications that there is a causal relationship 
between OAB and POP.
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Introduction
Pelvic organ prolapse (POP) includes anterior vaginal prolapse (cystocele), 
posterior vaginal prolapse (rectocele), apical or uterine prolapse, enterocele 
and perineal descent.. (1) It is a prevalent problem which has been reported to 
affect 50% of the parous women.(2) Women may not be aware o f a vaginal 
prolapse until it reaches the hymen. Eleven percent o f women will have 
undergone an operation for prolapse or urinary incontinence by the age o f 80 
years.(3)
Symptoms o f an overactive bladder (OAB) are often seen in patients with 
POP. According to the International Continence Society (ICS) OAB is 
defined as urgency with or without urge incontinence, usually with 
frequency and nocturia.(4) This term can only be used if  there is no proven 
infection or obvious pathology’’(4) It is a matter o f debate whether POP 
should be considered as “obvious pathology”. It is generally accepted that 
OAB is a highly prevalent disorder that increases with age in both sexes and 
that has a profound impact on quality o f life.
Fifteen percent o f the women aged 20-29 years reported having symptoms of  
OAB, this percentage increased to 21% for women older than 70 years.(5) 
Detrusor overactivity (DO) is usually considered to be related to OAB and is 
defined by the ICS as a urodynamic observation characterised by involuntary 
detrusor contractions during the filling phase that may be spontaneous or 
provoked.(4) However, the relationship between the symptoms of OAB and 
the observation o f the sign DO is still not completely clear. One large study 
found that in a group of 4500 women 18.7% of the women had OAB 
complaints, but only 54.2% of these women had DO. In the same population 
36.5% of the women had DO and only 27.6% of these women had OAB
symptoms.(6)
Since both POP and OAB are frequently seen in the elderly female 
population it would be expected that the two conditions are frequently 
encountered in the same patient. However it is unclear whether there is a 
causal relationship between the two. If there is a causal relationship it could
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be anticipated that OAB symptoms would improve after successful treatment 
of POP.
In this review we try to shed light on the following questions:
• How frequently are symptoms and signs o f OAB present in women 
with POP and is there a difference from women without POP?
• Is the presence o f OAB symptoms dependent on the compartment or 
stage o f the prolapse?
• What is the possible pathophysiology o f OAB in POP?
• Do OAB symptoms and DO change after conservative or surgical 
treatment o f a POP?
Methods and material
In this review we tried to analyse each single symptom which is included in 
the OAB syndrome definition; urgency, urge incontinence, frequency and 
nocturia in relation to POP.
POP can be defined as an abnormal loss o f support o f one or more of the 
pelvic organs leading to prolapse into or outside the vagina.(7) Most prolapse 
symptoms are non specific and do not show a strong association with the 
location or stage o f the prolapse.(8,9)
For this review we searched on Medline and Embase on March 22nd 2009 for 
studies with the following terms: (“overactive bladder” OR “urgency” OR 
“frequency” OR “nocturia” OR “urge incontinence” OR “micturition” OR 
“detrusor overactivity” OR “detrusor instability” OR “unstable bladder”) 
AND “prolapse”.
We initially selected 917 studies which could be eligible for our purpose. 
From all o f these studies we read the abstract. Out o f them, we then 
considered 123 papers on the basis o f what was reported in the abstract 
section. Finally we identified 46 studies with relevant and clear data, in 
which we also cross checked the reference list for missing studies. We also 
looked at the annual meeting abstracts o f the International Continence 
Society (ICS) from 2000-2008 using the following key words: reconstructive 
surgery pelvic floor, overactive bladder, urgency, urge inoontinence and
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frequency. We identified six ICS abstracts not available as a full article. All 
studies we collected met the following criteria:
• We only included studies in which actual data about OAB symptoms 
were available.
• Prevalence studies were included in the tables only if  prevalence 
data regarding OAB or DO with and without prolapse was 
mentioned.
• Studies about surgical treatment o f POP which included patients 
with concomitant operations for stress urinary incontinence (SUI) 
were only included in the study if  it was clear which patients 
underwent a concomitant SUI operation and could be excluded 
from the analysis. The reason for excluding concomitant 
incontinence surgery is that it is a well known risk factor for de novo
OAB symptoms.(10)
Results
Prevalence of OAB symptoms in relation to POP.
To study the prevalence o f OAB in relation to POP we differentiated 
between community and hospital based studies.
Community based studies.
Table 1 shows the prevalence o f OAB in relation to prolapse in the 
community based studies. In total four studies were found.(11-14) These 
studies searched a large population (12514 women o f which 1071 women 
had a prolapse). All four studies used questionnaires. Three studies took the 
symptom of urge incontinence and one study OAB symptoms as the main 
variable The Relative Risk (RR) was computed by dividing the frequency of 
OAB with POP by the frequency without POP. All four studies showed a 
higher prevalence o f OAB symptoms with POP than without POP. The 
largest study by Tegerstedt et al had even a RR of 5.8.(13)
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Table 1 Prevalence of OAB symptoms in relation to symptoms and signs of POP in community based 
studies.
Community _____________ _____________________________________________ ________________
Author n
Number and 
stages of 
women with 
POP
Outcome 
Instrument Parameter
Frequency of oab 
symptoms in 
women with POP
Frequency of oab 
symptoms in 
women without 
POP
RR (POP/ 
no POP)
T eg e rs ted t
(2005)
5489
"S ym ptom atic" 
P O P  454
questionnaire
urge
incon tinence
22.5%  (102/454) 3 .9%  (196/5035) 5.8
L aw rence
(2008)
4103 "A ny" P O P  233
E P IQ , clinical 
exam ination
O A B 36.8%  (88/239) 9 .1%  (347/3799) 4,0
O A B  + S U I 28.9%  (69/239) 6 .6%  (250/3799) 4,4
M iedel
(2008)
282
stage 0 44 
stage I 95 
stage II 117 
stage III 19 
stage IV  5
questionnaire,
clinical
exam ination
urge
incon tinence
S tage >=1 52.0%  
(1 16/223)
S tage 0 25.0%  
(11/44)
2.1
Frite 1 (2003) 2640
sym ptom atic 
P O P  96
"questionnaire"
urge
incon tinence
34,4%  (33/96) 16.2%  (412/2544) 2,1
Table 2 Prevalence of OAB symptoms in relation to symptoms and signs of POP in hospital based 
studies.
Author n
Num ber, 
stages and 
compartments 
of women with 
POP
Outcome 
Instrument Parameter
Frequency of oab 
symptoms in 
women with POP
Frequency of oab 
symptoms in 
women without 
POP
RR
(POP/no
POP)
R om anzi
(1999)
60
grade I or II: 35 
grade III or IV:
25
history, clin ical 
exam ination , 
p ad  test, 
vo id ing  diary, 
"questionnaire"
frequency  and 
u rgency
56%  (14/25) 20%  (7/35) 2,8
urge
incon tinence
16% (4/2 5) 14% (5/3 5) 1,1
Long
(2002)
101
No prolapse: 
40; stage III-IV: 
61
"questionnaire" ,
clinical
exam ination
frequency  and 
u rgency
70 .5%  (43/61) 45 .0%  (18/40) 1,6
n o c tu ria 54.1%  (33/61) 22.5%  (9/40) 2,4
urge
incon tinence
59.0%  (36/61) 17.5%  (7/40) 3,4
D igesu
(2005)
355
S ym ptom atic  (2 
33) m ed ian  
stage stage II 
A sym ptom atic  ( 
122) m ed ian  
stage I
P-Q O L ,
"questionnaire" ,
clinical
exam ination
u rg en cy 88%  (205/233) 37%  (45/122) 2,4
A li (2006) 401
stage m ean(sd) 
contro l group: 
0 .6 (0 .5 1 );1 .1(0.
55) 1.3(0.70) 
p ro lapse  group 
2.7(0.72)
structu red  
in terview , 
h isto ry  
questionnaires: 
Q O L, PFD I, 
clinical 
exam ination
u rg en cy 68%  (92/135) 24.4%  (65/266) 2,8
urge
incon tinence
50%  (67/135) 18.8%  (50/266) 2,7
S chim p f  
(2007)
109
no p ro lapse : 48 
stage II: 15 
stage III: 33 
stage IV: 13
"questionnaire" ,
clinical
exam ination
u rg en cy 77 .2%  (44/57) 64.3%  (27/42) 1,2
urge
incon tinence
57.4%  (35/61) 49 .0%  (23/47) 1,2
Hospital based studies
Table 2 shows the prevalence o f OAB symptoms in relation to prolapse in 
the hospital based studies. In total 10 studies were identified(2’15"24), but only 
five o f them included patients without p o p (2,17,19,21,24), which we included in 
Table 2. Most studies used non-validated questionnaires and clinical 
examination outcome as parameters. In all 5 studies(2,17,19,21,24) the prevalence 
of OAB symptoms was greater in the POP patients than in the patients 
without POP with a RR varying from 1.2 to 3.4. Figure 1 shows the 
prevalence o f OAB with POP for all identified studies(216-25).
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Figure 1 Prevalence o f OAB symptoms in relation to symptoms o f POP in 
hospital based studies
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The prevalence o f OAB with POP is mainly greater in the hospital based 
studies than in the community based studies, which is not surprising, given 
the selected nature o f the hospital samples.
Prevalence per prolapsed compartment and stage 
Only three studies, one community based and two hospital based, were 
identified which presented data specified per compartment (Table 3). For 
two of the three studies we were not able to recalculate the data per 
prolapsed compartment to an overall prevalence o f OAB symptoms in 
relation to POP. Therefore these data are not included in the table o f hospital 
based studies. The studies present conflicting data: in the study by Miedel et 
al there is a clear relationship between anterior and posterior compartment 
prolapse and OAB symptoms in contrast to central compartment prolapse.(12) 
In the studies by Bradley and Nygaard and Sobghol and Charandabee such a 
relation could not be identified.(26,27) In a study by Ellerkmann et all(no 
analysable data and therefore not included in the table) no correlation 
between worsening o f the anterior compartment and urge incontinence could 
be found .(8)
Data regarding the relationship between the stage o f prolapse and OAB are 
very sparse. Burrows et al found that urgency and urge incontinence occured 
more often in women with a less advanced prolapse overall.(28) Another 
study using ultrasound (no analysable data and therefore not included in the 
table) concluded the same; women with a higher grade o f bladder descent 
were less likely to suffer from urge incontinence(29).
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Table 3 Prevalence of OAB symptoms in relation to symptoms and signs of POP 
per compartment____________ ______________________ ____________ ________
Author n
Number and 
stages of 
women with 
POP
Outcome 
Instrument Parameter Compartment Stage O Stage I Stage II-IV
RR
(POP/no
POP)
Bradley
(2005)
270
anterior 
stage 0 111 
stage I 109 
stage II 39 
stage III-IV 11 
postenor 
stage 0 176 
stage 171 
stage >=II 22
modified 
PFDI, clinical 
examination
urge
incontinence
anterior 48%  (106/220) 52% (26/50) 1,1
posterior 47%  (117/247) 64% (14/22) 1,4
frequency
anterior 28% (62/220) 32% (16/50) 1,1
postenor 29% (71/247) 36% (8/22) 1,2
urgency
anterior 29% (63/220) 28% (14/50) 1,0
posterior 28% (68/247) 36% (8/22) 1,3
Mie del
(2008) 282
stage 0 44 
stage I 95 
stage II 117 
stage III 19 
stage IV 5
questionnaire,
clinical
examination
urge
incontinence
anterior
posterior
apical
re f
OR 1 7  
(0.9-3.1) OR 2.5 (1.2-5.3) 2.51
re f
re f
OR 2.2 
(0.9-5.5) OR 2.1 (0.9-5.5) 2 .11
OR 1.0 (0.5-1.8) 1.0s
stage <2: anterior 33.9% (37/109) 18.1% (40/221) 0.5
anterior 109 posterior 32.5% (41/126) 17.6% (36/204) 0.5
Sobhgol
(2008) 330
posterior 126 
apical 319 
stage >=2:
UDI and 
"questionnair 
e", clinical
oab
apical 23.8% (76/319) 9.0% (1/11) 0.4
anterior 221 examination
urge
incontinence
anterior 39.4% (43/109) 47.5% (105/221) 1.2
posterior 204 posterior 41.3% (52/126) 47.1% (96/204) 1.1
apical 11 apical 31,0% (99/319) 54.5% (6/11) 1.2
UDI: Urinary Distress Inventory, ref: reference,4OR(POPstage II-IV)
Pathophysiology of overactive bladder women with POP.
The pathophysiology o f OAB in women with POP is unclear. Several 
theories exist.
Bladder outlet obstruction
POP can cause bladder outlet obstruction and this is often regarded as an 
important mechanism for developing OAB in these patients.
Several studies found that patients with prolapse have a lower maximum
(17 20 30 31)flow rate (Qmax) during voiding than patients without a prolapse.( , , , ) 
The flow rate appeared to be the lowest in women with detrusor overactivity 
which suggests that some degree o f obstruction during voiding may play a 
role in detrusor overactivity.(20) Furthermore women with improvement of  
OAB symptoms after POP surgery also showed improvement o f flow rates 
in contrast to women without improvement in OAB whose flow rates stayed 
the same(32) However other authors could not find an increased prevalence of 
detrusor overactivity with more severe cystocele.(33,34) Predictors for urge 
incontinence resolution after POP surgery are DO and bladder 
trabeculation.(35) Bladder trabeculation is significantly more common in 
patients with bladder outlet obstruction and a higher degree o f prolapse.(36) 
Figure 3 illustrates the theories by which bladder outlet obstruction induces 
DO and OAB symptoms.
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Figure 3 Theories bladder obstruction in relation to detrusor overactivity
In the first theory the main idea is denervation of the obstructed bladder .
In human as well as in animal studies this denervation o f the autonomic 
nerve supply to the detrusor muscle is demonstrated in obstructed 
bladders.(37-40) The reaction to the main neurotransmitter for the bladder, 
acetylcholine, was supersensitised and reduced nerve mediated responses 
were found compared to the normal stable bladder.(41-43) These studies 
suggest that there is a supersensitivity to neurotransmitters secondary to 
partial denervation o f the obstructed bladder. Ischaemia and hypoxia o f the 
bladder wall caused by bladder distension and contraction might play an 
important role in this partial denervation in an obstructed bladder.(44)
A second theory regarding the pathophysiological processes which cause 
OAB after obstruction focuses on the detrusor muscle. In animal studies it 
was found that the number of contractile muscle units after nerve 
stimulation was reduced following obstruction.(45) There is a decrease in the 
cell to cell propagation o f the electrical activity.(46) Alternatively there is a
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greater instability of the membrane potential which might cause 
depolarisation o f the cell.(47,48) Therefore detrusor muscle in obstructed 
bladder is more irritable while synchronous activation is damaged.(48)
The last theory recognises changes in the spinal micturition reflexes after 
outlet obstruction.
In animal models it was found that obstruction leads to hypertrophy of the 
afferent neurons and is accompanied by the expression of neural growth 
factor (NGF) in the bladder wall.(49) Obstructed rats exhibit significant more 
short latency spinal reflexes than controls while the long latency reflexes 
where similar.(50) This suggests that obstruction in rats is accompanied by 
some degree of neural plasticity resulting in a more prominent spinal reflex 
that could contribute to the development o f the unstable bladder. (51-53)
Other pathophysiological mechanisms o f OAB in women with prolapse
• By bladder distension the stretch receptors in the urethelium release 
various chemical factors such as ATP, Ach and P2X3.(54-56) This 
stimulus reaches the sensory neurons and myofibroblasts in the 
urothelial and suburothelial region which conducts these stimuli to 
the detrusor.(57-59). Stretching o f the bladder wall which is likely to 
happen in vaginal prolapse and this might trigger the stretch 
receptors with detrusor contractions as a result.
• A prominent cystocele can put traction on the urethra resulting in an 
open urethra with urine entering the urethra. This mechanism is 
known to cause detrusor contractions.(60)
Do OAB symptoms improve after treatment of POP?
In this section we describe the influence of conservative and surgical 
treatment o f POP on the presence o f OAB symptoms.
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110 Table 4 Prevalence of oab symptoms before and during treatment with pessary.
Author N1
follow up 
(months)
Number, stages 
and
compartment of 
women with 
POP
Outcome 
Instrument Parameter
Frequency of 
OAB 
symptoms pre 
pessary
Frequency of 
OAB 
symptoms with 
pessary
De novo 
symptoms
RR
(pre/with)
dem ons
(2004)
73 2
stage II (27%) 
stage III (58%) 
stage IV (15%)
interview,
clinical
examination
urge
incontinence
36% (26/73) 19.2% (14/73) 4.1%  (3/73) 1,5
Fernando
(2006)
97 4
symptomtic 
pelvic organ 
prolapse
Sheffield
POP
symptom
questionnaire,
clinical
examination
urge
incontinence
83.5% (81/97) 54,6% (53/97) 0% 1,5
urgency 92.8% (90/97) 53.6% (52/97) 0% 1,7
Hanson
(2008)
661 3 54%) symptomatic 
POP
history,
clinical
examination
urge
incontinence
9.0% (59/661) 3.5% (23/661) n.a. 2,6
n.a. not available ^ Successfully fitted
Results o f  pessary treatment on symptoms o f OAB.
Table 4 shows the OAB symptoms before and during pessary treatment for 
patients with POP. We found in total three studies which met the criteria of 
available and analysable data.(61-63) The population (n) shows the number of 
patients with successfully fitted pessaries. The follow up of all studies is 
two-four months. The studies used interviews, questionnaires, history and 
clinical examinations. All studies used urge incontinence as the outcome 
measurement, one study also looked at urgency. All RR are greater than 1.5 
indicating that in all studies there is an improvement of OAB symptoms after 
pessary treatment. A significant improvement of OAB symptoms was also 
found in another study with women with symptomatic prolapse and pessary 
treatment (no analysable data and therefore not included in the table).(64)
Physiotherapy
We found no studies where the patients were treated with physiotherapy for 
pelvic organ prolapse which gave relevant data on OAB symptoms.
Can symptoms of OAB successfully be treated in cases of POP?
Only one study regarding this question could be identified (Table 5).(65) Most 
patients had a stage one prolapse and 51 patients had a stage > two prolapse. 
The follow up was three months and the outcome was measured by a non­
validated questionnaire and clinical examination. All patients had OAB 
symptoms and proven DO. After treatment 14.1% of the patients with stage 
one and 39.2% of the patients with stage > two still had OAB symptoms.
This study found an improvement of the overactive bladder in patients with a 
prolapse (RR 2.55), but the improvement in women without prolapse was 
much better (RR 7.09).
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112 Table 5 Prevalence of oab symptoms before and during treatment with to Iter odine in women with and without POP
Author N
Follow up 
(months) POP stage
Outcome 
Instrument Parameter
Frequency of 
OAB symptoms 
pre to Itero dine
Frequency of 
OAB symptoms 
post to Ite rodine
Denovo RR(pre/post)
Salvatore
(2007)
235 3
stage 1 184 questionnaire, 
clinical 
examination, 
uro dynamic 
evaluation
OAB and 
proven DO1
100% (184/184) 14.1% (26/184) n.a. 7,09
stage >= II 51 100% (51/51) 39.2% (20/51) n.a. 2,55
n.a. not available ^ M ethods, définitions and units conformed to the standards recommended b y  the International Continence Society.
Table 6 Prevalence of OAB symptoms before and after POP surgery without conconunittant incontinence surgery.
Author it
Type of 
surgery
Follow up 
months %
Stages and 
compartments 
of women 
with POP
Outcome 
Instrument Parameter
Frequency of 
OAB 
symptoms 
pre operative
Frequency 
o f OAB 
symptoms 
post 
operative
Denovo
RR
(pre/post)
Stan ton  t66) 44
anterior 
c olp o irhaphy 
and vaginal 
hysterectom y
24 54.5%
cystocele : 6; 
cystourethoroc 
ele: 28; cervix 
or vault 
descent :15; 
enterocele: 1
history,
clinical
exam ination
urgency 2 0.5% (9/44) 12.5% (3/24) n.a. 1,6
urge
incontinence
27.3% (12/44) 4.2% (1/24) n.a. 6,5
frequency 15.9%  (7/44) 0% (0/24) n.a. CQ
Jorgensen i67 16
kelly anterior 
c olp o irhaphy 
with part 
posterior 
c olp o irhaphy 
and/or 
M anchester 
repair
37 100%
anterior and/or 
posterior 
prolapse
h isto iy
urge
incontinence
87,5% (14 /16) 63% (1 0 /1 9 n.a. 1,4
Chaikin <6S) 10
antenor 
c olp orrhaphy
47 100%
all grade III or 
IV
history, 
voiding 
diary, pad  
te s t
urge
incontinence
40% (4/10) 20% (2/10) n.a. 2,0
N g u y en (y ) 38
uterine and/or 
vaginal vault 
prolapse
100%
grade II 34.2% 
grade III 
55.3% grade 
IV 10,5%
voiding 
diary and 
detailed 
histo ry
urge
incontinence
100% (38/38)
36.3% 
(14/385
n.a. 2,7
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Webei<®> 82
anterior
colporrhaphy
23 99%
stage I 7 
stage II 41 
stage III 51 
stage IV 2
questionnair 
es, clinical 
exam ination
uigency 52% (43/S 2) 28% (23/81)
12%
(10/81)
9% (7/81)
1,3
urge
incontinence
40% (33/82) 17% (14/81) 1,5
Sivasliioglu
(70) 30
infracoccygeal
sacropexy
16 100%
vault prolapse 
grade II: 5, 
grade III: 12; 
grade IV :3;
uterine 
prolapse 10
interview
urgency 53.3% (16/30) 13.3% (4/30T) n.a. 4,0
no cturia 46.7% (14/30) 6.7% (2/30) n.a. 7,0
Farnsw orth
(71) 59
cystocele 
repair w ith 
m esh
18.4 98.3% grade >=2
validated 
questionnair 
es, history
urgency 41% (24!59) 15.5% (9/58) n.a. 2,6
Farnsw orth
(72) 24
posterior repair 
with mesh, 
concom ittant 
anterior repair
19,4 95.8% prolapse
symptoms
validated
questionnair
es
urgency 62.5% (15/24) 21.7% (5/23) n.a. 2,9
M ilani 32
anterior and 
posterior m esh
17 100% all stage II-IV
KingJ s he alth 
questionnair 
e
urge
incontinence
16% (5/32) 16% (5/32) n.a. 1,0
urgency 50% (16/32) 40% (13/32) n.a. 1,3
Salvatore
64
anterior repair
10.7
100%
stage II 34 
stage III 21 
stage IV 9
uro dynamic 
tes t
urgency 92.2% (59/64)
31.3% 
(20/64)
n.a. 2,9
urge 
inc ontinenc e
81.3% (52/64)
21.9% 
(14/64)
n.a. 3,7
29 13.9
stage II 16 
stage III 12 
stage IV 1
interview
urgency 100% (29/29)) 31% (9/29) n.a. 3,2
urge
incontinence
62.1% (18/29) 13.8% (4/29) n.a. 4,5
Salvatore (7i 15
anterior repair 
and m esh
IS 93% stage >= II
questionnair
es
urgency 40% (6/15) 28% (4/14) n.a. 1,4
urge
incontinence
33% (5/15) 20% (3/14) n.a. 1,6
Brubaker t7S) 165
sacrocolpopex 
y  (wom en with 
concom ittant 
Burch 
colposuspensio 
n  excluded)
3 94.4%
100%
stage II 15.2% 
stage III 67.9% 
stage IV 17.0%
PFDI
questionnair
e
urge
incontinence
28.1%
(45/160)
11.9% 
(18/151)
n.a. 2,4
urge
symptoms
90.6%
(145/160)
80.9% 
(123/152)
n.a. 1,1
D igesu <77) 93
fascial anterior 
repair (  77pt 
also 
concom m itant 
vaginal 
hysterectom y 
and/or 
posterior 
repair)
12 >= stage II
voiding
diary
urge
incontinence
62.3% (58/93)
17.2%
16/93)
n.a. 3,7
urgency 100% (93/93) 30.1 (28/93) n.a. 3,3
frequency 100% (93/93) 41% (38/93) n.a. 2,4
Natale i78) 27
trans vaginal 
m esh repair
9 100% grade>II histo iy
urge
incontinence
44.4% (12/27) 14.8% (4/27) n.a. 3,0
urgency 48.1% (13/27) 18.5% (5/27) n.a. 2,6
fre quency 33.3% (9/27) 18.5% (5/27) n.a. 1,8
nocturia 14.8% (4/27) 11.1% (3/27) n.a. 1,3
B a su l32) 49 anterior repair 2,5 100% grade II or 
more
histo iy overactive
bladder
100% (49/49) 46.7%
(23/49)
n.a. 2,1
116 anterior histoiy, urgency 37,2% (19/51) 5.8% (3/51) n. a. 6,4
L iM a rs i!75) 51 transvaginal 
repair w ith 
mesh
17,7 100% stage >= II uro dynamic 
test, voiding 
diary
uge
incontinence
62.7% (32/51) 17.6% (9/51) n. a. 3,6
Miedel<8°> 111 anterior rep air 12 100%
symptomatic
cystocele
questionnait
e
urge
incontinence
27.9%
(31/111)
1S.0%
(20/111)
21.6%
(24/111) 1,6
urgency
55.9% 
(152/272)
33.8%
(92/272)
n. a. 1,7
Natale ¡01> 272
suspension 
vaginal apex 60 100% stage>=II h isto iy
frequency
46.7%
(127/272)
22.1%
(60/272)
n. a. 2,1
b y  h igh  levator 
m yorrhaphy
no cturia
45.6% 
(124/272)
34.6%
(94/272)
n. a. 1,3
urge
incontinence
44.5%
(121/272)
30.9% 
(S 4/2 72)
n. a. 1,4
anterior urgency 24.7% (21/S 5) 2.4% (2/85) n. a. 10,3
Sivasliioglu
(82f3) 85
polypropylene 
m esh or site 
specific 
cystocele 
repair
12 100% stage>=2
histoiy, 
uro dynamic 
tests, frequency 24.7% (21/S 5) 7.1% (6/S5) n. a. 3,5
n.a. not available; PFDI: Pelvic Floor Distress Inventoiy;UDI: Urinaiy Distress Inventoiy
The difference might be explained partly because OAB complaints are 
induced by the prolapse and still exist after drug therapy.
In contrast a recent study (no analysable data and therefore not included in 
the table) found that a greater anterior vaginal wall prolapse (point Aa) was 
associated with successful discontinuation o f tolterodine treatment (OR 1.33; 
95% CI (1.03; 1.7). The authors hypothesised that a more advanced prolapse 
results in less chance o f urine entering the urethra due to kinking.(84)
Results o f  prolapse surgery on OAB symptoms
Table 6 shows the studies related to OAB symptoms before and after pelvic 
organ prolapse surgery. As mentioned earlier only cases without 
concomitant SUI surgery were included. In total we included 12 
studies(32,35,66-68,70,73,76,80,85-88)and six ICS abstracts.(71J2,74,75 J9,89) The follow up 
varied between 2.5 and 60 months and was above 90% in most studies. One 
study considered the outcome on the overall OAB syndrome, whereas the 
rest focused only on one or more symptoms. “de novo” OAB symptoms 
were also considered. For computing RR we divided the frequency of OAB 
symptoms preoperative by the total postoperative symptoms (including also 
“de novo”). Only one study showed a RR of 1.0, all other RR are higher 
indicating that in practically all studies there is an improvement o f OAB 
symptoms after surgery for POP. The same results were found in a recent 
study (no analysable data and therefore not included in the table) where 
anterior and posterior repair gave a significant improvement in urgency and 
frequency and anterior repair also gave an improvement in urge 
incontinence.(90)
Detrusor overactivity
In the following part we describe the relation between the urodynamic 
diagnosis o f detrusor overactivity (DO) and POP. As mentioned before not 
all studies used the same definition for detrusor overactivity.
117
Detrusor overactivity and prolapse
We found no community based studies o f detrusor overactivity with pelvic 
organ prolapse. Table 7 shows the prevalence o f detrusor overactivity with 
prolapse in the hospital based studies. In total 11 studies were identified.1-16,18 
23,30,76,91,92) Only three studies included patients without POP(19,21,30), these 
studies where included in Table 7.
60,0%
50,0%
40,0%
30,0%
20 ,0%
1 0 ,0%
0 ,0%
□  F reque ncy of DO
Figure 2 Prevalence o f detrusor overactivity in women with POP
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Table 7 Prevalence of detrusor overactivity in relation to symptoms and signs of POP in hospital 
based studies.
Author n
Number , stages 
and
compartments of 
women with 
POP
Outcome
Frequency of 
DO in women 
with POP
Frequency of 
DO in women 
without POP
RR( POP/no 
POP)
C o a te s  P°> 655
no P O P  471 
s tage  III an d  stage 
IV  1S4
D e tru so r
in stab ility 4
25 .5%  (47/184) 15.7%  (74/471) 1,0
R om anzi
(19) 60
35 g rade  1 or 2 25 
g rade  3 or 4
D e tru so r
in stab ility 15
52%  (13/25) 20%  (7/35) 2,6
S ch im p f í21> 109
no p ro lap se  48 
stag e  2 15 
s tag e  3 33 
stag e  4 13
D e tru so r
o v e ra c tiv ity 1
28 .6%  (14/49) 11.4%  (5/44) 2,5
-1 Detrusor contraction in association with urgency and leakage ^M ethods, definitions and units conformed to the standards 
recommended b y  the International Continence Society;1 Not mentioned.
Table 8 Prevalence of detrusor overactivity before and after POP surgery without concomitant incontinence surgpry.
Follow up
Author N Type of surgery months °/o
Stages and 
compartments of 
women with 
POP
Outcome
Frequency oí 
DO 
pre operative
Frequency 
of DO post 
operative
De novo RR(pre/post)
Stanton 44
anterior 
colporrhaphy and 
vaginal 
hysterectomy
24 100%
44 patients 
continent: 
cystocele (6pt) 
cystourethorocele 
(2Spt) cervix or 
vault descent 
(15), entero cele 
(1)
Detrusor
instability11
11.4% (5/44) 2.3% (1/44) 2.3% (1/44) 2,5
Jorgensen
(67) 16
anterior 
colporrhaphy 
(IS), part 
posterior 
colporrhaphy of 
M anchester
37 81.3%
anterior and/or 
posterior prolapse
Detrusor
overactivity1 100% (16/16) 70% (9113) n. a. 1,4
Liang 47
vaginal 
hysterectomy, 
anterior and 
posterior 
colporrhaphy
12 100% stage III-IV
Detrusor
overactivityi 4.3% (2/47) 2.1% (1/47) 2.1% (1/47) 1
Digesu I93) 93
fascial anterior 
repair ( 77pt also 
concommitant 
surgey: vaginal 
hysterectomy 
and/or posterior 
repair)
12 100% >=stage II
Detrusor
overactivity1 91% (85/93)
57%
(53/93) n.a. U
Natale Is4 > 272 suspension 
vaginal apex
12 100% stage>=2 Detrusor
overactivity1
29.8%
(81/272)
19.1%
(52/272)
n.a. 1,6
Basu I32) 67
anterior, 
posterior, vaginal 
hysterectomy, 
vault suspension
30 59.7%
anterior wall 
prolapse grade II 
or above
Detrusor
overactivity^ 100% (67/67)
75%
(30/40) n.a. 1,3
n.a. not available1 Methods, definitions arid units conform the standards recommended b y  the International Continence Society.11 Definitions conform International 
Continence Society (1977)
1 Defined as a rise in intrinsic detrusor pressure o f > 15 cm H 20 during filling. “ Detrusor contraction in association with urgency and leakage1 Not mentioned
The outcome measure for all studies was DO, however two studies used the 
older term detrusor instability. Only one study used the ICS definition o f DO. 
All relative risks were greater than 1.6, indicating that the presence of a 
vaginal prolapse is a risk factor for finding signs o f DO.
Figure 2 shows the prevalence o f DO for all identified studies. Overall the 
prevalence o f DO and prolapse varied enormously between the studies (10­
50%).
Detrusor overactivity before and after prolapse surgery
Table 8 shows the studies o f patients with DO and POP before and after POP 
surgery. As mentioned earlier only cases without concomitant SUI surgery 
were included. In total we included seven studies.(31,32,66,67,73,95,96) One study 
was excluded because there was a strong bias at follow up: only cases with 
symptoms before operation where included for urodynamic studies after
operation(73).
The follow up is mentioned in months and was in all studies at least one year. 
Most studies used the ICS definition o f DO, some studies used the older term 
detrusor instability. “Denovo” are patients who acquired DO. For the 
calculation o f RR the preoperative percentage is divided by the total 
postoperative percentage (including ”denovo”). Most studies showed an 
improvement after pelvic organ surgery, except one study where surgery did 
not change the percentage o f DO. Overall the vast majority o f RR was larger 
than 1, indicating that there is a great likelihood of disappearance o f DO after 
surgery but the effect is not o f the same magnitude as for OAB symptoms 
before and after surgery.
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Discussion
In this study we searched for a relationship between OAB and POP.
This review is not a meta-analysis because we could not meet the requirement 
of having a standardised format allowing for comparison between several 
studies. The studies which we were able to include are not uniform in 
populations selected, criteria for OAB and POP nor outcome measures or 
follow up.
In community based studies and hospital based studies the prevalence o f OAB 
symptoms is greater in patients with POP than without POP. This gives good 
epidemiological evidence that OAB and POP co-exist. However by the 
nature o f these epidemiological studies a causal relationship can not be 
established. Treatment o f POP (surgery, pessaries) gives an improvement in 
OAB complaints as well as the signs o f DO which indicates that the 
relationship between the two syndromes is likely to be a causal one. However 
OAB and DO did not disappear in all cases. It is unclear what predicts 
whether the OAB symptoms disappear or not after surgery. One has to realise 
that, even after successful surgical correction of a prolapse, patients still have 
a “normal” risk o f having OAB symptoms which may be high due to the 
relative old age of this population.
We did not find good evidence that there is a correlation between the 
prolapsed compartment and the presence o f OAB symptoms. Intuitively one 
would consider a woman with a cystocele more at risk than a woman with a 
central or posterior compartment prolapse. However only very seldom is one 
compartment involved which makes studying this kind o f correlation difficult. 
Tolterodine treatment gives an improvement o f the OAB symptoms in women 
with prolapse, but this improvement was less than in women without a 
prolapse. No data for other antimuscarinics are available. Still antimuscarinic 
treatment might be a good start in women with POP and OAB if  she is 
predominantly bothered by OAB symptoms.
There are many possible theories regarding the pathophysiology o f OAB in 
relation to POP. It is likely that bladder obstruction plays an important role. 
However several other mechanisms might be considered. The
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pathophysiological relationship between OAB and POP needs to be studied 
further.
Strengths and limitations o f the study. This review is a large and extensive 
study in which we sometimes had to recalculate the original published data. 
For the effects o f surgery on OAB and DO we used only ‘clean’ data without 
concomitant SUI surgery, so we could investigate the real effect o f POP 
surgery on OAB without possible disturbance o f the results by surgery for 
SUI.
There appeared to be a wide variation in the definitions and criteria within the 
studies both with regard to elements o f the OAB syndrome and for the 
definition o f POP. Details about compartments and stages o f POP were 
seldom reported. Therefore it was impossible to perform a meta-analysis on 
these studies
In conclusion we found a strong co-existance o f both symptoms and signs of 
OAB and the presence o f POP. Careful examination in cases o f OAB is 
therefore essential. The pathophysiology o f the relationship is most likely 
through bladder outlet obstruction, but other factors might contribute. OAB 
symptoms and signs seem to disappear to a large extent after treatment which 
makes a causal relationship likely. However it is unclear which factors 
determine the persistence or disappearance o f these symptoms. The latter 
should be the focus o f further studies on this subject next to more detailed 
studies on the pathophysiology o f OAB in cases o f POP.
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Chapter 7
The prevalence and risk factors of 
overactive bladder symptoms and its 
relation to pelvic organ prolapse symptoms 
in a general female population
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Abstract
Objective: To study the prevalence and risk factors o f overactive bladder 
(OAB) symptoms and its relationship with symptoms o f pelvic organ prolapse 
(POP).
Methods: This is a cross-sectional study including women aged between 45­
85 years, registered in eight general practices. All women were asked to self 
complete the validated Dutch translated questionnaires. All symptoms were 
dichotomized as present or absent based on responses to each symptom and 
degree o f bother.
Results: 47% of the women filled out the questionnaire. Prevalence of 
urgency was 34% and the prevalence o f any OAB symptoms 49%. Prevalence 
of OAB symptoms increased with advancing age. Symptoms of POP were an 
independent risk factor for symptomatic OAB. Other risk factors were 
continence and prolapse surgery in the past, age above 75, overweight, 
postmenopausal status and smoking.
Conclusion: The prevalence o f any OAB symptoms was 49%. POP symptoms 
were an independent risk factor for symptomatic OAB.
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Introduction
Pelvic organ prolapse (POP) and overactive bladder (OAB) symptoms are 
important problems for women. POP is a prevalent problem which has been 
reported to affect 50% of parous women.(1) Eleven percent o f the women will 
have undergone an operation for prolapse or urinary incontinence by the age 
of 80.(2)
OAB is known to be a highly prevalent disorder that increases with age in 
both sexes and that has a profound impact on quality o f life.(3) According to 
the International Continence Society (ICS) OAB is defined as urgency with or 
without urge incontinence, usually with frequency and nocturia(4) This term 
can only be used if  there is no proven infection or “obvious pathology’’. It is 
a matter o f debate whether POP should be considered as “obvious pathology”. 
Symptoms o f OAB are often seen in patients with POP.(5) Community based 
studies showed that the prevalence o f OAB symptoms is higher in patients 
with POP than without POP.(5) The same tendency is found in hospital based 
studies.(5) Nevertheless the literature about the prevalence o f the combination 
of POP and OAB is scarce.To study the relation between POP and OAB, we 
used data from a cross sectional study which was performed in a small Dutch 
city about the prevalence of pelvic floor symptoms in the general 
population.(6)
The objective o f this study is to investigate risk factors for OAB and 
specifically to explore the relationship between OAB and prolapse. This is 
important for clinical practice because the two diagnoses are often co­
occurring which has possible consequences for diagnosis and treatment.
Methods
The study was cross-sectional in a small town, Brielle, in the Netherlands. 
Chosen is for Brielle as this is a homogenic population, where all women are 
registered in one o f the nine general practices. All women aged 45 to 85 years 
registered on the patients lists o f eight out o f nine general practices were 
invited to enrol in the study, which is 95% of the women in this age group. 
The women were sent information about the study and they could enrol by 
filling out an informed consent form. All the women who consented were
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asked to complete a self-report questionnaire. Non-responders recieved a 
reminder eight week later that contained the same questionnaire. To check for 
selection bias, permanent non-responders were invited to complete a short 
questionnaire that comprised five questions about age, parity, presence of 
stress urinary incontinence (yes/no), faecal incontinence (yes/no) and feeling 
of vaginal bulging (yes/no). To encourage a high response to the 
questionnaire, we used envelopes with the name and logo o f the Erasmus 
University, coloured paper and stamped addressed return envelopes.
Three options were possible: women refused to participate in the study, 
women filled out only the questionnaire and women filled out the 
questionnaire and underwent vaginal examination. For the purpose o f this 
study data on vaginal examination are not used. The relation between 
symptoms and signs o f vagina prolapse has been extensively described in an 
earlier study.(6) A flowchart o f the study design is presented in Figure l.In this 
study all women who answered the questionnaires are included.
The self-reported questionnaire used for this study are a composite of 
internationally well-known questionnaires that have been validated for the 
Dutch language. It contains, amongst others, disease-specific questions from 
the validated Dutch translation of the Urinary Distress Inventory(UDI)(7) next 
to other questionnaires and items which were not used for the present study.(6) 
Women rate the amount o f bother o f various symptom on a 5 point Likert 
scale, from 0 (no complaints at all) to 4 (very serious complaints). In addition 
questions were asked about ethnicity, parity, POP symptoms during 
pregnancy, family history, menopausal status, hormone replacement therapy 
(HRT), previous pelvic floor surgery, educational level, smoking and heavy 
physical work.
The Medical Ethics Research Committee (METC) of the Erasmus MC in 
Rotterdam, the Netherlands, approved this study.
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M easu rem en ts
For this study all symptoms were dichotomized as present or absent based on 
responses to each symptom and degree o f bother with these symptoms. 
Women who denied the presence of a specific symptom as well as women 
who answered confirmative on a specific question but answered not to be 
bothered by it were considered as negative (absent) while women who 
indicated that they were little to severe bothered were considered as positive 
(present). The item o f POP symptoms is merged from women who reported 
either seeing and/or feeling vaginal bulging. For the item any OAB symptoms 
women who had urgency and/or frequency and/or urge incontinence 
symptoms were included, see Figure 2.
Figure 2 Any OÂB symptoms in relation to urgency, frequency and urge 
incontinence.
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Data are presented as number of women (percentage), mean (standard 
deviation) or median (range) as appropriate. Chi-square test was used to 
compare the difference between the women with - versus without POP 
symptoms.
Logistic regression was used for the univariate and multivariate analysis. For 
logistic regression the backward elimination procedure was used. Variables 
with a P<0.3 in univariate analysis were included in the multivariate analysis. 
We presented the Odds Ratio and 95% CI for each of the OAB symptoms.
The level o f significance was set at alpha o f 0.05. All data were entered and 
analysed in a SPSS 15.0 database for Windows (SPSS, Inc., Chicago, IL).
Results
Of the 2979 women eligble for this study 1397 women filled out the 
questionnaire (47%). In the non-responder group 59% filled out and returned 
the short questionnaire (620/1051) giving a total response rate o f 62.7%. 
(Figure 1) Scores in the short questionnaire group where not significantly 
different from those in the total study group. Details o f the response rate are 
presented in a previous publication.(6)
Table 1 shows the characteristics o f the women included in this study. Table 2 
shows the prevalence of OAB symptoms per age category. In table 3 the 
prevalence o f POP symptoms in women with and without OAB symptoms is 
presented.
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Table 1 Patients characteristics , details of previous pelvic operations
Number o f women 1397
Age (years)a
45-55 647 (46.9%)
56-65 435 (31.5%)
66-75 233 (16.9%)
76-85 66 (4.8%)
Parity
0 120 (8.6%)
1 215 (15.4%)
2 675 (48.3%)
>=3 387 (27.7%)
Body Mass Index (kg/m2)b
<20 53 (3.9%)
20-25 599 (43.9%)
25-30 519 (38.0%)
>=30 193 (14.1%)
Race c
Caucasian 1351 (98.5%)
Non-Caucasian 20 (1.5%)
Smoking
Former smoking d 326 (23.6%)
Current smokingd 280 (20.3%)
Postmenopausal status 1009 (72.2%)
Hormone suppletione 88 (6.4%)
Previous gynaecological surgery
Prolapse surgeryh 103 (7.4%)
Hysterectomyi 234 (16.9%)
Incontinence surgeryJ 47 (3.4%)
Data are presented as number of women (percentage); a data on 16 women are missing; b data 
on 33 women are missing; c data on 26 women. are missing; d data on 15 women are 
missing; e data on 30 women. are missing; f data on 25 women are missing; g data on 18 
women. are missing; h data on 13 women are missing; 1 data on 14 women are missing; J 
data on 15 women are missing
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Table 2 Prevalence o f overactive bladder symptoms and any OAB symptoms 
per age groupa_______________________________________________________
Frequencyb Urgencyc Urge Any of the
incontinenced OAB
symptoms
45-55 162 (25.3%) 193 (30.9%) 178 (27.7%) 298 (46.1%)
56-65 121 (28.4%) 141 (33.7%) 116 (26.9%) 200 (46.2%)
66-75 80 (35.9%) 92 (40.5%) 79 (35.0%) 126 (54.5%)
76-85 24 (37.5%) 33 (54.1%) 32 (48.5%) 42 (63.6%)
Overall 393 (28.7%) 463 (34.4%) 411 (29.8%) 677 (48.6%)
Data are presented as number of women (percentage);a data on age category on 16 
women are missing; b data on frequency on 28 women are missing; c data on urgency 
on 52 women are missing; d data on urge incontinence on 16 women are missing
Table 3 Prevalence o f prolapse symptomse in women with symptoms of OAB
Prolapse No prolapse P
symptoms symptoms
Frequency a 66 (41.8%) 320 (26.9%) 0.000
Urgency b 77 (49.7%) 379 (32.4%) 0.000
Urge incontinencec 64 (40.3%) 340 (28.3%) 0.003
Any o f the OAB symptoms d 84 (69.4%) 588 (46.6%) 0.000
Data are presented as number of women (percentage); P = p value using Chi-square test 
to compare the difference between women with versus without prolapse symptoms; a 
data on 28 women are missing; b data on 52 women are missing; c data on 16 women are 
missing; d data on 4 women are missing; e data on prolapse symptoms on 24 women are 
missing
In table 4 the various possible risk factors including the presence o f POP 
symptoms for the presence of OAB symptoms are presented in a univariate 
logistic regression model.
The Odds Ratio (OR) shows the chance o f the presence of OAB symptoms.
An OR >1 indicates that the factor is positively correlated with the outcome 
variable; a OR<1 that the factor indicates a negative correlation.
Table 5 shows the multivariate analysis o f the OAB symptoms where all 
factors o f the univariate analysis with a p<0.3 are taken into account.
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Table 4 Factors o f the univariate logistic regression  analysis on the various O A B  symptoms
Age (years)1 
Parity
Body Mass Index (kg/m2)b
Smoking
Former smoking'
Current smoking 
Postmenopausal status
Frequency OR Urgency
Urge
incontinence Any OAB
(35% Cl) OR (95% Cl) OR (95% Cl) OR (95% Cl)
45-55 Ref Ref Ref Ref
56-65 1.2 (0.9;1.5) 1.1 (0.9;1.5) 1.0 (0.7;1.3) 1.0 (0.8;1.3j>
66-75 1.7 (1.2;2.3) 1.5 (1.1;2.1) 1.4 (l.O; 1.9) 1.4 (l.O; 1.9)
76-85 1.8 (1.0;3.0) 2.6 (1.5;4.5) 2.5 (1.5;4.1) 2.0 (1.2;3.5)
<=2 Ref Ref Ref Ref
>2 1.3 (1.0;1.7) 1.0 (0.8;1.3) 1.0 (0.8;1.3) 1.2 (0.9;1.5)
<20 0.7 (0.3;1.5) 0.4 (0.2;l.O) 0.7 (0.4;1.5^ 0.6 (0.3;1.0)
20-25 Ref Ref Ref Ref
25-30 1.6 (1.3;2.1) 1.3 (1.0;1.7) 1.5 (1.1; 1.9) 1.4 (1.1;1.7)
>=30 2.0 (1.4;2.S) 2.2 (1.6;3.1) 2.2 (1.6;3.1) 2.3 (1.7;3.2)
Yes 1.3 (l.O; 1.8) 1.2 (0.9;1.6) 1.0 (0.8;1.4) 1.1 (0.8;1.4)
No Ref Ref Ref Ref
Yes 1.0 (0.8;1.4) 1.3 (1.0;1.7) 1.3 (1.0;1.7) 1.2 (1.0;1.6)
No Ref Ref Ref Ref
Yes 1.5 (1.2;2.0) 1.6 (1.2;2.0) 1.4 (1.1; 1.8) 1.3 (1.0;1.7)
No Ref ref ref Ref
Hormonal suppletion therapy4 
Previous gynaecological surgery
Prolapse surgery*1
Hysterectomy11 
Incontinence surgery1 
Prolapse symptoms1
Yes 1.2 (0.7;1.9) 1.2 (0.7;1.8) 0.7 (0.4; 1.2) 0.9 (0.(5; 1.4)
No Ref Ref Ref Ref
Yes 2.5 (1.7;3.S) 2.6 (t.7;3.9) 1.9 (1.3 ;2.9) 2.9 (1.9;4.6)
No Ref Ref Ref Ref
Yes 1.5 (1.1;2.1) 1.3 (0.9;1.7) 1.3 (1.0;1.S) 1.3 (1.0; 1.7)
No Ref Ref Ref Ref
Yes 3.5 (1.9;6.5) 3.4 (1.9~,6.3) 4.3 (2.3;S.O) 6.5 (2.9,14.5)
No Ref Ref Ref Ref
Yes 2.0 (1.4;2.7) 2.1 (1.5;2.9) 1.7(1.2; 2.4) 2.6 (1.7;3.9)
No Ref Ref Ref Ref
All values with p< 0.05 are illustrated in bold; Ref: reference;1 data on 16 w om en are m issing ;0 data on. 33 w om en are m issing;
c data on 15 w om en are m issing ;d data on 13 w om en are m issing ;6 data o n 30 w om en are m is s in g /d a ta  o n 25 w om en are
m issing; 6 data on IS w om en are mis sing ;h in data 14 wom en are m issing;1 data on 24 w om en are missing.
Table 5 Risk factors on OAB symptoms after m ultivariate regression analysis
Age (years)1
Body Mass Index (kg/m2)b
Smoking
Smoking in the past*
Current smoking
Postmenopausal status 
Previous gynaecological surgery
Prolapse surgery*1
Urge
Frequency OR Urgency incontinence Any OAB
(95% Cl) OR (95% Cl) OR (95% Cl) OR (95% Cl)
45-55 Ref Ref Ref
56-65 1.0 (0.8;1.4) 0.9 (0.6;1.1) 0.9 (0.7;1.2)
66-75 1.4 (1.0;2.0) 1.3 (0.9;1.8) 1.3 (1.0;1.8)
76-85 2.7 (1.5;4.9) 2.2 (1.3;3.8) 2.1 (1.2;3.7)
<20 0.7 (0.3;1.6) 0.4 (0.2;0.9) 0.7 (0.3;1.5) 0.5 (0.3;1.0)
20-25 Ref Ref Ref Ref
25-30 1.5 (1.1;2.0) 1.2 (0.9;1.6) 1.3 (1.0;1.S) 1.3 (1.0;1.6)
>=30 1.7 (1.2;2.4) 2.2 (1.5;3.1) 2.0 (1.4;2.9) 2.2((1.5;3.1)
Yes 1.4 (1.1 ; 1.9)
No Ref
Yes 1.7 (1.2;2.3) 1.4 (1.0;1.8)
No Ref Ref
Yes 1.3 (1.0;1.S)
No Ref
Yes 2.3 (1.4;3.fi)
ri _ r
Prolapse symptoms*
Variance explained by the model1
Incontinence surgery4
Yes
No
Yes
No
2.9 (1.5;5.5) 
Ref 
2.4 (l.d;3.5) 
Ref 
5.8%
2.2 (1.4;3.3) 
Ref 
8 . 8%
4.3 (2.3;8.2) 
Ref 
1.8 ( 1. 2 ;2 .6) 
Ref 
6 . 6%
6.1 (2. S;16.3) 
Ref
2.3 (1.5;3.5) 
Ref 
9.1%
1 Nagelkerke R2 ; Ref: reference;1 data on 16 w om en are m issing ;1’ data o n 33 w om en are m issing ;c data on l i  w om en are 
m issing; d data on 13 w om en aie m issing ;6 data on IS w om en are mis sing ;f data on 24 w om en are missing.
Discussion
In this cross-sectional study we looked at the prevalence o f OAB symptoms and 
specifically the relationship between OAB symptoms and POP symptoms. We 
found a prevalence o f urgency, frequency and urge urinary incontinence of  
respectively 34%, 29% and 30%. The prevalence for any OAB symptoms was 
49% . This is comparable with other studies, where a prevalence o f 16.8%-49% 
was found in women (3,8) POP symptoms were present in 11.4% which is 
comparable with other studies where a prevalence o f 4-30% was found.(9-11)
Risk factors
This study found POP symptoms to be an independent risk factor for OAB 
symptoms. The sparse cross-sectional studies who mentioned a relationship 
between POP symptoms and OAB, showed a higher prevalence of OAB symptoms 
with POP symptoms than without POP symptoms!(5) but were not controlled for 
other risk factors. The same relationship between POP and OAB is found in 
hospital based studies, the prevalence o f OAB symptoms is greater in patients with 
POP than without POP.(5) However, by the nature o f these epidemiological studies 
a causal relationship can not be established. There are many possible theories 
regarding the pathophysiology o f OAB in relation to POP and it is likely that 
bladder obstruction plays an important role.(5) Nevertheless, several other 
mechanisms might be considered. The pathophysiological relationship between 
OAB and POP needs to be studied further. Important clinical implication of the 
relationship between POP and OAB is that treatment o f POP could give an 
improvement in OAB symptoms. This is consistent with the finding in a recent
review.(5)
Another important risk factor for OAB symptoms was surgery for urinary 
incontinence in the past. Many studies have shown a relationship between 
continence surgery and OAB symptoms where the prevalence o f denovo OAB 
varied between 15-29% on the short term (1-3 months postoperative)(12,13) and 0­
30% on the long term. (12-14)
As in other studies we found the prevalence o f OAB symptoms increased with 
advancing age.(3,8)
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Overweight (BMI greater then 30) was another independent risk factor for OAB 
symptoms. This is consistent with other studies, who found the same 
relationship.(15-19)} The study of Cheung found a similar OR for overweight (15), 
where the study o f Lawrence found a higher OR (2.73).(18) On the other hand, Choo 
found that BMI was only a predictor for OAB dry (urgency with or without 
frequency or nocturia), but not for OAB wet (urgency with urge incontinence, with 
or without frequency or nocturia).(16)
Another factor for achieving urgency was smoking. Other studies are not 
conclusive about the role of smoking in OAB.(17,20,21) The study o f Bradley found 
no relation between current smoking and urinary symptoms,(20) while a large cross­
sectional study showed that current and former smoking was associated with 
urgency.(21) One study found that current smokers were 1.44 time more likely to 
develop OAB, and the increased risk for former smokers was nearly significant.(17) 
The induction o f OAB in smoking could be related to an anti-oestrogenic hormonal 
effect on the bladder and uretra (22) and a nicotine induced phasic contraction of the 
detrusor muscle.(23).
Postmenopausal status was a risk factor for the symptom frequency in our study. 
This is consistent with another study who found postmenopausal status to be a 
predictor for OAB symptoms.(24) This can be explained because estrogen has an 
important role in the urogenital tract through estrogen receptors in urethra, bladder 
and pelvic floor,(25) where deficiency causes atrophic changes,(26) which is 
associated with OAB symptoms. Reversal o f the atrophy by estrogen treatment can 
have a positive influence on OAB symptoms.(27)
Surprisingly, we found previous prolapse surgery to be a predictor for the 
symptom urgency, this in contrast to practically all studies that showed an 
improvement o f OAB symptoms after prolapse surgery.(5) A possible explanation 
for this finding is that women after prolapse surgery achieved de novo urgency, as 
was found in one study in 5% o f the patients.(28)
Strengths and weaknesses.
Strong point about this study is that it was a large cross-sectional study in a 
homogenic female population which made multivariate analysis possible however
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genetic and racial factors could therefore not be included which is also a inherent 
weakness o f the design .
Another weakness o f this study is that not all factors of influence on OAB are 
included, such as food and beverages (coffee and alcoholic consumption) and the 
use o f OAB therapies (bladder training and pharmacotherapy).
Conclusion
In this study we found a prevalence o f urgency o f 34%, as the core symptom of the 
OAB spectrum, and o f any OAB symptoms of 49%. POP symptoms are an 
independent risk factor for OAB symptoms. Other risk factors are continence 
surgery in the past, age above 75, overweight and smoking.
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Chapter 8
Predictive factors for overactive bladder 
symptoms after pelvic organ prolapse surgery.
157
Abstract
Objective: This study focussed on the factors which predict the presence of  
symptoms of overactive bladder (OAB) after surgery for Pelvic Organ Prolapse 
(POP).
Methods: Consecutive women who underwent POP surgery with or without the use 
of vaginal mesh materials in the years 2004-2007 were included. Assessments were 
made preoperatively and at follow-up, including physical examination (POP-Q), 
and standardised questionnaires (IIQ, UDI and DDI).
Results: Five hundred and five (505) patients, were included with a median 
follow-up o f 12.7 (6-35) months. Bothersome OAB symptoms decreased after POP 
surgery. De novo bothersome OAB symptoms appeared in 5-6% of the women. 
Frequency and urgency were more likely to improve as compared with urge 
incontinence and nocturia. The best predictor for the absence o f postoperative 
symptoms was the absence o f preoperative bothersome OAB symptoms. 
Conclusion: The absence o f bothersome OAB symptoms preoperatively was the 
best predictor for the absence o f postoperative symptoms.
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Introduction
Pelvic organ prolapse (POP) is a prevalent problem which has been reported to 
affect 50% of parous women.(1) Eleven percent o f the women will have undergone 
an operation for prolapse or urinary incontinence by the age o f 80.(2)
Symptoms o f an overactive bladder (OAB) are often found in patients with POP. 
According to the International Continence Society (ICS) OAB is defined as 
urgency with or without urge incontinence, usually with frequency and nocturia.(3) 
This term can only be used if  there is no proven infection or “obvious 
pathology’’.(3) POP is in general not considered as “obvious pathology”. It is 
generally accepted that OAB is a highly prevalent disorder that increases with age 
in both sexes and that has a profound impact on quality o f life.
Community(4,5) based studies showed that the prevalence o f OAB symptoms is 
higher in patients with POP than without POP. Treatment o f POP (surgery, 
pessaries) results in an improvement o f the OAB symptoms.(6) It is not known 
which factors predict the persistence or disappearance o f OAB symptoms after 
POP surgery.
This study focussed on factors which predict the presence o f symptoms of 
overactive bladder after surgery for Pelvic Organ Prolapse.
Methods
The study group consist o f consecutive women who underwent pelvic organ 
prolapse surgery with or without mesh in the years 2004-2007 in two large 
hospitals in the Netherlands (Radboud University Nijmegen Medical Centre and 
Reinier de Graaf Group Delft). The mesh we used was the Prolift ® system. This 
was used in various combinations in the anterior compartment (53%), posterior 
compartment (65%) and central compartment(18%). All patients included 
completed questionnaires before surgery and at follow-up. The patient self-reported 
questionnaire is a composite o f internationally well-known questionnaires that have 
been validated for the Dutch language. It contains disease-specific questions from 
the validated Dutch translation o f the IIQ (7) and UDI(7) and the DDI.(8) Patients rate 
the amount o f bother o f each symptom on a 5 point Likert scale, from 0 (no 
complaints) to 4 (very serious complaints). Scores on various domains are
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composed (9) on the basis o f their Likert scale values on a scale ranging from 0 
(best quality o f life) and 100 (worst quality of life).
Preoperatively all women underwent a full gynaecological examination including 
the POP-Q quantification score(10) and were invited for a postoperative visit six 
months, one - and two years after operation in which the POP-Q was repeated and 
questionnaires filled out. The last available follow up in each patient was used in 
this study, and thus the minimum follow up was six months.
Patient characteristics and peri-operative complications were collected from the 
medical files.
Procedures were performed or supervised by senior (uro)gynaecologists 
Preoperatively none o f the women was on bladder training or used antimuscarinics. 
Postoperatively it appeared that a small number of women had utilised bladder 
training , usually advised by a general practicioner or physiotherapist in the period 
between operation and her control visit. None of the patients was on 
antimuscarinics at the time of follow-up. All data collected and analysed in the 
context o f a Quality o f Care project which was formally deemed exempt from 
CME / IRB approval.
Measurements
For this study the bother o f OAB symptoms were dichotomized in patients who 
were asymptomatic or with only little or no bother, versus those with symptoms 
and moderate to severe bother.
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Table 1 Patient characteristics, details of previous pelvic operations and
characteristics o f surgery in the study group
Number o f patients 505
Age (years)* 61 (32;93)
Parity* 2 (0;8)
Body Mass Index (kg/m2)* 26 (17;42)
Postmenopausal statusa 428 (88.1%)
Hormone replacement therapy3 32 (6.5%)
Previous urogynaecological surgery
Anterior compartment b 184 (36.4%)
Posterior compartment b 174 (34.4%)
Central compartment0 308 (64.0%)
Incontinence surgeryd 66 (16.0%)
Comorbidity
Central nervous system disease 43 (8.5%)
Cardiovascular disease 107 (21.2%)
Respiratory disease 36 (7.1%)
Gastrointestinal disease 47 (9.3%)
Endocrine disease 49 (9.7%)
Musculoskeletal disease 71 (14.1%)
Type of surgery
Anterior compartment 321 (63.6%)
Posterior compartment 398 (78.8%)
Central compartment 98 (19.4%)
Use o f vaginal mesh-material 253 (50.1%)
Stress incontinence surgery 21 (4.2%)
Data are presented as number of women (percentage) or * median (range);a note that data 
on 19 patients are missing; b note that data on 18 patients are missing; c note that data on 15 
patients are missing; d note that data on 21 patients are missing.
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Data are presented as number of women (percentage), mean (standard deviation) or 
median (range) as appropriate. McNemar test was used to compare the difference 
between the bother o f OAB symptoms before and after operation and the paired t- 
test was used to compare the difference in the domainscores. Logistic regression 
was used for univariate and multivariate analysis. For logistic regression the 
backward elimination procedure was used. Variables with a P<0.3 in univariate 
analysis were included in the multivariate analysis. Odds ratios (OR) and 95% 
confidence intervals (CI) for each of the OAB symptoms are presented. The level 
of significance was set at alpha of 0.05. All data were entered and analysed in a 
SPSS 15.0 database for Windows (SPSS, Inc., Chicago, IL).
Results
Table 1 shows the characteristics o f 505 women included in this study. The median 
duration of follow up was 12.7 (6-35) months. Only 21 patients underwent 
concomitant urinary stress incontinence surgery. Table 2 gives the overall and 
compartmental pre- and postoperative POP-Q stages showing a significant 
improvement for all compartments. In Table 3 the prevalence o f pre- and 
postoperative OAB symptoms is presented. De novo symptoms with moderate to 
severe bother are mentioned separately. For all symptoms there was a significant 
improvement after POP surgery.
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Table 2 Overall and compartmental POP-Q stages at baseline and at 
postoperative follow up_______________________________________
Overall
Anterior
Posterior
Central1
Stage Preoperative Postoperative2 P
0 0(0%) 42 (8.9%) 0.000
1 0 (0%) 195 (41.1%)
2 207 (41.0%) 215 (45.4%)
3 283 (56.0%) 18 (3.8%)
4 15 (3.0%) 4 (0.8%)
0 35 (6.9%) 171 (36.1%) 0.000
1 116 (23%) 139 (29.3%)
2 160 (31.7%) 148 (31.2%)
3 180 (35.6%) 12 (2.5%)
4 14 (2.8%) 4 (0.8%)
0 36 (7.1%) 250 (52.7%) 0.000
1 89 (17.6%) 144 (30.4%)
2 232 (45.9%) 69 (14.6%)
3 134 (26.5%) 7 (1.5%)
4 14 (2.8%) 4 (0.8%)
0 40 (8.2%) 130 (27.4%) 0.000
1 352 (72.6%) 320 (67.5%)
2 32 (6.6%) 14 (3.0%)
3 49 (10.1%) 6 (1.3%)
4 12 (2.5%) 4 (0.8%)
Data are presented as number of women (percentage) ; P = p value using McNemar 
comparing preoperative versus postoperative POP-Q in the anterior, posterior and 
central compartment; 1 note that in data 20 patients are missing preoperatively; 2 note that 
in data 31 patients are missing postoperatively.
Table 3 also shows the various UDI domainscores demonstrating an improvement 
in all domains including the domain o f OAB.
In Table 4 the various possible risk factors for the presence o f postoperative 
moderate to severe OAB symptoms, including the de novo symptoms, are
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presented in a univariate logistic regression model. The OR shows the chance of 
presence o f moderate to severe bother o f symptoms after operation. An OR >1 
indicates that the factor is positively correlated with the outcome variable; an 
OR<1 indicates that the factor has a negative correlation with postoperative OAB 
symptoms. Table 5 shows the multivariate analysis o f the OAB symptoms.
Discussion
The present paper reports on a study on OAB symptoms in relation with POP 
surgery and especially risk factors for the presence o f postoperative OAB 
symptoms. Overall an improvement o f OAB symptoms after POP surgery has been 
found, which is in line with the existing literature(11-20). Very few studies paid 
attention to de novo OAB symptoms. We specifically looked at de novo OAB 
symptoms and found, between the various symptoms, a surprisingly similar amount 
of 5-6%. We identified only one study on de novo symptoms and the authors 
detected a much higher percentage o f women with de novo OAB symptoms 
(21.6%).(15) This could be explained by the fact that in our study only women with 
moderate or severe bother o f OAB symptoms were included. In our view this is 
the more relevant outcome measure.
When comparing the various symptoms o f OAB it appeared that frequency and 
urgency showed more improvement (with an improvement o f 28%) as compared to 
urge incontinence and nocturia (12 and 14% respectively). As expected the 
improvement in OAB symptoms is also reflected in the improvement found in the 
UDI OAB domainscore .
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Table 3 Pne-and postoperative bother; denovo moderate to severe bother and UDI domainscores
Pre operative Postoperative
No symptoms or little M oderate to severe N o symptoms or !little
or no bother bother or no bother M oderate to severe bother P 1
De novo
Frequency 320 (63.4% ) 185 (36.6% ) 410 (81.2% ) 74 (14.6% ) 31 (6.1% ) 0.000
U rgency 323 (64.0% ) 182 (36.8% ) 415 (82.2% ) 65 (12.9% ) 25 (5.0% ) 0.000
Urge incontinence 398 (78.8% 107 (21.2% ) 447 (88.5% ) 31 (6.1% ) 27 (5.3% ) 0.000
Nocturia 368 (72.9% ) 137 (27.1% ) 421 (83.4% ) 56 (11.1% ) 28 (5.5% ) 0.000
UDI domainscores *
Pre operative
domains core Postoperative domainscore P2
Overactive bladder 33.0 (27.1) 20.8 (23.0) 0.000
Incontinence1 24.9 (26.6) 19.0 (22.2) 0.000
Obstructive micturition1. 28.4 (29.4) 15.3 (22.4) 0.000
Genital pro lap se1 51.4 (33.6) 6.0 (15.6) 0.000
Data are presented as number o f women (percentage) o r*  m eari(SD);1 p value using McNemar comparing the preoperativs versus postoperative bother o f 
OÂB symptoms;2 p  value using paired t-test comparing the preoperative versus postoperative UDÌ domamscores^note that data on 15 patients are missing;1, 
note that data on 13 patients aie missing;“ note that data on 27 patients are missing.
Table 4 Risk factors for moderate to severe bother on the various OAB symptoms in the univariate logistic regression analysis
Urge
Frequency Urgency incontinence Nocturia
O R (95%  Cl) OR ( 95% Cl) O R (95%  Cl) O R (95%  Cl)
Foliowup (months) 1.0 (0.91;1.0) 1.0 (0.9;1.0) 1.0 (0. 9;1.0)* 1.0 (1.0; 1.1)
Age (years) 1.0 (1.0;1.0) 1.0 (1.0;1.0) 1.0 (1.0;1.□) 1.0 (1.0;1.0)*
Parity <=2 ref. ref. ref. ref.
>2 0.9 (□.6;1. 5) 0 .7(0 . 5; 1.2)* 0.7 (0.4,1.2)* 1.1 (0.7; 1.7)
Body M ass Index (kg/m2) 1.1 (l.O; 1.1) 1.0 (1.0;1.1) 1.0 (1.0;1.1) 1.1 (1.0;1.1)*
Postm enopausal status1 Yes
No
1.0 (0. 5,2.0) 
ref.
1.4 (0.6,3.1) 
ref.
0.8 (0.4;1.8) 
ref.
1.3 (0.6;2.8) 
ref.
Previous urogynaecological surgery
Prolapse surgeiy1. Yes
No
1.0 (0.7;1.6) 
ref.
1.3 (0.S;2.0)* 
ref.
1.2 (0.7;2.1) 
ref.
1.4 (0.9;2.2)* 
ref.
Hysterectomy4 Yes
No
1.3 (0.8;2.1)* 
r e f
1.9 (1.1 ;3.2)
ref.
1.3 (0.7;2.4) 
ref.
0.9 (0.6;1.5) 
ref.
Incontinence surgeiy1 Yes
No
1.7 (0.96,3.1)* 
ref.
1.2 (0.7,2.3) 
ref.
2.1 (1. 1;4.2) 
ref.
1.4 (0.7,2.7)* 
ref.
Type of surgery
Anterior com partment Yes
No
0.7 (0.4;1.1)* 
ref.
0.5 (0.3;0.8)
ref.
0.6 (0.3;1.0)
ref.
0.9 (0.6;1.5) 
ref.
Posterior com partment Yes
No
0.9 (0.5; 1.(5) 
ref.
1.1 (0.6;1.9) 
ref.
1.0 (0.5;2.0) 
ref.
0.6 (0.4;1.0)* 
ref.
Central com partment Yes
No
0.5 (0.3;1.1)* 
ref.
0.7 (0.3; 1.2)* 
ref.
0.3 (O.l;0.8)
ref.
0.6 (0.3; 1.3)* 
ref.
Concomittant stress Yes 1.4 (0.5;3.82) 1.9 (0.7;5.1)* 1.9 (0.6,5.8)* 0.5 (0.1;2.3)
incontinence surgery No ref. ref. ref. ref.
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Mesh
T es
No
Preoperative POP-Q stage
Anterior 0/1
2
3 /4
Posterior 0/1
2
3 /4
Central 0/1
2
3 /4
Moderate to severe bother preoperative 
OAB symptoms
Frequency
Urgency
Urge incontinence 
Nocturia
Other pre operative micturition symptoms
Stress incontinence
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
0.9 (0.6;1.4) 0.6 (04,0.9) 1.2 (0.7;2.0) 0.9 (0.6;1.5)
ref. ref. ref. ref.
ref. ref. ref. ref.
0 7 (0 .4 ,1 .2 ) 0.5 (0.3;0.9) 0.7 (0.4; 1.4) 0.7 (0.4,1.3)
0.5 (0.3/J.9) 0.3 (0.2/J.5) 0.4 (0.2¡0.9) 0.7 (0.4,1.2)
ref. ref. ref. ref.
0.6 (0.36; 1.0) 0.8 (0.4,1.4) 0.6 (0.3,1.2) 0.6 (0.3,1.0)
1.1 (0.0,1.9) 1.5 (0.8,2.0) 1. 3 (0.6,2.54) 0.9 (0.5,1.5)
ref. ref. ref. ref.
0.4 (0.1,1.5) 1.0 (0.4,2.6) 0.2 (0.0;1.7) 0.7 (0.2,2.2)
1.1 (0.0,2.2) 0. 6 (0.3,1.3) 0.6 (0.2;1.7) 1.4 (0.7,2 7)
9.52 (5.6; 16.1) 6.4 (3.S;10.6) 4.6 (2.6;S.43) 3.7 (2.3;6.1)
ref. ref. ref. ref.
6.0 0 .7 ;9.S) 7.4 (4.4; 12.5) 3.9 (2.2;7.0) 2.5 (1.5;4.0)
ref. ref. ref. ref.
4.4(2.7; 715) 2.S (1.7;4.6) 5.5 (3.1;9.S) 2.4 (1.5;4.1)
ref. ref. ref. ref.
4.4 (2.7;7.0) 3.5 (2.2;5.6) 2.1 (1.2 ;3.7) S.45(50;14.0J
ref. ref. ref. ref.
7.9 (4.5; 14.0) 6.2 (3.5;11.0) 22.0 (11.5;42.3) 2.4 (1.3¡4.4)
ref. ref. ref. ref.
Urinary retention Yes 16.5 (8.9;30.S) (5.7; I S. 7) 10.2 (5.4; 19.1) 7.5 <4.2;13.5)
No ref. ref. ref. ref.
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Note: All values w ithp<0.05 are illustrated in bold-, * P<0.3 ;Tha factors withP<0.3 were included in the multivariate logistic regression analysis;1 note that data 
on 19 patients are missing,'1 note that data on 18 patients are missing,“ note that data on 15 patients are missing,1 note that data on 21 patients ate missing.
Table 5 Predictors for moderate to severe bother on the several QAB symptoms after multivariate analysis1_______
Urge
Frequency Urgency incontinence Nocturia
Followup (months) 0.9 (0.9; 1.0)*
Previous urogynaecological surgery
Hysterectomy1 Yes 2.3 (1.2;4.3)
No ref.
Type of surgery
Anterior Yes 0.5 (0.2;1.0)
No ref.
Mesh Yes 0.4 (0.2;0.S)
No ref.
Preoperative POP-Q stage
Anterior 0/1 ref. ref.
2 0.8 (0.4;1.5) 0.5 (0.3;1.0)
3 /4 0.4 (0.2;0.S) 0.3 (0.2;0.7)
Posterior 0/1 ref.
2 0.5 (0.2;0.9)
3 /4 0.9 (0.4;1.9)
Moderate to severe bother
pre operative
OAE symptoms
Frequency Yes 6.1 (3.3;11.3) 2.9 (1.4;5.9) 2.8 (1.3;6.1)
No ref. ref. ref.
Urgency Yes 4.1 (2.0;S.4)
No ref.
Urge incontinence 
Nocturia
Other pre operative 
micturition symptoms
Stress incontinence
Urinary retention
Variance explained by the 
model2
Yes 2.1 (1.11;3.7)
No ref.
Yes 1.8 (1.0;3.2)
No ref.
Yes
No
Yes
No
32.1%
4.1 (1.9;8.7) 
ref.
31.8%) 21.7%
2.4 (1.2;4.8) 
ref.
7.4 (4.2; 13.2) 
ref.
0.4 (0.2;0.8) 
ref.
2.0 (1.1;3.6) 
ref.
26.2%
1 All factors of the univariate analysis withP<0.3 are included in the multivariate logistic regression analysis;2 Nagiellserlse R1, ‘Not significant 
P>0.05;* note that dataon 15 patients are missing;'‘note that data on 21 patients are missing.
Predictive factors.
This is the first study on predictive factors for postoperative OAB symptoms. We 
have studied this in a uni- as well as a multivariate model. It appeared that patient 
characteristics such as age and BMI did not influence the risk o f bothersome OAB 
symptoms after POP surgery. Few studies have assessed the operated compartment
(11 13 15 17 18 21 23)in relation to the presence o f postoperative OAB ( -  , , , , - )and most could not 
demonstrate better results for surgery in the anterior compartment.(11,13,15,24,25)
Our study showed that urinary urge incontinence symptoms decreased more in case 
the anterior compartment was operated as compared to the other compartments. A 
limitation of this finding is that the vast majority o f women underwent surgery in 
more than one compartment.
The preoperative POP-Q stage was also assessed as a predictor o f postoperative 
OAB symptoms. In the multivariate analysis postoperative frequency and urgency 
appeared less common in women with higher preoperative POP-Q stages. Two 
previous studies showed heterogeneous results in this respect.(26,27)
It appeared that for different OAB symptoms different risk patterns emerge. For a 
symptom such as nocturia this is understandable. The presence o f nocturia may be 
more dependent on external factors such as poor sleep and nocturnal polyuria which 
are both unlikely to be influenced by the presence o f a vaginal prolapse, and 
probably more related to cardiac condition.(28)
However for the trias urgency, frequency and urge incontinence a more uniform 
pattern was expected. Apparently not all these symptoms are influenced by the 
presence o f a vaginal prolapse in a similar amount and by similar pathophysiology. 
The absence o f preoperative OAB symptoms was by far the best predictor for the 
absence o f postoperative OAB symptoms. In the univariate analysis this holds for 
all symptoms but in the multivariate model the absence o f frequency protects 
against the presence o f postoperative frequency, urgency and urge incontinence, the 
absence o f urgency protects only against urgency postoperatively and the absence 
of urge incontinence not only protects against postoperative urge incontinence but 
also against frequency and nocturia. The absence o f nocturia protected against 
postoperative frequency and nocturia, with an OR of more than 7. (as high as 7.4 
(95% CI 4.2;13.2).
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Interestingly, we have found that an operation with the use o f vaginal mesh material 
(Prolift®) had a favourable effect on urgency symptoms as compared to 
conventional surgery. Other studies have also shown this improvement o f the 
symptoms after mesh application, but overall the literature is inconclusive (18,29,30) 
Another interesting finding o f this study was that we have found that previous 
hysterectomy was a predictor for bothersome postoperative urgency. In the 
previous literature, we found that patients with vault prolapse after previous 
hysterectomy frequently report symptoms of urgency (79%), as well as other OAB 
symptoms (urge incontinence 63%, frequency and nocturia (42%).(31)
Pathophysiology o f  OAB in relation to POP.
In general OAB symptoms in relation with POP is still poorly understood. Possibly, 
bladder outlet obstruction is the dominant factor, but neurogenic factors have also 
been suggested.(11,32-37) Therefore if  the pathophysiology is not yet fully understood 
it can not be expected that the effect o f surgery, which can both induce and cure 
OAB symptoms, will be easy to understand.
Strengths and weaknesses.
Strengths o f this study is the large sample size which enables multivariate analysis 
and the assessment o f predictive factors for postoperative OAB symptoms. 
Furthermore, the median follow up was 13 months, which is considerable as 
compared to many other studies on POP surgery.
Weakness o f the study might be that the translation o f the results may not be 
applicable to a surgical naive population because the study has been performed in 
two tertiary referral centres with a high number o f complex and recurrent surgery. 
Our patient group is heterogenic with regards to history as well as surgeries 
performed. The vast majority o f women had undergone previous urogynecologic 
surgery and the majority o f women underwent surgery in more than one 
compartments which hampers interpretation of results per compartment. Since both 
participating centres are tertiary referral centres, the patients’ complaints in relation 
to the anatomic situation is sometimes difficult to understand and may sometimes 
even be the reason for referral.
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Conclusions.
Bothersome OAB symptoms decreased after POP surgery. Frequency and urgency 
were more likely to improve or disappear as compared to urinary urge incontinence 
and nocturia. De novo bothersome OAB symptoms appeared in 5-6% of women. 
The absence o f bothersome OAB symptoms preoperatively is the best predictor for 
the absence o f postoperative symptoms. Use of vaginal mesh material had a 
favourable effect on urgency symptoms.
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Chapter 9
General discussion
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Pelvic organ prolapse (POP) is a multidimensional disorder where anatomic defects 
and pelvic floor dysfunctions, such as urinary, anorectal and sexual symptoms have 
an enormous impact on the quality o f life o f women.(1) Therefore, the treatment of 
this disorder should be evaluated in multiple dimensions.(2)
One of the symptoms which is frequently (22.5-52.0%) found in women with POP 
is an overactive bladder (OAB). (chapters 7, 8 and 9) OAB is a disorder that is 
defined by the ICS as urgency, with or without urge incontinence, usually with 
frequency and nocturia.(3) This term can be used if there is no proven infection or 
obvious pathology.(3) It is a matter o f semantics whether POP should be considered 
as obvious pathology. There is however little information available on the relation 
between POP and OAB.
This thesis describes various aspects o f POP surgery with special emphasis on the 
question on the role of surgery in the treatment o f OAB symptoms. In this 
discussion we will focus on:
1. The prevalence and risk factors o f POP and/or urinary incontinence 
surgery;
2. The measurement o f results after surgery for POP;
3. The relationship between OAB symptoms and POP;
4. The outcomes o f OAB symptoms after POP surgery.
1. Prevalence o f prolapse/incontinence surgery
In this study (chapter 2) we found a prevalence o f POP and/or incontinence surgery 
that increased with advancing age, up to 20.3% by the age o f 76-85 years. This
percentage is significantly higher than the prevalence found in earlier studies that
were performed in the USA(4,5), but in line with a recent Australian study
(19.7%).(6) Elderly women have more pelvic floor problems(7) and the expectation
for the future is that life expectancy will increase in the Netherlands and other 
western countries.(8). As a consequence, it is plausible that the prevalence o f surgery
for POP will further rise. The expectation of an American study is that the number
of women with pelvic floor disorders or urinary incontinence will increase with
155% by the year 2050.(9)
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Many studies have focussed on the risk factors for POP(7,10,11) and our expectation 
was that these would have a large overlap with the risk factors for POP and/or 
incontinence surgery. We found that risk factors for POP and/or incontinence 
surgery were age, higher BMI, POP symptoms during pregnancy and previous 
hernia surgery (chapter 2). These risk factors explained 18.2% of POP and/or 
incontinence surgery in a statistical model (chapter 2). This means that other 
factors, still unknown, must play a significant role in the risk o f undergoing surgery. 
Since the risk factors we have found were rather unavoidable, the prevention of 
surgery is presently unrealistic in women. Given the increasing elderly population 
and their expectations o f life, we can expect that in the future POP and/or 
incontinence surgery will put a high claim on our health care system. We found that 
women with previous POP and/or incontience surgery (still) have significantly 
more pelvic floor complaints compared with women without previous surgery 
(chapter 2). This leads us to the conclusion that, despite our surgical efforts, we still 
have not found the optimal surgical method to solve the POP problems.
2. Measuring results after surgery for POP 
Traditionally the results o f surgery were assessed by studying the anatomical results 
only. In more recent years the functional results were considered more important. 
However, the rating o f the severity of complaints gives contradictory results 
between patient and physician.(12) We found that the physician was more positive 
about the results after surgery than the patients (chapter 3). Obviously, the patients 
rating should be considered as the gold standard. We have used validated 
questionnaires for measuring the functional results, which were filled out before 
and after surgery. An exception on this was the study about the results o f Pelvicol® 
(chapter 5) where only postoperative questionnaires were available.
Anatomic results
The POP-Q measurement to assess the anatomical result is the validated standard 
method for recording the results at vaginal examination. Only little interobserver 
and intraobserver variation has been described for the method.(13) For the POP-Q 
stage no significant differences have been found between measurement and
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estimation.(14) At present, most studies use the POP-Q staging(15), although the 
threshold for dichotomizing the POP-Q into success or failure is still arbitrary.
Some studies use POP-Q < stage 1, while others use a POP-Q < stage 2. Both have 
their pros and cons. In the normal population o f women without complaints of  
vaginal bulging, 39% of the women have a POP-Q stage 1.(16,17) Some women 
(35%) with symptoms of vaginal bulging, however, have a POP-Q staging o f <1. 
(16,17) Therefore it is difficult to establish criteria for anatomical success.
Very recently a new definition o f success after surgery for prolapse was supposed , 
which added functional results and the need for re-operation , and by introducing 
this new definition the success rate in a certain study increased from 30% to 
86%.(18)
In our studies we chose to define a good result as POP-Q< stage 1 and found an 
overall improvement o f the POP-Q in the operated compartment (chapters 4 and 5). 
In agreement with previous studies, we found that the anterior compartment is more 
susceptible to recurrence.(19,20) Remarkably, most recurrences appeared 
asymptomatic with regard to prolapse sensations.(chapters 4 and 5) This is in line 
with the finding that prolapse can also be found in the normal population without 
symptoms.(16,17)
Furthermore, 55% of recurrent prolapse was in the non-operated compartment 
(chapter 5); which may be considered as a de novo prolapse. De novo prolapse in 
the non-treated compartment has previously been recognized.(21,22) There are several 
possible explanations for de novo prolapse after surgery. First, there may be a 
diagnostic problem; during vaginal examination the most pronounced compartment 
was so prominent that the prolapse in other compartments remains unnoticed. 
Secondly, there may be an overestimation o f the quality o f the tissue o f other 
compartments, as this patient has a susceptibility to further prolapse. By restoring 
part o f the prolapse, there may be a change in the forces in the small pelvis with less 
counter pressure, resulting in prolapse in another compartment.
De novo prolapse deserves more attention, and research is needed into the role of 
the surgical techniques which are preventing or provoking this phenomena. 
However, as long as these de novo prolapses are asymptomatic, there is probably no 
need for further surgery.
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The purpose o f prolapse surgery should not be to achieve a POP-Q stage 0 or 1, but 
to cure the presenting symptoms and obtain normal bladder, bowel and sexual 
function without inducing new complaints such as pain.
Pelvic floor symptoms 
On the basis o f the validated questionnaires (IIQ, UDI, DDI)(23,24) and the PGI
(chapter 5) an evaluation on the effect o f surgery on symptoms of prolapse was
performed, as well as urinary and defaecatory symptoms and general quality of life.
These questionnaires include questions on the individual symptoms and the bother
of the symptoms.
The ideal measure o f outcomes for POP surgery has not been determined. It is 
standard to simply ask questions on the presence o f the symptoms. The bother of 
the symptoms is then not taken into consideration. This can give a biased view of 
the symptom as quite a number of women answer that they have symptoms, but 
they do not experience any bother from the symptom. To overcome this we 
calculated the domain scores on the basis of the questionnaires. Patients rate the 
amount o f bother o f each symptom on a 5 point Likert scale, from 0 (no complaints) 
to 4 (very serious complaints). Scores on various domains are composed (25) on the 
basis o f their Likert scale values on a scale ranging from 0 (best quality o f life) and 
100 (worst quality o f life). This method is validated to be used to evaluate the 
symptoms before and after surgery. (25) Whether this scale can be used to compare 
several populations has not been researched.
In this study we were especially interested in the micturition symptoms, but we also 
took the other symptoms into account.
After surgery we found an improvement o f the symptoms and the domain scores of 
all symptoms after surgery (chapter 4 and 8). These domain scores in women after 
surgery (chapter 4 and 8) were comparable to scores o f women who had undergone 
previous surgery in the general population.(chapter 2) However,the women without 
prolapse and / or incontinence surgery (chapter 2) had better domain scores than the 
domain scores we found after prolapse surgery. (chapters 2, 4 and 8)
Although we found an overall improvement in the pelvic organ symptoms after 
prolapse surgery (chapters 4 and 5), women after prolapse surgery have more
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symptoms than without surgery (chapter 2), this compels us to be cautious about the 
long term results.
The perfect measurement of the results after prolapse surgery does not seem to 
exist. Anatomical and functional results are both important. Ideally the 
measurement should take both aspects into account, but also the patient’s 
expectations as well as additional therapy after the intervention.
3. OAB symptoms and POP 
Many studies on OAB symptoms focus on factors that apply to both men and 
women.(26,27) Our research question was whether OAB symptoms were more 
prevalent in women with a prolapse, and if  yes, whether they resolve with 
treatment.
The review study as well as the cross-sectional study showed that OAB symptoms 
were more prevalent in women with POP than without POP (chapters 6 and 7). 
Furthermore, we found that POP is a risk factor for all OAB symptoms (chapter 7), 
in addition to the already known risk factors such as previous incontinence or 
prolapse surgery, age above 75, overweight, postmenopausal status and 
smoking.(26 28-36)
The pathophysiological mechanism that underlies this relationship between OAB 
and POP is still unclear and needs to be studied further. Bladder outlet obstruction 
might play an important role in this relationship.
We choose to study the separate OAB symptoms (urgency,frequency, urge 
incontinence) ,in stead of the formally defined OAB syndrome because the results 
can be easier compared to other studies. The fact that the risk factors for the various 
OAB symptoms differ (chapter 7), is consistent with the literature.(26,28-36) For 
example, smoking is a risk factor for urgency and postmenopausal status is a risk 
factor for frequency. To better understand these differences between the various 
OAB symptoms, the individual symptoms should be studied in more detail.
One of our hypotheses was that women with a prolapse in the anterior compartment 
had more OAB symptoms compared to women with a prolapse in the middle or
184
posterior compartment. However, in our review study as well as in the cross­
sectional study, we did not find evidence for this hypothesis. (chapters 6 and 7)
4. Treatment o f POP and the effect on OAB symptoms 
If there is a causal relationship between POP and OAB it is likely that OAB 
symptoms will improve after successful treatment o f POP. We studied this both in 
the literature as well in our own patients.
Both pessary treatment and POP surgery resulted in an improvement o f the OAB 
complaints (chapters 6 and 7). However, OAB did not disappear in all cases. Even 
after successful surgical correction of a prolapse, women still have a ‘normal’ risk 
of having OAB symptoms. In view of the relative high age o f this population, this 
risk is substantial.
The improvement was greatest after POP surgery for women with symptoms of 
urgency and/or frequency. Furthermore, we found that the various OAB symptoms 
had different predictors for improvement. This might imply that the individual 
symptoms respond differently to surgery.
We have found no relation between the compartment o f surgery and improvement 
of the OAB symptoms. (chapters 6 and 8). Nor did we find a relationship with the 
overall degree o f the prolapse (chapters 6 and 8).
We had expected that anterior compartment surgery would be strongly involved in 
OAB symptom improvement. The review study showed an improvement o f the 
OAB symptoms after surgery in the anterior compartment.(chapter 6) We 
confirmed this in our own data, but the improvement was equal for surgery in other 
compartments.(chapter 8)
Remarkable was the finding that a higher stage o f prolapse in the anterior 
compartment prior to surgery was a protector for urgency after surgery (chapter 8) 
and that surgery in the anterior compartment was a protector for urge incontinence 
after surgery .(chapter 8) On the basis o f these findings we can conclude that the 
anterior compartment plays a role in OAB, but details need further investigation. 
What was notable was our finding that POP surgery with mesh had a more 
favourable effect on postoperative urgency as compared to conventional 
surgery.(chapter 8) In the light of the increasing use o f synthetic meshes this is an
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important finding and should be studied in future studies. The most important 
predictor for post-operative OAB symptoms was that the patient already had 
preoperative OAB symptoms. This is an important finding for councelling women 
for POP surgery. As most o f these women with a prolapse are older, it is possible 
that age plays a role on the higher risk for OAB.(chapter 7)
Complaints o f de novo or persistent OAB are known to negatively influence the 
satisfaction with the procedure . This holds true even in patients with improved goal 
achievements when patient centred-goals were used.(37) Therefore, paying attention 
to and treatment o f OAB is very important to achieve patient satisfaction.
The fact that POP is a risk factor for OAB has clinical implications: vaginal 
examination for POP must always be part o f the standard management o f OAB both 
by the general practitioner, urogynecologist and urologist. In case o f concomitant 
POP the treatment for the OAB symptoms should focus on the combination of 
problems because the standard therapy for OAB symptoms might be less effective.
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Conclusions
• The prevalence o f POP/incontinence surgery increased with age, up till 
20.3% by the age o f 76-85 years.
• In a cross sectional study, women with previous surgery had more pelvic 
floor symptoms than women who had not umdergone surgery.
• After POP surgery there was an improvement o f POP, urinary and 
defecatory symptoms, which was shown in a decrease o f the domainscores 
of the questionnaires. The domainscores o f women after POP surgery one 
year after surgery remained higher, however, compared with women who 
have never undergone POP surgery.
• The physician was more optimistic about the outcome of the surgery than 
was justified by the answers on patient self-assessment questionnaires. 
Therefore validated self-assessment questionnaires should be used to 
evaluate surgical outcome.
• The anterior compartment was more susceptible to recurrence and de novo 
prolapse, although most o f these prolapses were asymptomatic.
• The modified manchester procedure with uterine preservation is an 
excellent option to treat the middle compartment in women who wish to 
preserve their uterus.
• Pelvicol® showed a low complication rate and satisfactory overall results.
• POP has been identified as a risk factor for OAB symptoms. This implies 
that vaginal examination should always be part o f the management of OAB 
in women.
• No relation was found between compartment o f POP or degree o f POP on 
the improvement o f OAB symptoms.
• In the general female population aged 45-85 the prevalence o f urgency was 
34% and of any OAB symptoms it was 49% .
• De novo bothersome OAB symptoms appeared in 5-6% of the women after 
POP surgery.
• Overall, OAB symptoms improved after POP surgery.
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• For different OAB symptoms different risk patterns emerge after POP 
surgery. However, the most important predictor for OAB symptoms after 
prolapse surgery were OAB symptoms before surgery.
Resulting from this thesis, we consider the following as possible topics for future 
research:
- Further investigation of the risk factors for POP/incontinence surgery in a 
less homogenic population .
- Further longitudinal and regularly repeated research on the prevalence of 
POP/incontinence surgery in the Netherlands .
- Further research on the real long term results o f women after POP surgery 
with follow-up of at least 5-10 years.
- Further research on de novo prolapse and need for reoperation with special 
attention to the role o f the surgical technique and the role o f the not 
operated compartment .
- Further study on the modified manchester with uterine perservation by a 
large prospective randomized controlled trial in comparison to the vaginal 
hysterectomy.
- Further study with convential surgery as compared with non-resorbable 
synthetic mesh .
- Further assessment o f the pathophysiological mechanism that underlies the 
relation between OAB and POP.
- Further investigation of the role of the anterior compartment on achieving 
OAB symptoms after single compartment surgery.
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Summary
Samenvatting
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Summary
In this thesis we have studied various aspects of prolapse surgery and investigated 
whether there was a relation between pelvic organ prolapse (POP) and overactive 
bladder (OAB) symptoms. We studied the results after prolapse surgery in a general 
hospital as well as in university hospital and further analysed the data of a cross 
sectional study in the Netherlands.
Chapter 1 is the general introduction on POP, OAB and the aims of the thesis.
In the study of Chapter 2 the prevalence and risk factors for previous POP and/or 
incontinence surgery have been studied. For this cross-sectional study, all women 
aged 45-85 years registered on patients lists of eight general practices, were invited 
to enrol in the study. They filled out standardised questionnaires (IIQ, UDI and 
DDI).
Of 2979 women, eligble for this study, 1380 women were included. Previous 
prolapse/incontinence surgery had been performed in 119 women. Prevalence of 
prolapse/incontinence surgery increases with age, with a prevalence of 20.3% in the 
age group 76-85 years. Associated symptoms such as urinary symptoms and vaginal 
bulging were more frequent in these women. The UDI and DDI scored higher in 
this group indicating more bothersome pelvic floor symptoms. Risk factors of 
prolaps/incontinence surgery were increasing age, postmenopausal status, POP 
symptoms during pregnancy and previous hernia surgery.
In Chapter 3, we have investigated whether there were discrepancies between the 
physician interview and a patients self-assessment questionnaire on the functional 
results after surgery for POP. In this study, 79 patients completed a 
urogynaecological questionnaire (UDI, DDI, IIQ and 2 questions from PGI). At the 
follow-up visit, the physician interviewed the patients with the use of a checklist 
with ten symptoms and scored the items as present or absent.
In the 72 patients (91.1%) who attended the follow-up visit and had completed the 
questionnaire, we found a poor to slight agreement between the interview score and
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the self-reported responses to the questionnaire on the vast majority of items. This 
was illustrated by low Kappa coefficients. The physician was in general more 
optimistic about the outcome of the operation than was justified according to the 
answers to a patient self-assessment questionnaire. The use of validated self­
assessment questionnaires is thus advised, because they provide a more realistic 
view on the functional results.
In Chapter 4 and 5 we studied the results of two different operation techniques. In 
Chapter 4 we evaluated cervical amputation with uterosacral ligament plication 
(Modified Manchester) and compared the results to vaginal hysterectomy with high 
uterosacral ligament plication procedure with special regard to the middle 
compartment. Consecutive women with POP who underwent either vaginal 
hysterectomy or a modified manchester procedure were included. Assessments 
were made preoperatively and at one year follow-up, including physical 
examination with POP-Q, standardised questionnaires (IIQ, UDI and DDI). 
Between 2002-2007, 156 patients, were included, of whom 98 patients returned at 
one year follow-up. There was no difference in the pre and postoperative subjective 
scores, but there was a lower preoperative POP-Q stage in the modified Manchester 
group. In the modified manchester group we found no middle compartment 
recurrence versus two recurrences (4%) in the vaginal hysterectomy group. 
Anatomical anterior and posterior compartment prolapse recurrences (stage>2) 
were similar (approximately 50%). The overall functional outcome was comparable 
to earlier studies. In conclusion an excellent performance of both procedures was 
found regarding middle compartment recurrences. Considering operating time and 
blood loss, modified manchester was more favourable.
Chapter 5 evaluated factors influencing POP recurrence after surgical repair with a 
porcine dermal collagen implant (Pelvicol®). Between December 2003 and August 
2005, 78 patients of whom the majority had POP-Q stage 3 underwent vaginal 
repair using porcine dermal implant. Assessments were made preoperatively, at 6 
weeks and at one year follow-up. These included physical examination with POP- 
Q, IIQ, UDI, DDI and questions from the PGI. Changes in functional status, mesh 
erosion and adverse events were recorded. Procedural success was defined as POP-
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Q stage 0 or 1. In total 71 patients (91%) returned for 1 year follow-up. The overall 
success rate was 74.6%. The chance of a successful operation in the younger age 
group (i.e. < 75 years) was significantly higher than in the older group (OR: 7.5; 
95%CI (1.38;40.69), but this effect was no longer statistically significant after 
adjusting for compartment (posterior, anterior, combination posterior and anterior) 
(adjusted OR: 5.5; 95%CI (0.92; 32.6). In conclusion, a low complication rate and 
satisfactory overall results were observed in a group of women after surgical POP 
repair with Pelvicol®. The difference in effectiveness as compared with 
conventional surgery or non resorbable mesh implantation has not been studied. 
There was a strong tendency towards better results in the younger women. We did 
not find an explanation for this phenomenon.
The goal of Chapter 6 to 8 was to study the relation between OAB and POP.
Chapter 6 was a review of the literature regarding the following questions:
How frequently are symptoms of OAB and is detrusor overactivity (DO) present in 
patients with POP and is there a difference from women without POP?
Does the presence of OAB symptoms depend on the prolapsed compartment and/or 
stage of the prolapse?
What is the possible pathophysiology of OAB in POP?
Do OAB symptoms and DO change after conservative or surgical treatment of 
POP?
For this study we searched on Medline and Embase for relevant studies. We only 
included studies in which actual data on OAB symptoms were available. All data 
for prolapse surgery were without the results of concomitant stress urinary 
incontinence (SUI) surgery.
Community and hospital based studies showed that the prevalence of OAB 
symptoms was greater in patients with POP than without POP. No evidence was 
found for a relationship between the compartment or stage of the prolapse and the 
presence of OAB symptoms. All treatments for POP (surgery, pessaries) resulted in 
an improvement in OAB symptoms. It is unclear which factors predict whether 
OAB symptoms disappear or not. When there is concomitant detrusor overactivity 
and POP, following POP surgery DO disappeared in the majority of the patients.
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Bladder outlet obstruction is likely to be the most important mechanism which 
induces OAB symptoms and DO signs in POP. However, several other mechanisms 
may also play a role.
In conclusion we found strong indications that there is a causal relationship between 
OAB and POP.
Chapter 7 had as objective to study the prevalence and risk factors of OAB 
symptoms and the relation with symptoms of POP in the general population .
In this cross-sectional study all women aged 45-85 years registered in eight general 
practices were invited to enrol. All women were asked to fill out validated Dutch 
translated questionnaires. All symptoms were dichotomized as present or absent 
based on responses to each symptom and degree of bother in which the symptom 
was considered as absent if only little or no bother was indicated and in all other 
cases as positive.
In total 47% of the women filled out the questionnaire. Urgency was present in 
34%, and the prevalence of any OAB symptom was 49%. The prevalence of OAB 
symptoms increased with advancing age. Symptoms of POP were an independent 
risk factor for symptomatic OAB. Other risk factors were incontinence and prolapse 
surgery in the past, age above 75 years, overweight (i.e. BMI >30), postmenopausal 
status and smoking.
Chapter 8 focussed on the factors which predict the presence of symptoms of OAB 
after surgery for POP. For this study consecutive women were included who 
underwent POP surgery with or without the use of vaginal mesh materials in the 
years 2004-2007. Assessments were made preoperatively and at follow-up, 
including physical examination (POP-Q), and standardised questionnaires (IIQ, 
UDI and DDI). In total 505 patients were included with a median follow-up of 12.7 
(6-35) months. Bothersome OAB symptoms decreased after POP surgery. De novo 
bothersome OAB symptoms appeared in 5-6% of the women. Frequency and 
urgency were more likely to improve as compared with urge incontinence and
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nocturia. The best predictor for the absence of postoperative symptoms was the 
absence of preoperative bothersome OAB symptoms.
Chapter 9 reviews the results in a broader sense with special attention to the 
relation between POP and OAB.
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Samenvatting
Verlies van steun van de baarmoeder, blaas, dikke darm of rectum kan leiden tot 
een verzakking (prolaps) van een of meer van deze organen in de vagina. De 
locatie van de prolaps kan beschreven worden als anterior, oftewel voorzijde, 
midden of posterior, oftewel achterzijde. Een prolaps kan zich bevinden in een of 
meerdere van bovengenoemde compartimenten en kan gepaard gaan met diverse 
klachten van urinewegen, ontlasting of sexualiteit. Prolaps wordt gevonden bij 
lichamelijk onderzoek bij 50% van de vrouwen, terwijl 4-12% van de vrouwen er 
daadwerkelijk klachten van ondervindt. Er zijn diverse behandelingsmogelijkheden, 
zoals bekkenfysiotherapie , diverse soorten pessaria en chirurgie. De chirurgische 
behandeling staat centraal in dit onderzoek.
Overactieve blaasklachten (OAB) zijn een andere veelvuldig voorkomende klacht 
bij vrouwen. Het is een syndroom waarbij verschillende symptomen een rol spelen. 
Frequency is het symptoom van frequent moeten plassen gedurende de dag. 
Urgency is het symptoom van overweldigende aandrang te voelen tot mictie die 
zodanig sterk is dat de angst bestaat urine te verliezen. Urge incontinentie is het 
symptoom waarbij veelvuldig urine wordt verloren, welk gepaard gaat met het 
gevoel van aandrang. Nycturie is de klacht dat de patiënt ’s nachts een of meerdere 
malen wakker wordt om te plassen.
In dit proefschrift hebben we diverse aspecten van overactieve blaas en prolaps en 
prolaps chirurgie onderzocht daarbij kijkend of er een relatie bestaat tussen een 
prolaps en overactieve blaas symptomen. De data die hiervoor geanalyseerd zijn, 
zijn afkomstig uit onderzoeken uitgevoerd in algemene ziekenhuizen, 
universiteitsziekenhuizen en een cross-sectionele studie in Nederland.
In Hoofdstuk 2 werd het voorkomen van prolaps (de prevalentie) onderzocht en 
risico factoren voor prolaps en/of incontinentie chirurgie. Voor deze cross- 
sectionele studie zijn alle vrouwen tussen de 45-85 jaar die waren ingeschreven bij 
8 huisartspraktijken in Brielle uitgenodigd om deel te nemen aan deze studie. Zij 
hebben hiervoor gestandaardiseerde vragenlijsten van de Werkgroep
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Bekkenbodem(WBB) van de Nederlandse Vereniging voor Obstetrie en 
Gynaecologie(NVOG) ingevuld. (IIQ, UDI en DDI). 2979 vrouwen waren 
beschikbaar voor de studie, waarvan er 1380 hebben deelgenomen. In totaal hadden 
119 vrouwen binnen deze groep in het verleden prolaps en/of incontinentie 
chirurgie ondergaan. De prevalentie van prolaps/ incontinentie chirurgie nam toe 
met de leeftijd, waarbij de prevalentie voor de leeftijdsgroep 76-85 jaar 20,3% was. 
Bekkenbodem symptomen, zoals mictie-, defaecatie- en verzakkingssymptomen, 
kwamen vaker voor bij vrouwen die eerder prolaps en/of incontinentie chirurgie 
hebben ondergaan. Verder was de score voor de UDI en DDI hoger in deze groep. 
Risico factoren voor eerdere prolaps en/of incontinentie chirurgie waren leeftijd, 
postmenopauzale status, prolaps tijdens de zwangerschap en eerdere hernia 
chirurgie.
In Hoofdstuk 3 werd onderzocht of er verschil was tussen de anamnese afgenomen 
door de arts en de vragenlijsten die door patiënten zelf zijn ingevuld over de 
aanwezige bekkenbodem symptomen na prolaps chirurgie. Voor deze studie werd 
voorafgaand aan de controle afspraak bij de dokter aan 79 vrouwen een 
urogynaecologische vragenlijst toegezonden en gevraagd deze vooraf in te vullen. 
Tijdens de controle afspraak heeft de arts aan de hand van een checklist met tien 
symptomen de anamnese afgenomen, waarbij aangegeven werd of de symptomen al 
dan niet aanwezig waren. Bij 72 patiënten die daadwerkelijk voor de controle 
afspraak kwamen (91.1%) en de vragenlijst volledig hadden ingevuld, werd een 
geringe afwijking gevonden op vrijwel alle onderdelen tussen de anamnese en de 
antwoorden op de vragenlijst. Dit werd bevestigd door een lage Kappa coëfficiënt. 
Geconcludeerd kon worden dat de artsin het algemeen optimistischer was ten 
aanzien van de operatie resultaten dan de patiënt zelf, blijkens de zelf ingevulde 
vragenlijst. Het gebruik van gevalideerde vragenlijsten die door de patiënt zelf 
worden ingevuld om de operatieresultaten te evalueren wordt dan ook aanbevolen, 
want ze leveren waarschijnlijk een meer realistisch beeld op van de functionele 
resultaten.
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In Hoofdstuk 4 en 5 werden de resultaten van een tweetal operatietechnieken 
bestudeerd. In Hoofdstuk 4 werd een gemodificeerde manchester procedure met 
sacrouteriene ligament plicatie vergeleken met de vaginale hysterectomie met een 
hoge sacrouteriene ligament plicatie, waarbij we specifiek hebben gekeken naar het 
middelste compartiment. Voor deze studie zijn vrouwen geincludeerd met een 
prolaps die een vaginale hysterectomie of een gemodificeerde manchester 
procedure ondergingen. De vrouwen zijn preoperatief en een jaar na operatie 
gecontroleerd waarbij vaginaal onderzoek plaatsvond met een POP-Q score en 
tevens zijn gestandaardiseerde vragenlijsten ingevuld. (IIQ, UDI en DDI). Tussen 
2002 en 2007 zijn in totaal 156 patienten in deze studie geincludeerd, waarvan 98 
patiënten voor controle na 1 jaar zijn teruggekomen. We vonden in de 
gemodificeerde manchester groep geen recidieven van het middelste compartiment, 
terwijl 2 patienten (4%) een recidief hadden na een vaginale hysterectomie. Het 
recidiefpercentage in het anterior en posterior compartiment (stadium 2 of groter) 
was tussen beide groepen vergelijkbaar.
De aangepaste manchester procedure had betere resultaten ten aanzien van 
operatieduur en bloedverlies. Er werd geen verschil gevonden in de pre- en 
postoperatieve functionele resultaten. Over het algemeen was de uitkomst ten 
aanzien van functionele symptomen vergelijkbaar met de resultaten van eerdere 
studies. Concluderend: we vonden uitstekende resultaten voor het middelste 
compartiment voor beide operatietechnieken.
In hoofdstuk 5 werden de factoren die van invloed zijn op recidief prolaps na 
chirurgie met varkenshuid collageen implantaat (Pelvicol®) geevalueerd. Tussen 
december 2003 en augustus 2005 zijn 78 patiënten met voornamelijk een stadium 3 
prolaps geopereerd met Pelvicol®. De patiënten zijn preoperatief, na 6 weken en 
één jaar na operatie gecontroleerd. Dit onderzoek bestond uit een vaginaal 
onderzoek met POP-Q bepaling en vragenlijsten. Verder werden data bijgehouden 
ten aanzien van de verandering in de functionele symptomen, erosie door 
implantaten en negatieve resultaten. Succes werd gedefinieerd als een POP-Q 
stadium 0 of 1. In totaal kwamen 71 patiënten voor controle na 1 jaar. 75% van de 
patiënt had een verbetering. De kans op succes na een operatie was significant 
hoger in de jongere groep dan in de oudere groep (OR:7.5;95%CI(1.38;40.69), maar
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na correctie voor het compartiment is dit effect kleiner en niet langer statistisch 
significant (posterior, anterior, posterior in combinatie met anterior) (adjusted OR: 
5.5; 95%CI (0.92; 32.6). Concluderend was er een laag complicatie percentage en 
over het algemeen een voldoende resultaat in een groep vrouwen na prolaps 
chirurgie met Pelvicol®. Of deze resultaten beter zijn of slechter dan na 
gebruikmaking van de traditionale operatietechnieken of bij het gebruik van niet 
resorbeerbare implantaten is onduidelijk, en kan alleen worden vastgesteld door een 
gerandomiseerd gecontroleerd onderzoek.
In de Hoofdstukken 6 tot en met 8 werd de relatie tussen een overactieve blaas en 
een prolaps onderzocht.
In Hoofdstuk 6 werd een review van de huidige literatuur verricht met als doel zicht 
te krijgen op de volgende vragen: Hoe vaak worden symptomen van een 
overactieve blaas en detrusor overactiviteit gevonden bij patiënten met een prolaps 
en is er een verschil met de vrouwen zonder een prolaps? Zijn de overactieve blaas 
symptomen afhankelijk van het compartiment of het stadium van de prolaps? Wat is 
het mogelijke pathofysiologisch mechanisme van overactieve blaasklachten bij 
prolaps? Veranderen overactieve blaas symptomen en detrusor overactiviteit na 
conservatieve of chirurgische behandeling van prolaps?
Voor deze studie hebben we op Medline en Embase gezocht naar relevante studies. 
We hebben alleen studies geincludeerd waarin data over overactieve blaas 
symptomen beschikbaar waren. Data van operaties met gelijktijdige stress 
incontinentie chirurgie werden geexcludeerd. Dwarsdoorsnede onderzoek in de 
bevolking en studies in ziekenhuizen lieten zien dat de prevalentie van overactieve 
blaas symptomen groter was bij vrouwen met een prolaps dan zonder een prolaps.
Er werd geen bewijs gevonden voor een relatie tussen het compartiment of stadium 
van de prolaps en de aanwezigheid van overactieve blaas symptomen.
Alle behandelingen voor bekkenbodem prolaps (chirurgie, pessaria) resulteerden in 
een verbetering van de overactieve blaas symptomen. Het blijft onduidelijk wat de 
voorspellers zijn voor het verdwijnen of het blijven van de overactieve 
blaassymptomen. Als er sprake was van detrusor overactiviteit in combinatie met 
een prolaps verdween bij een groot deel van de patiënten na prolaps chirurgie de 
detrusor overactiviteit.
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Blaasuitgangsobstructie is waarschijnlijk het belangrijkste mechanisme bij prolaps 
dat overactieve blaassymptomen en tekenen van detrusor overactitiviteit 
veroorzaakt. Mogelijk spelen verschillende andere mechanismen ook een rol. 
Concluderend: we vonden in de literatuur een sterke indicatie dat er een causaal 
verband bestaat tussen overactieve blaasklachten en prolaps.
In hoofdstuk 7 werden de prevalentie en risico factoren voor overactieve blaas 
symptomen en de relatie met prolaps symptomen bestudeerd.
In een dwarsdoorsnede onderzoek werden alle vrouwen tussen de 45-85 jaar die bij 
een van de 8 huisartspraktijken in Brielle waren ingeschreven uitgenodigd om deel 
te nemen aan de studie. Ze hebben allemaal gestandaardiseerde vragenlijsten 
beantwoord (IIQ, UDI en DDI). Alle symptomen werden voor deze studie 
gedichotomiseerd als aanwezig of afwezig op basis van de antwoorden op elk 
symptoom en de mate van last van een symptoom waarbij in het geval van weinig 
tot geen klachten het symptoom als afwezig werd geregistreerd en in alle andere 
gevallen als aanwezig.
Eenenvijftig procent van de vrouwen heeft de vragenlijst ingevuld. De prevalentie 
van urgency en ‘het hebben van minstens een van de overactieve blaassymptomen’ 
was respectievelijk 34% en 49%. De prevalentie van de overactieve 
blaassymptomen nam toe met de leeftijd. Prolaps symptomen waren een 
onafhankelijke risico factor voor symptomatische overactieve blaasklachten.
Andere risico factoren waren eerdere incontinentie chirurgie, leeftijd boven de 75 
jaar, overgewicht, eerdere prolaps chirurgie, postmenopauzale status en roken.
In Hoofdstuk 8 werden de voorspellende factoren voor overactieve blaasklachten na 
prolaps chirurgie onderzocht. Voor deze studie werden vrouwen geincludeerd die 
in de periode 2004 en 2007 waren geopereerd voor een prolaps met of zonder het 
gebruik van implantaten. De patiënten werden preoperatief en bij controle 
nagekeken middels vaginaal onderzoek (POP-Q) en gestandaardiseerde 
vragenlijsten (IIQ, UDI en DDI). In totaal werden 505 patiënten geincludeerd met 
een mediane follow up van 13(6-35) maanden. Hinderlijke overactieve 
blaassymptomen namen af na prolaps chirurgie. Nieuwe hinderlijke 
blaassymptomen deden zich voor bij 5-6% van de vrouwen. Frequency en urgency 
hadden meer kans te verbeteren in vergelijking tot urge incontinentie en nycturie.
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De afwezigheid van hinderlijke overactieve blaasklachten voor de operatie is de 
beste voorspeller voor de afwezigheid van postoperatieve symptomen.
In hoofdstuk 9 worden diverse aspecten van bekkenbodem chirurgie met speciale 
aandacht voor de overactieve blaasklachten in een bredere context bediscussieerd.
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Dankwoord
Het afstudeeronderzoek naar Pelvicol® en de daaruit voortkomende presentaties 
zijn het begin geweest voor dit promotieonderzoek en hebben er toe geleid dat 
onderzoek mij in haar greep heeft gekregen. Nu ik dit dankwoord schrijf om een 
ieder die een rol heeft gespeeld bij mijn promotie onderzoek te bedanken, weet ik al 
dat de liefde voor onderzoek hiermee niet aan zijn einde is gekomen.
Beste Mark,
Mijn baken voor al mijn artikelen ben jij. Toen ik in augustus 2007 bij je kwam en 
aangaf graag een promotie onderzoek te willen doen, kwam je meteen met een 5-tal 
onderwerpen op de proppen. Al snel hadden wij een begin gemaakt om de 
resultaten van het eerdere Pelvicol® onderzoek te verwerken tot artikelen. 
Aanvankelijk spraken we altijd af in Nijmegen, later ook in Rotterdam en 
uiteindelijk was ons contact vooral telefonisch, maar niet minder intensief. Je was 
een goed toehoorder bij het zoeken naar mijn weg binnen de medische wereld, 
waarin ik graag een combinatie wilde realiseren van onderzoek en patient contacten. 
Ondertussen wist je iemand die wel SPSS beheerste, maar schriftelijk minder 
ervaren was, te motiveren het schrijven gestructureerd aan te pakken. Mark, ik kon 
geen betere promotor hebben! Overigens de borrel naar aanleiding van de publicatie 
van ons eerste artikel, en de vele daarna, moet nog steeds een keer plaatsvinden.....
Beste Kirsten,
Wat kunnen lunches toch heerlijk (en) verhelderend zijn om tot een goede start te 
komen. Bij een tweetal artikelen hebben we reeds samen op de tandem gezeten, 
waarbij ik veel respect heb gekregen voor je wetenschappelijke inzicht, je inzet en 
je kennis van de Engelse taal. Kirsten, ik ben er zeker van dat wij samen nog vele 
publicaties tot stand gaan brengen!
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Beste Dirk,
Bij de eerste stapjes die ik maakte binnen geneeskundig onderzoek was jij 
betrokken. Menig uur hebben we doorgebracht op koude dagen in jouw keuken en 
in de zomer periode in jouw tuin. Vele koppen koffie zijn daarbij genuttigd en 
Liesbeth haar heerlijke pastamaaltijden en lunches zijn zeker niet te vergeten. Mijn 
kennis van SPSS en jouw onderzoekende geest hebben geleid tot een goed 
afstudeeronderzoek. Ook wist je mij nieuwsgierig te maken voor de voor mij toen 
nog onbekende wereld van de bekkenbodem. Nadat je tijdens mijn vakantie van 
januari 2007 tot mijn verrassing een abstract van ons onderzoek voor de IUGA had 
ingediend, hebben we in voorbereiding hierop wederom vele uren in je tuin 
doorgebracht. Dirk, mijn dank hiervoor!
Beste Marijke en Curt,
In het Briele onderzoek wordt voor de eerste maal in Nederland de prevalentie en 
risicofactoren van POP onderzocht. Ik was dan ook in mijn nopjes, toen ik de kans 
kreeg om op basis van jullie Brielle database een tweetal artikelen te schrijven. 
Marijke bedankt dat ik gebruik mocht maken van deze data en voor al je 
commentaar op onze gezamenlijke artikelen. Curt, bedankt voor je medewerking 
aan de twee ‘Brielse’artikelen.
Beste Marielle en Fred,
Naast jullie drukke werkzaamheden wisten jullie beiden toch altijd tijd vrij te 
maken om nog een kritische blik te werpen op onze gezamenlijke artikelen. Veel 
dank hiervoor.
Nu kom ik toe aan de groep mensen, die in elk promotie traject voorkomt, de 
verwaarloosde vrienden en familie. Ik weet dat ik jullie de afgelopen jaren minder 
heb gezien dan ik idealiter zou doen. Ik was in deze periode te vergelijken met 
iemand die aan het begin van een nieuwe verliefdheid staat: die vergeet wat om zich 
heen gebeurt. Natuurlijk is dit niet goed te praten, maar ja, jullie weten hoe het is als 
je aandacht heftig wordt getrokken, dan is het moeilijk het onderwerp los te laten!
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Beste Iris,
Reeds tijdens geneeskunde ondervond je dat ik minder bereikbaar was en je loste dit 
op door mij een mobiel te geven. Helaas kwam je er snel achter dat ik deze overal 
liet slingeren en wel in mijn buurt was stond deze vaak niet aan. Toch heb ik altijd 
genoten van de momenten dat we elkaar zagen, het was net of tijd niet bestond.
Vele uren hebben we ter ontspanning doorgebracht in diverse sauna’s, waarna ik 
weer vol frisse moed aan de slag ging. Op de promotiedag sta je naast mij als 
paranimf om deze periode goed af te sluiten. Ik hoop jou en je kinderen nu weer 
eens wat vaker te zien!
Beste Ellen,
Al jarenlang is ons voornaamste contact telefonisch. Toch niet minder belangrijk, jij 
die altijd een overmatig vertrouwen hebt in mijn kunnen. Ik kan je verklappen dat 
dit niet helemaal de realiteit is. Ik hoop dat we nog vaak bellen!
Beste Paul enYsor,
Jullie kennen elkaar niet toch noem ik jullie in een adem. De maaltijden, de 
gezellige avonden, de gezellige gesprekken over het leven van alledag, maar zeker 
ook als klankbord, zijn belangrijke waarden geweest in de afgelopen jaren.Dit gaan 
we continueren!
Paul, ik waardeer het bijzonder dat je mijn paranimf wil zijn, maar daar ‘zeur’ik 
verder niet over!
Beste Pim,
Wat jij deed, een promotieonderzoek, daarvan dacht ik dat kan ik ook. En het is me 
gelukt! Dus nu weer tijd om mijn oude patroon op te pakken en leuke dingen doen, 
waaronder veel films kijken en gezellig babbelen.
Verder wil ik mijn collega’s van de afgelopen jaren en met name Amani Aloraiby, 
bedanken voor de interesse en steun tijdens het onderzoek.
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Beste Heit en Mem,
Heit, het idee: ”Wil een meisje zelfstandig in de wereld kunnen staan dan zal zij 
haar best moet doen met leren”, ben ik nooit vergeten. Misschien heb ik het zelfs 
wel een beetje overdreven. Door meer tijd voor elkaar na het stoppen met jullie 
werkzame leven, was er de laatste jaren altijd een luisterend oor.
Mem, je bent er altijd voor mij. Op jonge leeftijd met kopjes thee en iets lekkers uit 
de bureaulade en later ook altijd telefonisch. Heit en Mem, ik hoop dat we nog lang 
van elkaar kunnen genieten!
Beste Willy en Sybolt,
Tijdens het schrijven van de artikelen wenste ik regelmatig Willy's taalgevoel en het 
denkvermogen van Sybolt. Vakanties waarin ik hernieuwde inspiratie en energie 
opdeed, waren voor mij dan ook belangrijk. Hoe vaak hebben jullie dit niet 
mogelijk gemaakt door op Poek te passen? Willy, zelfs als we al in het vliegtuig 
zaten, wist je zonodig nog voor oppas te zorgen. Sybolt, lange wandeling in de 
vrije natuur zorgden voor de beste gesprekken. We moeten gauw weer eens op pad. 
Willy en Sybolt, jullie blijven mij altijd weer verrassen!
Beste Mama Annemarie en Papa Klaas,
Als laatste aanwinst in de familie, steunden jullie mij op wezenlijke momenten. Zo 
was het bijvoorbeeld super dat jullie je huis 2 maanden voor mij openstelden, zodat 
ik mijn laatste co-schap goed (en verantwoord) kon afronden!
Last but not least... Alain, de rots in de branding: 16 jaar hebben wij al lief en leed 
gedeeld. Jij was altijd vol vertrouwen over mijn kunnen, ik iets minder over mijzelf. 
Als jij mij niet op 30 jarige leeftijd voor ogen had gehouden dat je nooit te oud bent 
om je droom te verwezelijken en mij niet hiervoor alle mogelijkheid had geboden 
dan had dit onderzoek nooit plaatsgevonden. In ons drukke bestaan, waarin we 
beiden hard werken maken we gelukkig ook tijd vrij voor heerlijke lange vakanties 
om samen weer helemaal tot rust te komen. Lieverd, bedankt voor je grenzeloze 
vertrouwen in mij, ik hoop van jou nog erg lang te mogen genieten!!
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Tiny Anna de Boer werd geboren op 18 september 1969 in Leeuwarden. Reeds op 
jonge leeftijd was het voor haar duidelijk dat ze graag binnen de medische wereld 
werkzaam wilde zijn. Na het voltooien van de middelbare school is zij na uitloting 
voor de studie geneeskunde, gestart met Economie aan de Rijksuniversiteit van 
Groningen, waarvan ze de propadeuse heeft gehaald. De wens om geneeskunde te 
studeren bleef, waarop ze in 1991 een jaar de in-service opleiding tot 
verpleegkundige heeft gevolgd. Na dit jaar is ze gestart met de hbo opleiding 
Vrijetijdskunde, aan de christelijke Hogeschool Noord Nederland, die ze in 1994 
met goed gevolg heeft afgerond. De arbeidsmarkt was op het moment van afronden 
zeer krap, waarop ze besloot, na een jaar diverse banen te hebben gedaan op 
uitzendbasis, te starten met Bedrijfswetenschappen aan de Katholieke Universiteit 
in Nijmegen. Deze studie heeft ze binnen 2 jaar in 1997 met goed gevolg afgerond. 
Hierna is ze enkele jaren werkzaam geweest bij Robeco Nederland, aanvankelijk als 
trainee automatisering en al snel als hoofd projectenbureau en later als hoofd van 
bedrijfsbureau van Rabo Beleggings Advies.
Geneeskunde bleef toch trekken en in 2001 heeft ze dan ook haar baan aan de 
wilgen gehangen en is alsnog gestart met haar studie Geneeskunde aan de 
Universiteit van Utrecht nadat ze via de decentrale selectie was aangenomen. Mei 
2007 is zij afgestudeerd en aansluitend gestart in het UMC St Radboud met haar 
promotieonderzoek naast haar werkzaamheden als zaalarts gynaecologie in 
ditzelfde ziekenhuis. In 2008 heeft ze de overstap gemaakt naar het Amphia 
Ziekenhuis in Breda, aanvankelijk als fertiliteitsarts later als arts-assistent interne 
geneeskunde om zich daarmee voor te bereiden op de huisartsopleiding. In 
september 2010 heeft ze hiermee een start gemaakt, waarmee een hartewens in 
vervulling is gegaan.
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